data_2meu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2meu _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.593 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 7.8 mt -52.39 -53.37 45.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.92 -37.82 3.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 16.9 mt -79.34 -39.6 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 49.1 mt -55.97 -36.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.72 -55.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 10' ' ' LEU . 18.4 mt -49.91 -48.14 51.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 35.3 t -59.03 -49.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.9 mt-10 -45.51 -47.49 14.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.41 -59.01 6.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.7 -29.56 53.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.729 HG12 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -63.88 -65.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.77 HD13 ' H ' ' A' ' 16' ' ' ILE . 1.0 OUTLIER -41.98 -44.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.52 78.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.657 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.5 mtp -66.81 -57.24 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' B' ' 119' ' ' GLU . 2.2 mm-40 -41.1 -48.55 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t80 -67.73 -31.17 70.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.636 ' CZ3' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.02 -39.85 72.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.636 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 24.3 mt -61.79 -60.28 3.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.486 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 5.7 mt -54.95 -52.94 61.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 28' ' ' LEU . 6.1 tt -55.71 -48.26 75.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 21' ' ' TRP . 2.4 t -58.6 -66.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.8 mt -54.14 -20.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 8.0 mt -79.32 -43.86 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 24' ' ' LEU . 9.1 mt -72.97 -49.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HD2' HG12 ' A' ' 25' ' ' VAL . 28.6 mtp85 -58.46 -47.7 83.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.47 -54.44 40.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 13.5 t -44.46 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -68.9 -36.01 77.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.581 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.592 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 7.7 mt -52.84 -53.07 53.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.88 -37.37 2.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.9 mt -80.01 -40.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.592 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 42.8 mt -55.77 -36.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.453 ' CG1' HD11 ' A' ' 8' ' ' ILE . 5.4 mt -75.75 -55.08 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 18.1 mt -49.83 -48.15 51.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 32.7 t -58.95 -49.72 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.9 mt-10 -45.35 -47.53 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.43 -58.84 6.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.472 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.75 -29.6 54.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.723 ' CG2' HG11 ' A' ' 15' ' ' VAL . 1.4 t -63.96 -66.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.771 HD13 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -41.92 -44.68 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.58 79.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.649 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.83 -57.22 7.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 2.2 mm-40 -41.23 -48.46 3.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 46.5 t80 -67.84 -31.02 70.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.623 ' CZ3' ' CD2' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.08 -40.01 71.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.623 ' CD2' ' CZ3' ' B' ' 121' ' ' TRP . 24.9 mt -61.73 -60.27 3.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.486 ' O ' ' CG1' ' B' ' 127' ' ' ILE . 5.7 mt -54.92 -52.96 61.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.425 HD21 HD13 ' B' ' 128' ' ' LEU . 6.1 tt -55.68 -48.32 75.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.501 HG23 ' CD1' ' B' ' 121' ' ' TRP . 2.4 t -58.53 -66.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.8 mt -54.15 -20.66 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 7.9 mt -79.38 -43.78 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.425 HD13 HD21 ' B' ' 124' ' ' LEU . 9.0 mt -73.11 -49.75 26.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.479 ' HD2' HG12 ' B' ' 125' ' ' VAL . 28.6 mtp85 -58.48 -47.73 83.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.34 -54.44 40.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 13.7 t -44.51 -43.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -68.95 -35.84 77.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.581 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 8.5 mt -49.14 -53.47 20.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.13 -43.63 7.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.4 mt -72.75 -42.14 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 59.7 mt -52.53 -33.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' HD11 ' B' ' 108' ' ' ILE . 5.4 mt -75.62 -57.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.3 mt -49.8 -45.36 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.465 ' CG1' ' OE1' ' B' ' 112' ' ' GLU . 17.7 t -60.73 -48.08 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.5 mt-10 -47.63 -47.96 28.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -57.44 -60.47 3.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.12 -28.28 51.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.741 HG11 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.62 -65.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.752 HD11 ' H ' ' A' ' 16' ' ' ILE . 1.1 mp -42.94 -42.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.39 80.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.649 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.4 -60.61 2.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 29.7 mt-10 -41.05 -48.09 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.02 -32.06 73.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.606 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.84 -42.35 70.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.606 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 23.0 mt -58.79 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.518 ' CD2' HD12 ' B' ' 126' ' ' ILE . 5.2 mt -53.31 -56.16 18.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 28' ' ' LEU . 2.5 tt -55.0 -40.65 70.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG22 ' CD1' ' A' ' 21' ' ' TRP . 2.1 t -63.86 -67.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.609 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 4.0 mt -55.27 -20.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.47 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 15.9 mt -79.85 -40.87 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.518 ' CD1' HD22 ' A' ' 24' ' ' LEU . 10.2 mt -75.26 -49.5 19.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -59.35 -47.19 86.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 9.5 m -62.17 -55.06 32.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.3 -43.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -68.61 -35.57 77.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.428 ' C ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.596 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 8.2 mt -49.11 -53.33 21.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.24 -43.8 7.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 17.0 mt -72.61 -42.11 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.596 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 59.5 mt -52.51 -33.57 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.537 ' CG1' HD11 ' A' ' 8' ' ' ILE . 5.5 mt -75.65 -57.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 34.7 mt -49.7 -45.24 48.74 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.468 ' CG1' ' OE1' ' A' ' 12' ' ' GLU . 18.1 t -60.91 -48.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.479 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.5 mt-10 -47.69 -48.06 29.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.3 -60.64 3.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.02 -28.32 51.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.745 HG11 ' N ' ' B' ' 116' ' ' ILE . 1.4 t -64.61 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.751 HD11 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -42.94 -42.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.38 80.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.651 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.3 -60.65 2.58 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.0 mt-10 -41.05 -48.26 3.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -65.85 -32.02 73.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.614 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.76 -42.47 70.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.614 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 23.3 mt -58.8 -60.13 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.517 ' CD2' HD12 ' A' ' 26' ' ' ILE . 5.2 mt -53.26 -56.2 18.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.521 HD22 ' CD1' ' B' ' 128' ' ' LEU . 2.4 tt -55.01 -40.62 70.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.54 HG22 ' CD1' ' B' ' 121' ' ' TRP . 2.2 t -63.89 -66.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.609 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.41 -20.76 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.474 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 16.3 mt -79.8 -40.79 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' B' ' 124' ' ' LEU . 10.3 mt -75.33 -49.63 18.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -59.23 -47.21 86.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.1 m -62.08 -54.89 35.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 12.2 t -44.33 -43.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -68.58 -35.84 77.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.431 ' C ' ' HD3' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 7.5 mt -51.48 -51.59 53.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -44.29 -42.99 7.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.8 mt -73.35 -42.18 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 61.4 mt -52.53 -33.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.532 ' CG1' HD13 ' B' ' 108' ' ' ILE . 4.5 mt -75.64 -57.3 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.7 mt -49.72 -45.93 49.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 17.3 t -60.2 -48.42 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.4 mt-10 -47.2 -48.03 24.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -57.4 -60.48 3.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.05 -28.3 51.26 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.739 HG12 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.5 -65.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 16' ' ' ILE . 1.1 mp -43.07 -42.12 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.29 79.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.651 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.42 -60.76 2.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.7 mt-10 -40.97 -48.27 3.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -66.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.609 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.92 -41.2 71.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.609 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 39.4 mt -59.82 -60.15 4.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' B' ' 126' ' ' ILE . 5.4 mt -53.82 -54.73 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 28' ' ' LEU . 3.4 tt -55.75 -42.36 75.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.536 HG23 ' CD1' ' A' ' 21' ' ' TRP . 2.2 t -62.55 -66.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 4.5 mt -55.01 -20.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 12.0 mt -79.86 -42.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.507 ' CD1' HD22 ' A' ' 24' ' ' LEU . 9.9 mt -73.85 -49.32 25.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -59.48 -47.58 84.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 11.5 m -62.46 -54.74 35.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 11.4 t -44.24 -43.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -68.42 -34.95 76.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.553 ' NE ' ' NE ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.596 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 7.7 mt -50.61 -52.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.39 -43.47 7.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.452 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 17.8 mt -72.61 -42.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.596 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 62.3 mt -52.48 -33.55 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.527 ' CG1' HD13 ' A' ' 8' ' ' ILE . 4.8 mt -75.57 -57.18 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 30.6 mt -49.84 -45.58 50.47 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 17.7 t -60.53 -47.98 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.48 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.4 mt-10 -47.77 -47.99 30.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.38 -60.73 3.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.0 -28.29 50.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.749 HG12 ' N ' ' B' ' 116' ' ' ILE . 1.4 t -64.44 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.752 ' H ' HD12 ' B' ' 116' ' ' ILE . 1.1 mp -43.1 -42.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.47 80.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.651 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.45 -60.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' B' ' 119' ' ' GLU . 29.7 mt-10 -40.93 -48.31 3.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.94 -32.16 73.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.604 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.83 -41.28 71.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.604 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 39.8 mt -59.76 -60.24 4.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' A' ' 26' ' ' ILE . 5.3 mt -53.74 -54.79 33.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.508 HD22 ' CD1' ' B' ' 128' ' ' LEU . 3.4 tt -55.63 -42.32 74.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' B' ' 121' ' ' TRP . 2.2 t -62.68 -66.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.4 mt -55.01 -20.7 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 12.2 mt -79.76 -42.24 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.508 ' CD1' HD22 ' B' ' 124' ' ' LEU . 9.8 mt -73.93 -49.45 24.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -59.27 -47.53 85.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 11.2 m -62.38 -54.63 37.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 11.7 t -44.25 -44.0 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -68.56 -34.92 76.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.553 ' NE ' ' NE ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.59 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 8.1 mt -53.41 -53.44 51.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.64 -37.16 2.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 16.7 mt -79.71 -40.81 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 41.6 mt -55.27 -36.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -75.51 -54.82 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 10' ' ' LEU . 19.4 mt -50.16 -46.95 54.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 26.0 t -60.23 -47.86 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.6 mt-10 -47.17 -47.08 24.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.99 -60.57 3.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.69 -27.92 43.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.738 HG12 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.57 -66.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.755 ' H ' HD12 ' A' ' 16' ' ' ILE . 1.1 mp -43.06 -42.09 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.31 79.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.649 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.51 -60.33 2.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 30.5 mt-10 -41.13 -48.06 3.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -65.83 -32.1 73.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.606 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.74 -42.36 70.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.606 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 24.7 mt -58.87 -60.02 4.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' B' ' 126' ' ' ILE . 5.2 mt -53.35 -56.08 19.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 28' ' ' LEU . 2.3 tt -55.09 -40.75 70.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 21' ' ' TRP . 2.1 t -63.69 -66.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.59 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 4.0 mt -55.5 -20.68 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.47 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 15.5 mt -79.91 -40.5 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.522 ' CD1' HD21 ' A' ' 24' ' ' LEU . 10.2 mt -75.7 -49.45 18.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HD2' HG13 ' A' ' 25' ' ' VAL . 23.3 mtp180 -59.47 -46.81 87.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.43 -54.85 34.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.4 -43.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.22 -35.95 78.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' C ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.587 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 7.9 mt -53.38 -53.36 52.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.59 -37.18 2.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.7 mt -79.8 -40.66 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.587 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 42.3 mt -55.53 -36.31 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 3.9 mt -75.66 -54.79 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 18.8 mt -50.15 -46.79 54.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 26.8 t -60.39 -47.74 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.6 mt-10 -47.24 -47.1 24.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.98 -60.56 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.72 -27.85 43.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.745 HG12 ' N ' ' B' ' 116' ' ' ILE . 1.4 t -64.6 -66.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.755 ' H ' HD12 ' B' ' 116' ' ' ILE . 1.1 mp -43.14 -42.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.33 79.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.649 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.4 -60.38 2.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.426 ' OE1' ' HE1' ' A' ' 18' ' ' MET . 29.8 mt-10 -41.2 -48.09 3.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -65.72 -32.04 73.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.611 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.91 -42.27 70.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.611 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 24.9 mt -58.9 -60.14 4.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.537 ' CD2' HD12 ' A' ' 26' ' ' ILE . 5.3 mt -53.24 -56.08 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' B' ' 128' ' ' LEU . 2.3 tt -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.551 HG23 ' CD1' ' B' ' 121' ' ' TRP . 2.2 t -63.59 -66.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.59 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.39 -20.84 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.474 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 15.4 mt -79.83 -40.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.524 ' CD1' HD21 ' B' ' 124' ' ' LEU . 10.2 mt -75.71 -49.49 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.441 ' HD2' HG13 ' B' ' 125' ' ' VAL . 23.3 mtp180 -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.7 m -62.37 -54.79 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 12.7 t -44.43 -43.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.19 -36.05 78.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.43 ' C ' ' HD3' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.599 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 9.0 mt -48.57 -54.18 15.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.67 -40.87 6.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 14.9 mt -75.05 -40.18 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 74.8 mt -52.54 -38.94 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.526 ' CD1' HD12 ' B' ' 108' ' ' ILE . 5.4 mt -72.88 -57.45 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.1 mt -48.48 -39.58 23.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 52.3 t -64.79 -46.47 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 1.6 mt-10 -49.97 -49.85 48.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -55.87 -61.34 2.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.663 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -50.58 -37.48 40.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.781 HG13 ' N ' ' A' ' 16' ' ' ILE . 1.3 t -55.16 -66.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.811 ' H ' HD12 ' A' ' 16' ' ' ILE . 1.2 mp -42.59 -39.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.62 -40.94 84.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.663 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 3.1 mtm -66.5 -55.58 14.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.522 ' CD ' ' CE ' ' B' ' 118' ' ' MET . 47.6 mt-10 -39.38 -47.71 1.81 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.454 ' CZ ' HD13 ' A' ' 24' ' ' LEU . 23.7 t80 -67.37 -36.67 81.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.619 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.87 -39.6 90.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.619 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 17.9 mt -61.17 -61.15 2.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.487 ' CD2' HD11 ' B' ' 126' ' ' ILE . 6.7 mt -55.83 -52.68 63.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.454 HD13 ' CZ ' ' A' ' 20' ' ' PHE . 5.2 tt -54.71 -48.67 72.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.547 HG21 ' CD1' ' A' ' 21' ' ' TRP . 2.6 t -59.14 -66.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.5 mt -53.29 -21.86 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.475 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 8.8 mt -78.42 -44.95 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 24' ' ' LEU . 9.3 mt -72.08 -51.58 20.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HD2' HG13 ' A' ' 25' ' ' VAL . 8.8 mtp180 -56.32 -47.55 78.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.0 m -62.68 -54.58 37.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 16.1 t -44.33 -43.04 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -69.63 -35.0 74.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.592 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.6 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 8.7 mt -48.73 -54.25 15.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.51 -40.8 5.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 14.9 mt -74.96 -40.46 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.6 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 74.9 mt -52.39 -38.97 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.527 ' CD1' HD12 ' A' ' 8' ' ' ILE . 5.3 mt -72.85 -57.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 20.8 mt -48.46 -39.57 23.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 51.3 t -64.74 -46.41 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mt-10 -50.08 -49.92 49.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.75 -61.22 2.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.647 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.75 -37.5 42.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.77 HG13 ' N ' ' B' ' 116' ' ' ILE . 1.3 t -55.13 -66.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.817 ' H ' HD12 ' B' ' 116' ' ' ILE . 1.2 mp -42.55 -39.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.84 84.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.651 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 3.1 mtm -66.53 -55.65 14.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 18' ' ' MET . 48.1 mt-10 -39.37 -47.61 1.79 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.462 ' CZ ' HD13 ' B' ' 124' ' ' LEU . 23.9 t80 -67.47 -36.63 81.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.613 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -65.9 -39.62 90.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.613 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 17.9 mt -61.24 -61.05 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.474 ' CD2' HD11 ' A' ' 26' ' ' ILE . 6.5 mt -55.86 -52.73 63.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.462 HD13 ' CZ ' ' B' ' 120' ' ' PHE . 5.2 tt -54.7 -48.55 72.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' B' ' 121' ' ' TRP . 2.6 t -59.15 -66.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.5 mt -53.36 -21.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 9.0 mt -78.47 -44.81 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.429 HD12 HD21 ' B' ' 124' ' ' LEU . 9.4 mt -72.3 -51.37 21.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.495 ' HD2' HG13 ' B' ' 125' ' ' VAL . 8.8 mtp180 -56.54 -47.62 79.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.1 m -62.56 -54.46 39.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 15.8 t -44.47 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -69.61 -34.84 74.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.592 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 9.7 mt -51.25 -54.28 27.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -44.75 -39.57 5.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.0 mt -78.27 -36.42 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 50.4 mt -57.53 -38.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' B' ' 108' ' ' ILE . 3.4 mt -73.78 -57.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.1 mt -50.27 -39.83 46.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 71.7 t -64.23 -45.73 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.636 ' N ' ' HE2' ' B' ' 112' ' ' GLU . 1.1 mt-10 -50.81 -50.8 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -54.69 -60.25 3.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.674 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -51.05 -38.11 49.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.767 HG13 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -55.51 -66.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.803 HD13 ' H ' ' A' ' 16' ' ' ILE . 1.1 mp -41.71 -40.23 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.74 87.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.684 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 2.9 mtm -67.03 -55.19 15.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 119' ' ' GLU . 3.4 mm-40 -39.58 -47.98 2.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -68.47 -34.86 76.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.671 ' CZ3' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -67.34 -38.75 85.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.671 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 20.1 mt -62.33 -61.02 2.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.492 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 6.1 mt -55.67 -51.66 66.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.434 HD22 ' CD1' ' A' ' 28' ' ' LEU . 5.8 tt -56.6 -47.69 79.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 21' ' ' TRP . 2.7 t -59.6 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 6.2 mt -53.35 -21.3 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 7.1 mt -78.84 -45.61 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD23 ' NZ ' ' A' ' 32' ' ' LYS . 8.7 mt -71.6 -50.51 30.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HD2' HG13 ' A' ' 25' ' ' VAL . 18.3 mtp180 -57.4 -47.99 80.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.61 -54.34 41.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 15.0 t -44.39 -43.45 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' NZ ' HD23 ' A' ' 28' ' ' LEU . 16.1 mttp -68.35 -36.34 79.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.591 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 9.0 mt -51.26 -54.62 24.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -43.77 -41.18 4.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.6 mt -75.69 -39.84 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 55.6 mt -53.93 -37.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.534 ' CD1' HD13 ' A' ' 8' ' ' ILE . 4.0 mt -73.31 -57.81 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 20.6 mt -48.72 -41.33 31.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.634 HG11 ' HE2' ' A' ' 12' ' ' GLU . 48.4 t -64.35 -43.74 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.636 ' HE2' ' N ' ' A' ' 12' ' ' GLU . 1.7 mm-40 -51.47 -50.57 59.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.88 -59.2 5.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.658 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.77 -38.37 47.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.757 HG13 ' N ' ' B' ' 116' ' ' ILE . 1.3 t -55.37 -65.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.809 HD13 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -41.75 -40.27 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.64 87.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.674 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 3.0 mtm -66.95 -55.27 15.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.476 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 3.7 mm-40 -39.65 -48.03 2.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -68.5 -34.59 76.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.665 ' CZ3' ' CD2' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -67.47 -38.76 84.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.665 ' CD2' ' CZ3' ' B' ' 121' ' ' TRP . 20.5 mt -62.47 -61.03 2.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.492 ' O ' ' CG1' ' B' ' 127' ' ' ILE . 5.6 mt -55.47 -51.6 66.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.439 HD22 ' CD1' ' B' ' 128' ' ' LEU . 5.7 tt -56.83 -47.33 80.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' B' ' 121' ' ' TRP . 2.6 t -59.62 -66.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.6 mt -53.47 -21.04 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 7.1 mt -79.04 -45.34 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.439 ' CD1' HD22 ' B' ' 124' ' ' LEU . 8.7 mt -71.76 -50.35 30.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.481 ' HD2' HG13 ' B' ' 125' ' ' VAL . 18.4 mtp180 -57.68 -48.05 80.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.56 -54.05 45.58 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 14.0 t -44.59 -43.34 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.32 -36.57 79.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.497 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.519 HD21 ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.591 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 7.4 mt -57.24 -51.06 70.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.95 -34.87 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.457 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.5 mt -81.87 -37.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 51.6 mt -58.88 -39.35 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.407 HG13 ' CG2' ' B' ' 108' ' ' ILE . 4.7 mt -74.47 -57.04 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 10' ' ' LEU . 26.7 mt -49.54 -44.6 46.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.503 HG11 ' HE2' ' B' ' 112' ' ' GLU . 69.8 t -60.49 -47.92 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 mt-10 -48.78 -48.05 41.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -56.46 -61.06 2.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.93 -28.91 54.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.744 HG11 ' N ' ' A' ' 16' ' ' ILE . 1.3 t -64.17 -65.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.744 ' N ' HG11 ' A' ' 15' ' ' VAL . 1.1 mp -42.89 -42.48 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.43 79.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.65 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.52 -60.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.9 mt-10 -40.88 -48.13 3.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -66.32 -32.24 73.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.607 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.23 -41.19 73.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.607 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 23.2 mt -60.43 -60.58 3.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.522 ' CD2' HD12 ' B' ' 126' ' ' ILE . 5.4 mt -53.53 -53.06 57.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.432 HD21 HD13 ' A' ' 28' ' ' LEU . 3.9 tt -57.33 -41.99 81.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 21' ' ' TRP . 2.2 t -63.55 -66.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 5.5 mt -53.84 -20.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 10.3 mt -80.04 -45.72 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 10.1 mt -69.64 -49.79 50.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.473 ' HD2' HG13 ' A' ' 25' ' ' VAL . 7.3 mtp180 -59.12 -50.2 74.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.629 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 25.2 m -62.96 -52.93 61.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 3.6 t -44.28 -36.36 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 28' ' ' LEU . 23.2 mtmt -79.52 -35.57 39.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.629 ' HG3' ' HA ' ' A' ' 30' ' ' THR . 6.2 mtp180 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.437 ' HA ' HD21 ' B' ' 104' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.579 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 7.5 mt -56.22 -51.7 67.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.66 -35.75 1.91 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.7 mt -81.05 -41.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.579 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 36.5 mt -55.7 -38.53 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.474 ' CG1' HD12 ' A' ' 8' ' ' ILE . 5.0 mt -73.99 -57.52 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' B' ' 110' ' ' LEU . 27.7 mt -47.88 -45.48 30.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 61.4 t -60.37 -47.93 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.503 ' HE2' HG11 ' A' ' 11' ' ' VAL . 1.8 mm-40 -48.21 -46.63 35.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -58.14 -60.09 4.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.17 -29.71 46.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.752 HG11 ' N ' ' B' ' 116' ' ' ILE . 1.3 t -63.18 -65.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.754 HD11 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -42.93 -42.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.1 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.639 ' HE1' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -67.09 -60.43 2.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' B' ' 119' ' ' GLU . 30.3 mt-10 -40.67 -47.83 2.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.32 -32.64 74.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.607 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.07 -41.09 74.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.607 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 21.8 mt -60.14 -60.56 3.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.52 ' CD2' HD12 ' A' ' 26' ' ' ILE . 5.7 mt -53.75 -53.38 53.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.422 HD21 HD13 ' B' ' 128' ' ' LEU . 3.8 tt -56.77 -42.16 78.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.513 HG23 ' CD1' ' B' ' 121' ' ' TRP . 2.2 t -63.57 -66.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 5.8 mt -53.82 -20.67 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 10.5 mt -80.13 -45.74 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.481 ' O ' ' HE3' ' B' ' 132' ' ' LYS . 10.2 mt -69.65 -49.65 51.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.474 ' HD2' HG13 ' B' ' 125' ' ' VAL . 7.3 mtp180 -59.25 -50.24 74.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.642 ' HA ' ' HG3' ' B' ' 133' ' ' ARG . 25.3 m -62.92 -52.83 61.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 3.7 t -44.39 -36.39 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.481 ' HE3' ' O ' ' B' ' 128' ' ' LEU . 23.2 mtmt -79.47 -35.33 40.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.642 ' HG3' ' HA ' ' B' ' 130' ' ' THR . 6.1 mtp180 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 8.4 mt -54.08 -52.51 60.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -43.9 -36.17 2.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.2 mt -81.27 -36.59 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 50.5 mt -59.63 -38.35 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.94 -56.82 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 10' ' ' LEU . 34.9 mt -50.55 -44.04 56.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 73.1 t -61.27 -46.81 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.5 mt-10 -49.74 -48.45 50.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -56.42 -61.44 2.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.94 -28.59 52.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.725 HG13 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.31 -65.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.743 ' H ' HD13 ' A' ' 16' ' ' ILE . 1.1 mp -43.03 -42.42 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.59 80.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.644 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.36 -59.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.549 ' HE2' HG11 ' A' ' 15' ' ' VAL . 28.1 mt-10 -41.38 -48.27 3.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -67.54 -30.08 69.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.617 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -72.03 -38.49 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.617 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 32.1 mt -64.24 -60.79 2.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.52 ' HA ' HD12 ' B' ' 126' ' ' ILE . 6.0 mt -52.38 -48.25 65.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 28' ' ' LEU . 3.8 tt -64.6 -38.32 90.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 21' ' ' TRP . 2.4 t -66.48 -65.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.618 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 7.6 mt -52.37 -21.61 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.475 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 9.1 mt -79.62 -49.79 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' CD1' HD21 ' A' ' 24' ' ' LEU . 9.6 mt -66.42 -50.4 63.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.476 ' HD2' HG11 ' A' ' 25' ' ' VAL . 27.7 mtp85 -57.99 -53.34 59.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.822 HG23 HH22 ' B' ' 133' ' ' ARG . 22.4 m -58.99 -49.1 79.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 4.4 t -44.93 -42.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 27.3 mtmt -77.41 -33.4 55.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.819 HH22 HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.595 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 8.6 mt -52.63 -53.19 50.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.06 -37.83 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.3 mt -79.53 -41.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.595 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 33.5 mt -54.56 -37.11 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.517 ' CG1' HD11 ' A' ' 8' ' ' ILE . 5.4 mt -74.49 -57.72 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' B' ' 110' ' ' LEU . 35.3 mt -47.93 -44.76 30.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 43.5 t -61.29 -47.7 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 1.7 mm-40 -48.36 -46.85 37.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.5 m -58.17 -60.28 4.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.29 -29.44 47.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.727 HG13 ' N ' ' B' ' 116' ' ' ILE . 1.4 t -63.32 -65.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.755 ' H ' HD13 ' B' ' 116' ' ' ILE . 1.1 mp -42.96 -42.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.49 78.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.641 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.84 -59.12 3.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.5 ' HE2' HG11 ' B' ' 115' ' ' VAL . 30.3 mt-10 -41.42 -47.79 3.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -67.76 -30.33 69.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.624 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.7 -38.54 70.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.624 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 31.9 mt -64.24 -60.79 2.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 26' ' ' ILE . 6.3 mt -52.38 -48.26 65.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' B' ' 128' ' ' LEU . 3.9 tt -64.52 -38.49 91.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' B' ' 121' ' ' TRP . 2.4 t -66.42 -66.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.618 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 7.9 mt -52.28 -21.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.475 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 8.7 mt -79.59 -50.03 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.506 ' CD1' HD21 ' B' ' 124' ' ' LEU . 9.3 mt -66.36 -50.26 64.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.479 ' HD2' HG11 ' B' ' 125' ' ' VAL . 27.6 mtp85 -58.07 -53.1 62.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.819 HG23 HH22 ' A' ' 33' ' ' ARG . 22.2 m -59.2 -48.64 80.86 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 4.6 t -45.09 -42.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 27.4 mtmt -77.15 -33.4 56.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.822 HH22 HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.596 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 9.1 mt -49.41 -53.85 20.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -43.97 -44.12 7.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 16.8 mt -72.16 -41.79 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 49.8 mt -54.1 -33.23 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' CG1' HD12 ' B' ' 108' ' ' ILE . 3.9 mt -74.61 -56.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.5 mt -51.26 -48.74 62.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 17.4 t -56.92 -48.31 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.9 mt-10 -47.75 -51.25 22.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -53.3 -60.13 3.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -56.84 -26.35 58.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.715 HG12 ' N ' ' A' ' 16' ' ' ILE . 1.2 t -69.82 -63.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.715 ' N ' HG12 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -43.46 -38.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.36 -29.29 59.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.821 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 3.2 mtp -63.54 -54.23 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' CG ' ' CG ' ' B' ' 119' ' ' GLU . 23.7 mt-10 -59.91 -46.44 89.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.86 -64.32 0.87 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.821 ' CD1' ' HA ' ' A' ' 18' ' ' MET . 0.6 OUTLIER -57.43 -37.56 72.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD21 ' CH2' ' A' ' 21' ' ' TRP . 12.4 mt -55.5 -61.63 2.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' B' ' 126' ' ' ILE . 8.4 mt -59.42 -51.14 71.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -41.57 62.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 HG23 ' CE3' ' A' ' 21' ' ' TRP . 2.2 t -69.51 -66.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.63 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 4.8 mt -50.83 -20.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.449 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 18.1 mt -81.22 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.18 -48.33 73.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.431 ' HD2' HG11 ' A' ' 25' ' ' VAL . 15.9 mtp-105 -60.78 -52.52 64.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 7.6 m -57.31 -51.58 68.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 19.5 t -44.64 -47.62 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -68.16 -34.01 75.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.591 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 8.8 mt -49.55 -53.91 21.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -43.87 -44.16 6.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.6 mt -72.15 -41.89 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 49.0 mt -54.06 -33.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.506 ' CG1' HD12 ' A' ' 8' ' ' ILE . 3.9 mt -74.54 -56.4 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 42.4 mt -51.38 -48.85 62.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 17.5 t -56.68 -48.41 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 1.9 mt-10 -47.77 -51.37 22.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -53.1 -60.12 3.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -56.85 -26.35 58.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.724 HG12 ' N ' ' B' ' 116' ' ' ILE . 1.2 t -69.92 -63.31 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.724 ' N ' HG12 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -43.55 -38.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.4 59.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.826 ' HA ' ' CD1' ' B' ' 121' ' ' TRP . 3.2 mtp -63.46 -54.02 43.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.445 ' CG ' ' CG ' ' A' ' 19' ' ' GLU . 23.8 mt-10 -60.09 -46.56 89.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -53.77 -64.17 0.91 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.826 ' CD1' ' HA ' ' B' ' 118' ' ' MET . 0.6 OUTLIER -57.47 -37.63 73.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.58 HD21 ' CH2' ' B' ' 121' ' ' TRP . 12.4 mt -55.51 -61.49 2.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.504 HD23 ' CD1' ' A' ' 26' ' ' ILE . 8.6 mt -59.57 -51.09 71.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -41.41 62.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.454 HG23 ' CE3' ' B' ' 121' ' ' TRP . 2.2 t -69.67 -66.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.63 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 4.9 mt -50.81 -21.04 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 18.6 mt -81.21 -49.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.98 -48.24 74.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.436 ' HD2' HG11 ' B' ' 125' ' ' VAL . 16.0 mtp-105 -60.92 -52.71 63.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 7.5 m -57.12 -51.5 69.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 20.3 t -44.56 -47.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -68.59 -33.57 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 8.7 mt -51.62 -54.12 31.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.74 -40.3 4.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 16.8 mt -76.68 -41.01 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 46.4 mt -54.05 -35.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' CD1' HD13 ' B' ' 108' ' ' ILE . 1.6 mt -75.54 -56.53 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.0 mt -49.57 -45.53 47.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.464 ' CG1' ' OE1' ' B' ' 112' ' ' GLU . 23.2 t -61.22 -47.51 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.6 mt-10 -47.61 -47.84 28.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -58.07 -59.92 4.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.23 -28.26 51.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.736 HG11 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.61 -65.91 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.751 HD13 ' H ' ' A' ' 16' ' ' ILE . 1.1 mp -43.0 -42.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.39 80.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.65 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.66 -60.14 2.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.442 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 30.3 mt-10 -41.2 -47.97 3.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -66.37 -31.59 72.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.605 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.0 -41.86 70.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.605 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 24.5 mt -59.75 -60.15 4.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' B' ' 126' ' ' ILE . 5.2 mt -53.34 -54.78 31.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.521 HD22 ' CD1' ' A' ' 28' ' ' LEU . 2.6 tt -56.26 -41.33 75.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.568 HG13 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.39 -66.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.598 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 4.7 mt -54.69 -22.15 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.475 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 11.6 mt -78.28 -43.54 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' A' ' 24' ' ' LEU . 10.1 mt -72.19 -52.71 15.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HD2' HG11 ' A' ' 25' ' ' VAL . 12.7 mtp180 -55.98 -46.98 78.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 16.6 m -64.48 -54.98 23.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 7.5 t -44.2 -34.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -79.89 -33.59 39.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.506 ' HE ' ' HE ' ' B' ' 133' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.597 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 9.0 mt -51.7 -54.09 32.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.72 -40.28 4.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.6 mt -76.74 -41.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.597 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 44.8 mt -54.13 -34.99 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.525 ' CD1' HD13 ' A' ' 8' ' ' ILE . 1.6 mt -75.61 -56.32 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 110' ' ' LEU . 19.8 mt -49.64 -45.66 48.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.464 ' CG1' ' OE1' ' A' ' 12' ' ' GLU . 22.0 t -61.11 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.6 mt-10 -47.39 -47.85 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -58.09 -60.06 4.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.17 -28.1 50.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.745 HG11 ' N ' ' B' ' 116' ' ' ILE . 1.3 t -64.81 -65.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.751 HD13 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -42.99 -42.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.39 80.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.652 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.43 -60.46 2.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' B' ' 119' ' ' GLU . 29.5 mt-10 -41.12 -48.2 3.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -66.11 -31.66 72.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' TRP . . . . . 0.616 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.9 -41.95 70.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.616 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 25.4 mt -59.8 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 26' ' ' ILE . 5.2 mt -53.22 -54.96 28.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' B' ' 128' ' ' LEU . 2.5 tt -56.42 -40.72 75.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.566 HG13 ' N ' ' B' ' 126' ' ' ILE . 2.3 t -63.95 -66.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.7 mt -54.39 -23.57 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.484 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 12.9 mt -76.68 -45.52 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.518 ' CD1' HD22 ' B' ' 124' ' ' LEU . 10.0 mt -70.53 -54.49 11.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.479 ' HD2' HG11 ' B' ' 125' ' ' VAL . 12.6 mtp180 -53.55 -45.37 69.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' B' ' 133' ' ' ARG . 21.2 m -68.02 -50.64 54.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 3.8 t -42.98 -35.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -87.96 -27.94 21.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . 0.506 ' HE ' ' HE ' ' A' ' 33' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.478 ' HA ' HD13 ' A' ' 5' ' ' LEU . 9.8 ttpp -72.18 -22.12 61.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -48.61 -52.81 21.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -43.99 -58.04 3.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.593 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 7.8 mt -52.39 -53.37 45.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.92 -37.82 3.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 16.9 mt -79.34 -39.6 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 49.1 mt -55.97 -36.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.72 -55.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 10' ' ' LEU . 18.4 mt -49.91 -48.14 51.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 35.3 t -59.03 -49.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.9 mt-10 -45.51 -47.49 14.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.41 -59.01 6.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.7 -29.56 53.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.729 HG12 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -63.88 -65.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.77 HD13 ' H ' ' A' ' 16' ' ' ILE . 1.0 OUTLIER -41.98 -44.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.52 78.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.657 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.5 mtp -66.81 -57.24 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' B' ' 119' ' ' GLU . 2.2 mm-40 -41.1 -48.55 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t80 -67.73 -31.17 70.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.636 ' CZ3' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.02 -39.85 72.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.636 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 24.3 mt -61.79 -60.28 3.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.486 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 5.7 mt -54.95 -52.94 61.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 28' ' ' LEU . 6.1 tt -55.71 -48.26 75.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 21' ' ' TRP . 2.4 t -58.6 -66.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.8 mt -54.14 -20.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 8.0 mt -79.32 -43.86 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 24' ' ' LEU . 9.1 mt -72.97 -49.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HD2' HG12 ' A' ' 25' ' ' VAL . 28.6 mtp85 -58.46 -47.7 83.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.47 -54.44 40.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 13.5 t -44.46 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.2 mttt -68.9 -36.01 77.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.581 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -49.48 -29.82 7.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -70.32 -66.16 0.63 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 32' ' ' LYS . 3.5 p30 -69.17 -5.9 25.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . -59.98 -24.43 60.55 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.974 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.45 ' HA ' HD13 ' B' ' 105' ' ' LEU . 10.6 ttpp -73.85 -21.82 59.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -48.08 -53.33 16.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -43.95 -58.3 2.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.592 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 7.7 mt -52.84 -53.07 53.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.88 -37.37 2.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.9 mt -80.01 -40.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.592 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 42.8 mt -55.77 -36.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.453 ' CG1' HD11 ' A' ' 8' ' ' ILE . 5.4 mt -75.75 -55.08 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 18.1 mt -49.83 -48.15 51.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 32.7 t -58.95 -49.72 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.9 mt-10 -45.35 -47.53 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.43 -58.84 6.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.472 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.75 -29.6 54.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.723 ' CG2' HG11 ' A' ' 15' ' ' VAL . 1.4 t -63.96 -66.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.771 HD13 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -41.92 -44.68 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.58 79.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.649 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.83 -57.22 7.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 2.2 mm-40 -41.23 -48.46 3.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 46.5 t80 -67.84 -31.02 70.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.623 ' CZ3' ' CD2' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.08 -40.01 71.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.623 ' CD2' ' CZ3' ' B' ' 121' ' ' TRP . 24.9 mt -61.73 -60.27 3.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.486 ' O ' ' CG1' ' B' ' 127' ' ' ILE . 5.7 mt -54.92 -52.96 61.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.425 HD21 HD13 ' B' ' 128' ' ' LEU . 6.1 tt -55.68 -48.32 75.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.501 HG23 ' CD1' ' B' ' 121' ' ' TRP . 2.4 t -58.53 -66.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.8 mt -54.15 -20.66 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 7.9 mt -79.38 -43.78 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.425 HD13 HD21 ' B' ' 124' ' ' LEU . 9.0 mt -73.11 -49.75 26.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.479 ' HD2' HG12 ' B' ' 125' ' ' VAL . 28.6 mtp85 -58.48 -47.73 83.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.34 -54.44 40.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 13.7 t -44.51 -43.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 136' ' ' GLY . 68.5 mttt -68.95 -35.84 77.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.581 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -49.56 -29.81 7.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.574 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -70.36 -66.33 0.61 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 132' ' ' LYS . 3.4 p30 -68.83 -5.76 22.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 132' ' ' LYS . . . -59.97 -24.55 60.66 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -71.98 -22.14 61.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.0 m -51.54 -46.59 63.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.58 -58.21 5.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 8.5 mt -49.14 -53.47 20.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.13 -43.63 7.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.4 mt -72.75 -42.14 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 59.7 mt -52.53 -33.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG1' HD11 ' B' ' 108' ' ' ILE . 5.4 mt -75.62 -57.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.3 mt -49.8 -45.36 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.465 ' CG1' ' OE1' ' B' ' 112' ' ' GLU . 17.7 t -60.73 -48.08 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.5 mt-10 -47.63 -47.96 28.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -57.44 -60.47 3.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.12 -28.28 51.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.741 HG11 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.62 -65.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.752 HD11 ' H ' ' A' ' 16' ' ' ILE . 1.1 mp -42.94 -42.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.39 80.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.649 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.4 -60.61 2.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 29.7 mt-10 -41.05 -48.09 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.02 -32.06 73.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.606 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.84 -42.35 70.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.606 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 23.0 mt -58.79 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.518 ' CD2' HD12 ' B' ' 126' ' ' ILE . 5.2 mt -53.31 -56.16 18.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 28' ' ' LEU . 2.5 tt -55.0 -40.65 70.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG22 ' CD1' ' A' ' 21' ' ' TRP . 2.1 t -63.86 -67.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.609 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 4.0 mt -55.27 -20.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.47 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 15.9 mt -79.85 -40.87 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.518 ' CD1' HD22 ' A' ' 24' ' ' LEU . 10.2 mt -75.26 -49.5 19.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -59.35 -47.19 86.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 9.5 m -62.17 -55.06 32.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.3 -43.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -68.61 -35.57 77.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.577 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.89 -29.7 8.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.577 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.49 -39.58 62.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 37' ' ' GLY . 14.8 m-20 -68.79 -63.99 0.95 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.9 -21.13 0.19 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 C--N 1.336 0.536 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -73.21 -22.28 60.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 60.8 m -51.12 -46.7 61.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.6 -58.27 4.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.596 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 8.2 mt -49.11 -53.33 21.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.24 -43.8 7.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 17.0 mt -72.61 -42.11 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.596 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 59.5 mt -52.51 -33.57 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.537 ' CG1' HD11 ' A' ' 8' ' ' ILE . 5.5 mt -75.65 -57.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 34.7 mt -49.7 -45.24 48.74 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.468 ' CG1' ' OE1' ' A' ' 12' ' ' GLU . 18.1 t -60.91 -48.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.479 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.5 mt-10 -47.69 -48.06 29.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.3 -60.64 3.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.02 -28.32 51.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.745 HG11 ' N ' ' B' ' 116' ' ' ILE . 1.4 t -64.61 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.751 HD11 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -42.94 -42.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.38 80.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.651 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.3 -60.65 2.58 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.0 mt-10 -41.05 -48.26 3.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -65.85 -32.02 73.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.614 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.76 -42.47 70.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.614 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 23.3 mt -58.8 -60.13 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.517 ' CD2' HD12 ' A' ' 26' ' ' ILE . 5.2 mt -53.26 -56.2 18.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.521 HD22 ' CD1' ' B' ' 128' ' ' LEU . 2.4 tt -55.01 -40.62 70.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.54 HG22 ' CD1' ' B' ' 121' ' ' TRP . 2.2 t -63.89 -66.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.609 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.41 -20.76 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.474 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 16.3 mt -79.8 -40.79 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' B' ' 124' ' ' LEU . 10.3 mt -75.33 -49.63 18.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -59.23 -47.21 86.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.1 m -62.08 -54.89 35.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 12.2 t -44.33 -43.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -68.58 -35.84 77.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.566 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -49.6 -29.66 7.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.566 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.63 -39.74 61.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.457 ' C ' ' N ' ' B' ' 137' ' ' GLY . 15.2 m-20 -68.37 -64.16 0.92 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -43.84 -20.91 0.17 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -66.61 -21.2 66.13 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.9 m -53.89 -45.09 70.96 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -58.29 6.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 7.5 mt -51.48 -51.59 53.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -44.29 -42.99 7.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.8 mt -73.35 -42.18 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 61.4 mt -52.53 -33.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.532 ' CG1' HD13 ' B' ' 108' ' ' ILE . 4.5 mt -75.64 -57.3 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.7 mt -49.72 -45.93 49.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 17.3 t -60.2 -48.42 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.4 mt-10 -47.2 -48.03 24.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -57.4 -60.48 3.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.05 -28.3 51.26 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.739 HG12 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.5 -65.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 16' ' ' ILE . 1.1 mp -43.07 -42.12 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.29 79.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.651 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.42 -60.76 2.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.7 mt-10 -40.97 -48.27 3.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -66.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.609 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.92 -41.2 71.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.609 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 39.4 mt -59.82 -60.15 4.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' B' ' 126' ' ' ILE . 5.4 mt -53.82 -54.73 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 28' ' ' LEU . 3.4 tt -55.75 -42.36 75.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.536 HG23 ' CD1' ' A' ' 21' ' ' TRP . 2.2 t -62.55 -66.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 4.5 mt -55.01 -20.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 12.0 mt -79.86 -42.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.507 ' CD1' HD22 ' A' ' 24' ' ' LEU . 9.9 mt -73.85 -49.32 25.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -59.48 -47.58 84.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 11.5 m -62.46 -54.74 35.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 11.4 t -44.24 -43.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -68.42 -34.95 76.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -50.73 -29.04 10.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.679 ' C ' ' H ' ' A' ' 36' ' ' GLY . . . -75.79 -46.25 31.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -57.82 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -89.07 37.44 3.32 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.508 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' B' ' 102' ' ' LYS . 0.0 OUTLIER -64.83 -21.63 66.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -53.58 -45.71 70.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -58.19 6.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.596 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 7.7 mt -50.61 -52.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.39 -43.47 7.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.452 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 17.8 mt -72.61 -42.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.596 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 62.3 mt -52.48 -33.55 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.527 ' CG1' HD13 ' A' ' 8' ' ' ILE . 4.8 mt -75.57 -57.18 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 30.6 mt -49.84 -45.58 50.47 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 17.7 t -60.53 -47.98 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.48 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.4 mt-10 -47.77 -47.99 30.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.38 -60.73 3.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.0 -28.29 50.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.749 HG12 ' N ' ' B' ' 116' ' ' ILE . 1.4 t -64.44 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.752 ' H ' HD12 ' B' ' 116' ' ' ILE . 1.1 mp -43.1 -42.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.47 80.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.651 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.45 -60.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' B' ' 119' ' ' GLU . 29.7 mt-10 -40.93 -48.31 3.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.94 -32.16 73.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.604 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.83 -41.28 71.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.604 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 39.8 mt -59.76 -60.24 4.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' A' ' 26' ' ' ILE . 5.3 mt -53.74 -54.79 33.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.508 HD22 ' CD1' ' B' ' 128' ' ' LEU . 3.4 tt -55.63 -42.32 74.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' B' ' 121' ' ' TRP . 2.2 t -62.68 -66.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.4 mt -55.01 -20.7 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 12.2 mt -79.76 -42.24 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.508 ' CD1' HD22 ' B' ' 124' ' ' LEU . 9.8 mt -73.93 -49.45 24.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -59.27 -47.53 85.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 11.2 m -62.38 -54.63 37.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 11.7 t -44.25 -44.0 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -68.56 -34.92 76.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.588 ' CZ ' ' HA ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.688 ' C ' ' H ' ' B' ' 136' ' ' GLY . . . -75.55 -46.18 33.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -57.5 4.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.688 ' H ' ' C ' ' B' ' 134' ' ' ALA . . . -88.83 37.4 3.31 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' HA ' HD13 ' A' ' 5' ' ' LEU . 14.7 ttmm -54.34 -21.52 9.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.1 m -47.59 -51.79 19.96 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.09 -57.54 3.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.59 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 8.1 mt -53.41 -53.44 51.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.64 -37.16 2.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 16.7 mt -79.71 -40.81 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 41.6 mt -55.27 -36.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -75.51 -54.82 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 10' ' ' LEU . 19.4 mt -50.16 -46.95 54.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 26.0 t -60.23 -47.86 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.6 mt-10 -47.17 -47.08 24.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.99 -60.57 3.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.69 -27.92 43.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.738 HG12 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.57 -66.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.755 ' H ' HD12 ' A' ' 16' ' ' ILE . 1.1 mp -43.06 -42.09 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.31 79.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.649 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.51 -60.33 2.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 30.5 mt-10 -41.13 -48.06 3.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -65.83 -32.1 73.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.606 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.74 -42.36 70.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.606 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 24.7 mt -58.87 -60.02 4.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' B' ' 126' ' ' ILE . 5.2 mt -53.35 -56.08 19.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 28' ' ' LEU . 2.3 tt -55.09 -40.75 70.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 21' ' ' TRP . 2.1 t -63.69 -66.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.59 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 4.0 mt -55.5 -20.68 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.47 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 15.5 mt -79.91 -40.5 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.522 ' CD1' HD21 ' A' ' 24' ' ' LEU . 10.2 mt -75.7 -49.45 18.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HD2' HG13 ' A' ' 25' ' ' VAL . 23.3 mtp180 -59.47 -46.81 87.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.43 -54.85 34.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.4 -43.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.22 -35.95 78.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.46 -29.88 7.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.574 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.26 -41.61 61.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -66.86 -30.47 70.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.39 24.22 1.29 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.541 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.481 ' HA ' HD13 ' B' ' 105' ' ' LEU . 14.7 ttmm -54.96 -21.38 11.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.4 m -47.41 -51.96 18.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.97 -57.88 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.587 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 7.9 mt -53.38 -53.36 52.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.59 -37.18 2.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.7 mt -79.8 -40.66 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.587 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 42.3 mt -55.53 -36.31 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 3.9 mt -75.66 -54.79 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 18.8 mt -50.15 -46.79 54.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 26.8 t -60.39 -47.74 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.6 mt-10 -47.24 -47.1 24.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.98 -60.56 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.72 -27.85 43.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.745 HG12 ' N ' ' B' ' 116' ' ' ILE . 1.4 t -64.6 -66.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.755 ' H ' HD12 ' B' ' 116' ' ' ILE . 1.1 mp -43.14 -42.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.33 79.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.649 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.4 -60.38 2.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.426 ' OE1' ' HE1' ' A' ' 18' ' ' MET . 29.8 mt-10 -41.2 -48.09 3.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -65.72 -32.04 73.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.611 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.91 -42.27 70.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.611 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 24.9 mt -58.9 -60.14 4.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.537 ' CD2' HD12 ' A' ' 26' ' ' ILE . 5.3 mt -53.24 -56.08 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' B' ' 128' ' ' LEU . 2.3 tt -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.551 HG23 ' CD1' ' B' ' 121' ' ' TRP . 2.2 t -63.59 -66.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.59 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.39 -20.84 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.474 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 15.4 mt -79.83 -40.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.524 ' CD1' HD21 ' B' ' 124' ' ' LEU . 10.2 mt -75.71 -49.49 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.441 ' HD2' HG13 ' B' ' 125' ' ' VAL . 23.3 mtp180 -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.7 m -62.37 -54.79 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 12.7 t -44.43 -43.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.19 -36.05 78.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.565 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -49.36 -29.88 6.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.565 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.2 -41.54 61.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -66.87 -30.32 70.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.48 24.49 1.25 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.554 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HA ' HD12 ' A' ' 5' ' ' LEU . 15.7 ttmt -68.69 -23.47 64.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.5 m -49.91 -49.35 50.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -45.71 -58.3 3.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.599 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 9.0 mt -48.57 -54.18 15.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.67 -40.87 6.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 14.9 mt -75.05 -40.18 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 74.8 mt -52.54 -38.94 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' CD1' HD12 ' B' ' 108' ' ' ILE . 5.4 mt -72.88 -57.45 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.1 mt -48.48 -39.58 23.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 52.3 t -64.79 -46.47 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 1.6 mt-10 -49.97 -49.85 48.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -55.87 -61.34 2.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.663 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -50.58 -37.48 40.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.781 HG13 ' N ' ' A' ' 16' ' ' ILE . 1.3 t -55.16 -66.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.811 ' H ' HD12 ' A' ' 16' ' ' ILE . 1.2 mp -42.59 -39.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.62 -40.94 84.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.663 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 3.1 mtm -66.5 -55.58 14.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.522 ' CD ' ' CE ' ' B' ' 118' ' ' MET . 47.6 mt-10 -39.38 -47.71 1.81 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.454 ' CZ ' HD13 ' A' ' 24' ' ' LEU . 23.7 t80 -67.37 -36.67 81.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.619 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.87 -39.6 90.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.619 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 17.9 mt -61.17 -61.15 2.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.487 ' CD2' HD11 ' B' ' 126' ' ' ILE . 6.7 mt -55.83 -52.68 63.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.454 HD13 ' CZ ' ' A' ' 20' ' ' PHE . 5.2 tt -54.71 -48.67 72.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.547 HG21 ' CD1' ' A' ' 21' ' ' TRP . 2.6 t -59.14 -66.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.5 mt -53.29 -21.86 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.475 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 8.8 mt -78.42 -44.95 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 24' ' ' LEU . 9.3 mt -72.08 -51.58 20.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HD2' HG13 ' A' ' 25' ' ' VAL . 8.8 mtp180 -56.32 -47.55 78.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.0 m -62.68 -54.58 37.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 16.1 t -44.33 -43.04 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -69.63 -35.0 74.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.592 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -50.47 -30.19 12.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.575 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -73.41 -31.45 63.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -78.92 -25.69 43.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.12 -14.36 11.12 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.49 ' HA ' HD12 ' B' ' 105' ' ' LEU . 16.0 ttmt -69.0 -23.88 64.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 56.1 m -49.68 -49.39 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -45.75 -58.31 3.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.6 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 8.7 mt -48.73 -54.25 15.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.51 -40.8 5.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 14.9 mt -74.96 -40.46 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.6 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 74.9 mt -52.39 -38.97 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.527 ' CD1' HD12 ' A' ' 8' ' ' ILE . 5.3 mt -72.85 -57.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 20.8 mt -48.46 -39.57 23.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 51.3 t -64.74 -46.41 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mt-10 -50.08 -49.92 49.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.75 -61.22 2.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.647 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.75 -37.5 42.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.77 HG13 ' N ' ' B' ' 116' ' ' ILE . 1.3 t -55.13 -66.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.817 ' H ' HD12 ' B' ' 116' ' ' ILE . 1.2 mp -42.55 -39.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.84 84.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.651 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 3.1 mtm -66.53 -55.65 14.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 18' ' ' MET . 48.1 mt-10 -39.37 -47.61 1.79 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.462 ' CZ ' HD13 ' B' ' 124' ' ' LEU . 23.9 t80 -67.47 -36.63 81.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.613 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -65.9 -39.62 90.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.613 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 17.9 mt -61.24 -61.05 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.474 ' CD2' HD11 ' A' ' 26' ' ' ILE . 6.5 mt -55.86 -52.73 63.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.462 HD13 ' CZ ' ' B' ' 120' ' ' PHE . 5.2 tt -54.7 -48.55 72.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' B' ' 121' ' ' TRP . 2.6 t -59.15 -66.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.5 mt -53.36 -21.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 9.0 mt -78.47 -44.81 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.429 HD12 HD21 ' B' ' 124' ' ' LEU . 9.4 mt -72.3 -51.37 21.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.495 ' HD2' HG13 ' B' ' 125' ' ' VAL . 8.8 mtp180 -56.54 -47.62 79.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.1 m -62.56 -54.46 39.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 15.8 t -44.47 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -69.61 -34.84 74.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.592 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -50.63 -30.11 12.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.582 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -73.36 -31.44 63.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -78.91 -25.77 43.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.76 -14.24 9.52 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.535 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 2' ' ' LYS . 11.9 ttpt -70.25 -23.31 62.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.2 m -49.44 -52.12 31.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -44.09 -56.04 4.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 9.7 mt -51.25 -54.28 27.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -44.75 -39.57 5.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.0 mt -78.27 -36.42 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 50.4 mt -57.53 -38.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' B' ' 108' ' ' ILE . 3.4 mt -73.78 -57.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.1 mt -50.27 -39.83 46.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 71.7 t -64.23 -45.73 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.636 ' N ' ' HE2' ' B' ' 112' ' ' GLU . 1.1 mt-10 -50.81 -50.8 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -54.69 -60.25 3.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.674 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -51.05 -38.11 49.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.767 HG13 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -55.51 -66.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.803 HD13 ' H ' ' A' ' 16' ' ' ILE . 1.1 mp -41.71 -40.23 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.74 87.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.684 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 2.9 mtm -67.03 -55.19 15.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 119' ' ' GLU . 3.4 mm-40 -39.58 -47.98 2.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -68.47 -34.86 76.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.671 ' CZ3' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -67.34 -38.75 85.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.671 ' CD2' ' CZ3' ' A' ' 21' ' ' TRP . 20.1 mt -62.33 -61.02 2.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.492 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 6.1 mt -55.67 -51.66 66.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 HD22 ' CD1' ' A' ' 28' ' ' LEU . 5.8 tt -56.6 -47.69 79.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 21' ' ' TRP . 2.7 t -59.6 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 6.2 mt -53.35 -21.3 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 7.1 mt -78.84 -45.61 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD23 ' NZ ' ' A' ' 32' ' ' LYS . 8.7 mt -71.6 -50.51 30.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HD2' HG13 ' A' ' 25' ' ' VAL . 18.3 mtp180 -57.4 -47.99 80.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.61 -54.34 41.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 15.0 t -44.39 -43.45 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' NZ ' HD23 ' A' ' 28' ' ' LEU . 16.1 mttp -68.35 -36.34 79.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.0 -29.76 5.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.49 -41.55 60.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.636 ' C ' ' H ' ' A' ' 37' ' ' GLY . 14.3 m-20 -65.82 -22.01 66.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.16 2.72 0.15 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 CA--C 1.523 0.539 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' B' ' 102' ' ' LYS . 11.9 ttpt -68.91 -24.85 64.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 48.8 m -49.65 -51.06 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.51 -56.04 4.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.591 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 9.0 mt -51.26 -54.62 24.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -43.77 -41.18 4.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.6 mt -75.69 -39.84 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 55.6 mt -53.93 -37.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.534 ' CD1' HD13 ' A' ' 8' ' ' ILE . 4.0 mt -73.31 -57.81 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 20.6 mt -48.72 -41.33 31.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.634 HG11 ' HE2' ' A' ' 12' ' ' GLU . 48.4 t -64.35 -43.74 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.636 ' HE2' ' N ' ' A' ' 12' ' ' GLU . 1.7 mm-40 -51.47 -50.57 59.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.88 -59.2 5.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.658 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.77 -38.37 47.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.757 HG13 ' N ' ' B' ' 116' ' ' ILE . 1.3 t -55.37 -65.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.809 HD13 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -41.75 -40.27 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.64 87.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.674 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 3.0 mtm -66.95 -55.27 15.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.476 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 3.7 mm-40 -39.65 -48.03 2.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -68.5 -34.59 76.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.665 ' CZ3' ' CD2' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -67.47 -38.76 84.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.665 ' CD2' ' CZ3' ' B' ' 121' ' ' TRP . 20.5 mt -62.47 -61.03 2.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.492 ' O ' ' CG1' ' B' ' 127' ' ' ILE . 5.6 mt -55.47 -51.6 66.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.439 HD22 ' CD1' ' B' ' 128' ' ' LEU . 5.7 tt -56.83 -47.33 80.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' B' ' 121' ' ' TRP . 2.6 t -59.62 -66.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.6 mt -53.47 -21.04 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 7.1 mt -79.04 -45.34 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.439 ' CD1' HD22 ' B' ' 124' ' ' LEU . 8.7 mt -71.76 -50.35 30.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.481 ' HD2' HG13 ' B' ' 125' ' ' VAL . 18.4 mtp180 -57.68 -48.05 80.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.56 -54.05 45.58 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 14.0 t -44.59 -43.34 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.32 -36.57 79.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.571 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -48.78 -29.78 4.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.571 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.32 -41.66 60.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.645 ' C ' ' H ' ' B' ' 137' ' ' GLY . 14.3 m-20 -65.69 -21.83 66.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.05 2.8 0.14 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.645 ' H ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 CA--C 1.522 0.494 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' HA ' HD13 ' A' ' 5' ' ' LEU . 20.2 ttpt -70.36 -21.96 62.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -47.51 -51.68 19.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.519 HD21 ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -44.89 -56.26 4.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.591 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 7.4 mt -57.24 -51.06 70.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.95 -34.87 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.457 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.5 mt -81.87 -37.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 51.6 mt -58.88 -39.35 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.407 HG13 ' CG2' ' B' ' 108' ' ' ILE . 4.7 mt -74.47 -57.04 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 10' ' ' LEU . 26.7 mt -49.54 -44.6 46.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.503 HG11 ' HE2' ' B' ' 112' ' ' GLU . 69.8 t -60.49 -47.92 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 mt-10 -48.78 -48.05 41.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -56.46 -61.06 2.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.93 -28.91 54.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.744 HG11 ' N ' ' A' ' 16' ' ' ILE . 1.3 t -64.17 -65.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.744 ' N ' HG11 ' A' ' 15' ' ' VAL . 1.1 mp -42.89 -42.48 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.43 79.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.65 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.52 -60.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.9 mt-10 -40.88 -48.13 3.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -66.32 -32.24 73.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.607 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.23 -41.19 73.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.607 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 23.2 mt -60.43 -60.58 3.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.522 ' CD2' HD12 ' B' ' 126' ' ' ILE . 5.4 mt -53.53 -53.06 57.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.432 HD21 HD13 ' A' ' 28' ' ' LEU . 3.9 tt -57.33 -41.99 81.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 21' ' ' TRP . 2.2 t -63.55 -66.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 5.5 mt -53.84 -20.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 10.3 mt -80.04 -45.72 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 10.1 mt -69.64 -49.79 50.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.473 ' HD2' HG13 ' A' ' 25' ' ' VAL . 7.3 mtp180 -59.12 -50.2 74.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.629 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 25.2 m -62.96 -52.93 61.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 3.6 t -44.28 -36.36 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 28' ' ' LEU . 23.2 mtmt -79.52 -35.57 39.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.629 ' HG3' ' HA ' ' A' ' 30' ' ' THR . 6.2 mtp180 -52.32 -35.89 51.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 36' ' ' GLY . . . -67.85 -31.33 71.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 37' ' ' GLY . 26.5 m-20 -74.35 15.47 0.33 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -50.48 -10.06 0.32 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.494 ' HA ' HD13 ' B' ' 105' ' ' LEU . 20.7 ttpt -70.25 -21.98 62.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 14.4 m -48.2 -51.03 27.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.437 ' HA ' HD21 ' B' ' 104' ' ' ASN . 0.0 OUTLIER -45.1 -56.65 4.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.579 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 7.5 mt -56.22 -51.7 67.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.66 -35.75 1.91 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.7 mt -81.05 -41.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.579 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 36.5 mt -55.7 -38.53 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.474 ' CG1' HD12 ' A' ' 8' ' ' ILE . 5.0 mt -73.99 -57.52 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' B' ' 110' ' ' LEU . 27.7 mt -47.88 -45.48 30.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 61.4 t -60.37 -47.93 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.503 ' HE2' HG11 ' A' ' 11' ' ' VAL . 1.8 mm-40 -48.21 -46.63 35.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -58.14 -60.09 4.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.17 -29.71 46.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.752 HG11 ' N ' ' B' ' 116' ' ' ILE . 1.3 t -63.18 -65.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.754 HD11 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -42.93 -42.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.1 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.639 ' HE1' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -67.09 -60.43 2.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' B' ' 119' ' ' GLU . 30.3 mt-10 -40.67 -47.83 2.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.32 -32.64 74.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.607 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.07 -41.09 74.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.607 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 21.8 mt -60.14 -60.56 3.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.52 ' CD2' HD12 ' A' ' 26' ' ' ILE . 5.7 mt -53.75 -53.38 53.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.422 HD21 HD13 ' B' ' 128' ' ' LEU . 3.8 tt -56.77 -42.16 78.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.513 HG23 ' CD1' ' B' ' 121' ' ' TRP . 2.2 t -63.57 -66.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.594 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 5.8 mt -53.82 -20.67 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 10.5 mt -80.13 -45.74 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.481 ' O ' ' HE3' ' B' ' 132' ' ' LYS . 10.2 mt -69.65 -49.65 51.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.474 ' HD2' HG13 ' B' ' 125' ' ' VAL . 7.3 mtp180 -59.25 -50.24 74.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.642 ' HA ' ' HG3' ' B' ' 133' ' ' ARG . 25.3 m -62.92 -52.83 61.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 3.7 t -44.39 -36.39 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.481 ' HE3' ' O ' ' B' ' 128' ' ' LEU . 23.2 mtmt -79.47 -35.33 40.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.642 ' HG3' ' HA ' ' B' ' 130' ' ' THR . 6.1 mtp180 -52.59 -36.12 55.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' B' ' 136' ' ' GLY . . . -67.58 -31.53 71.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' B' ' 137' ' ' GLY . 26.2 m-20 -74.25 15.86 0.29 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' B' ' 134' ' ' ALA . . . -50.48 -10.0 0.31 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 C--N 1.336 0.532 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HA ' HD13 ' A' ' 5' ' ' LEU . 28.1 ttpt -71.44 -21.51 61.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -47.37 -53.53 13.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -43.8 -57.42 3.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 8.4 mt -54.08 -52.51 60.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -43.9 -36.17 2.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 17.2 mt -81.27 -36.59 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 50.5 mt -59.63 -38.35 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.94 -56.82 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 10' ' ' LEU . 34.9 mt -50.55 -44.04 56.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 73.1 t -61.27 -46.81 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.5 mt-10 -49.74 -48.45 50.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -56.42 -61.44 2.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.94 -28.59 52.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.725 HG13 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.31 -65.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.743 ' H ' HD13 ' A' ' 16' ' ' ILE . 1.1 mp -43.03 -42.42 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.59 80.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.644 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.36 -59.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.549 ' HE2' HG11 ' A' ' 15' ' ' VAL . 28.1 mt-10 -41.38 -48.27 3.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -67.54 -30.08 69.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.617 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -72.03 -38.49 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.617 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 32.1 mt -64.24 -60.79 2.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.52 ' HA ' HD12 ' B' ' 126' ' ' ILE . 6.0 mt -52.38 -48.25 65.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 28' ' ' LEU . 3.8 tt -64.6 -38.32 90.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 21' ' ' TRP . 2.4 t -66.48 -65.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.618 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 7.6 mt -52.37 -21.61 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.475 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 9.1 mt -79.62 -49.79 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' CD1' HD21 ' A' ' 24' ' ' LEU . 9.6 mt -66.42 -50.4 63.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.476 ' HD2' HG11 ' A' ' 25' ' ' VAL . 27.7 mtp85 -57.99 -53.34 59.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.822 HG23 HH22 ' B' ' 133' ' ' ARG . 22.4 m -58.99 -49.1 79.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 4.4 t -44.93 -42.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 27.3 mtmt -77.41 -33.4 55.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.819 HH22 HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -55.09 -30.03 58.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.659 ' N ' ' HD3' ' A' ' 33' ' ' ARG . . . -75.18 -51.55 13.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -49.48 -66.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.68 74.74 0.04 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.499 ' HA ' HD13 ' B' ' 105' ' ' LEU . 28.3 ttpt -72.22 -21.67 61.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -47.04 -53.35 12.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.89 -58.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.595 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 8.6 mt -52.63 -53.19 50.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.06 -37.83 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.3 mt -79.53 -41.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.595 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 33.5 mt -54.56 -37.11 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.517 ' CG1' HD11 ' A' ' 8' ' ' ILE . 5.4 mt -74.49 -57.72 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' B' ' 110' ' ' LEU . 35.3 mt -47.93 -44.76 30.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 43.5 t -61.29 -47.7 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 1.7 mm-40 -48.36 -46.85 37.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.5 m -58.17 -60.28 4.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.29 -29.44 47.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.727 HG13 ' N ' ' B' ' 116' ' ' ILE . 1.4 t -63.32 -65.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.755 ' H ' HD13 ' B' ' 116' ' ' ILE . 1.1 mp -42.96 -42.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.49 78.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.641 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.84 -59.12 3.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.5 ' HE2' HG11 ' B' ' 115' ' ' VAL . 30.3 mt-10 -41.42 -47.79 3.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -67.76 -30.33 69.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.624 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.7 -38.54 70.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.624 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 31.9 mt -64.24 -60.79 2.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 26' ' ' ILE . 6.3 mt -52.38 -48.26 65.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' B' ' 128' ' ' LEU . 3.9 tt -64.52 -38.49 91.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' B' ' 121' ' ' TRP . 2.4 t -66.42 -66.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.618 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 7.9 mt -52.28 -21.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.475 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 8.7 mt -79.59 -50.03 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.506 ' CD1' HD21 ' B' ' 124' ' ' LEU . 9.3 mt -66.36 -50.26 64.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.479 ' HD2' HG11 ' B' ' 125' ' ' VAL . 27.6 mtp85 -58.07 -53.1 62.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.819 HG23 HH22 ' A' ' 33' ' ' ARG . 22.2 m -59.2 -48.64 80.86 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 4.6 t -45.09 -42.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 27.4 mtmt -77.15 -33.4 56.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.822 HH22 HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -55.16 -29.78 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.651 ' N ' ' HD3' ' B' ' 133' ' ' ARG . . . -75.32 -50.74 15.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -50.13 -66.1 0.45 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 170.55 74.7 0.04 OUTLIER Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -50.99 -21.71 1.91 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.5 m -50.54 -47.24 57.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -47.84 -58.13 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.596 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 9.1 mt -49.41 -53.85 20.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -43.97 -44.12 7.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 16.8 mt -72.16 -41.79 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 49.8 mt -54.1 -33.23 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' CG1' HD12 ' B' ' 108' ' ' ILE . 3.9 mt -74.61 -56.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.5 mt -51.26 -48.74 62.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 17.4 t -56.92 -48.31 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.9 mt-10 -47.75 -51.25 22.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -53.3 -60.13 3.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -56.84 -26.35 58.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.715 HG12 ' N ' ' A' ' 16' ' ' ILE . 1.2 t -69.82 -63.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.715 ' N ' HG12 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -43.46 -38.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.36 -29.29 59.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.821 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 3.2 mtp -63.54 -54.23 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' CG ' ' CG ' ' B' ' 119' ' ' GLU . 23.7 mt-10 -59.91 -46.44 89.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.86 -64.32 0.87 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.821 ' CD1' ' HA ' ' A' ' 18' ' ' MET . 0.6 OUTLIER -57.43 -37.56 72.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD21 ' CH2' ' A' ' 21' ' ' TRP . 12.4 mt -55.5 -61.63 2.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' B' ' 126' ' ' ILE . 8.4 mt -59.42 -51.14 71.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -41.57 62.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 HG23 ' CE3' ' A' ' 21' ' ' TRP . 2.2 t -69.51 -66.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.63 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 4.8 mt -50.83 -20.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.449 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 18.1 mt -81.22 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.18 -48.33 73.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.431 ' HD2' HG11 ' A' ' 25' ' ' VAL . 15.9 mtp-105 -60.78 -52.52 64.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 7.6 m -57.31 -51.58 68.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 19.5 t -44.64 -47.62 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' ND2' ' A' ' 35' ' ' ASN . 69.0 mttt -68.16 -34.01 75.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -52.44 -32.41 39.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.54 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -62.12 -35.94 80.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 32' ' ' LYS . 4.7 p30 -100.72 -2.08 33.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.41 -66.16 2.39 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -52.03 -21.8 3.47 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 36.0 m -50.27 -47.38 55.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -47.67 -58.16 4.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.591 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 8.8 mt -49.55 -53.91 21.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -43.87 -44.16 6.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.6 mt -72.15 -41.89 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 49.0 mt -54.06 -33.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.506 ' CG1' HD12 ' A' ' 8' ' ' ILE . 3.9 mt -74.54 -56.4 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 42.4 mt -51.38 -48.85 62.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' B' ' 107' ' ' ILE . 17.5 t -56.68 -48.41 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 1.9 mt-10 -47.77 -51.37 22.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -53.1 -60.12 3.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -56.85 -26.35 58.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.724 HG12 ' N ' ' B' ' 116' ' ' ILE . 1.2 t -69.92 -63.31 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.724 ' N ' HG12 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -43.55 -38.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.4 59.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.826 ' HA ' ' CD1' ' B' ' 121' ' ' TRP . 3.2 mtp -63.46 -54.02 43.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.445 ' CG ' ' CG ' ' A' ' 19' ' ' GLU . 23.8 mt-10 -60.09 -46.56 89.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -53.77 -64.17 0.91 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.826 ' CD1' ' HA ' ' B' ' 118' ' ' MET . 0.6 OUTLIER -57.47 -37.63 73.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.58 HD21 ' CH2' ' B' ' 121' ' ' TRP . 12.4 mt -55.51 -61.49 2.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.504 HD23 ' CD1' ' A' ' 26' ' ' ILE . 8.6 mt -59.57 -51.09 71.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -41.41 62.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.454 HG23 ' CE3' ' B' ' 121' ' ' TRP . 2.2 t -69.67 -66.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.63 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 4.9 mt -50.81 -21.04 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 18.6 mt -81.21 -49.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.98 -48.24 74.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.436 ' HD2' HG11 ' B' ' 125' ' ' VAL . 16.0 mtp-105 -60.92 -52.71 63.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 7.5 m -57.12 -51.5 69.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 20.3 t -44.56 -47.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.504 ' HA ' ' ND2' ' B' ' 135' ' ' ASN . 69.2 mttt -68.59 -33.57 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -52.79 -32.71 45.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -61.8 -35.71 78.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' B' ' 132' ' ' LYS . 4.6 p30 -101.27 -2.42 31.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -49.81 -66.14 2.47 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.439 ' HG3' HD13 ' A' ' 5' ' ' LEU . 4.9 ttpm? -62.31 -21.4 65.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 m -49.61 -52.22 31.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.15 -58.11 3.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . 8.7 mt -51.62 -54.12 31.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.74 -40.3 4.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 16.8 mt -76.68 -41.01 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 5' ' ' LEU . 46.4 mt -54.05 -35.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' CD1' HD13 ' B' ' 108' ' ' ILE . 1.6 mt -75.54 -56.53 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.0 mt -49.57 -45.53 47.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.464 ' CG1' ' OE1' ' B' ' 112' ' ' GLU . 23.2 t -61.22 -47.51 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.6 mt-10 -47.61 -47.84 28.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -58.07 -59.92 4.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.23 -28.26 51.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.736 HG11 ' N ' ' A' ' 16' ' ' ILE . 1.4 t -64.61 -65.91 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.751 HD13 ' H ' ' A' ' 16' ' ' ILE . 1.1 mp -43.0 -42.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.39 80.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.65 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.66 -60.14 2.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.442 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 30.3 mt-10 -41.2 -47.97 3.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -66.37 -31.59 72.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.605 ' CE3' ' HG ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.0 -41.86 70.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.605 ' HG ' ' CE3' ' A' ' 21' ' ' TRP . 24.5 mt -59.75 -60.15 4.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' B' ' 126' ' ' ILE . 5.2 mt -53.34 -54.78 31.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.521 HD22 ' CD1' ' A' ' 28' ' ' LEU . 2.6 tt -56.26 -41.33 75.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.568 HG13 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.39 -66.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.598 ' CD1' ' CD1' ' B' ' 126' ' ' ILE . 4.7 mt -54.69 -22.15 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.475 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 11.6 mt -78.28 -43.54 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' A' ' 24' ' ' LEU . 10.1 mt -72.19 -52.71 15.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HD2' HG11 ' A' ' 25' ' ' VAL . 12.7 mtp180 -55.98 -46.98 78.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 16.6 m -64.48 -54.98 23.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 7.5 t -44.2 -34.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -79.89 -33.59 39.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -53.53 -23.41 10.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.581 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -81.25 -29.26 34.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -81.17 -50.44 9.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.34 38.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.429 ' HG3' HD13 ' B' ' 105' ' ' LEU . 4.9 ttpm? -61.6 -21.71 64.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 18.1 m -49.28 -52.62 26.39 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.98 -58.16 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.597 ' HA ' ' CD1' ' B' ' 108' ' ' ILE . 9.0 mt -51.7 -54.09 32.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.72 -40.28 4.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' B' ' 111' ' ' VAL . 16.6 mt -76.74 -41.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.597 ' CD1' ' HA ' ' B' ' 105' ' ' LEU . 44.8 mt -54.13 -34.99 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.525 ' CD1' HD13 ' A' ' 8' ' ' ILE . 1.6 mt -75.61 -56.32 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 110' ' ' LEU . 19.8 mt -49.64 -45.66 48.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.464 ' CG1' ' OE1' ' A' ' 12' ' ' GLU . 22.0 t -61.11 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.6 mt-10 -47.39 -47.85 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -58.09 -60.06 4.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.17 -28.1 50.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.745 HG11 ' N ' ' B' ' 116' ' ' ILE . 1.3 t -64.81 -65.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.751 HD13 ' H ' ' B' ' 116' ' ' ILE . 1.1 mp -42.99 -42.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.39 80.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.652 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.43 -60.46 2.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' B' ' 119' ' ' GLU . 29.5 mt-10 -41.12 -48.2 3.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -66.11 -31.66 72.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.616 ' CE3' ' HG ' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.9 -41.95 70.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.616 ' HG ' ' CE3' ' B' ' 121' ' ' TRP . 25.4 mt -59.8 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 26' ' ' ILE . 5.2 mt -53.22 -54.96 28.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' B' ' 128' ' ' LEU . 2.5 tt -56.42 -40.72 75.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.566 HG13 ' N ' ' B' ' 126' ' ' ILE . 2.3 t -63.95 -66.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.7 mt -54.39 -23.57 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.484 ' CG1' ' O ' ' B' ' 123' ' ' LEU . 12.9 mt -76.68 -45.52 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.518 ' CD1' HD22 ' B' ' 124' ' ' LEU . 10.0 mt -70.53 -54.49 11.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.479 ' HD2' HG11 ' B' ' 125' ' ' VAL . 12.6 mtp180 -53.55 -45.37 69.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' B' ' 133' ' ' ARG . 21.2 m -68.02 -50.64 54.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' B' ' 127' ' ' ILE . 3.8 t -42.98 -35.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -87.96 -27.94 21.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.506 ' HE ' ' HE ' ' A' ' 33' ' ' ARG . 0.2 OUTLIER -63.68 -23.12 67.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.96 32.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -78.54 -50.3 11.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 158.71 38.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.033 HD22 ' HB3' ' B' ' 105' ' ' LEU . 7.8 mt -52.39 -53.37 45.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.92 -37.82 3.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.881 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.9 mt -79.34 -39.6 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.012 ' CG2' HG22 ' B' ' 108' ' ' ILE . 49.1 mt -55.97 -36.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.802 HG13 HG21 ' B' ' 108' ' ' ILE . 5.4 mt -75.72 -55.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 10' ' ' LEU . 18.4 mt -49.91 -48.14 51.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 7' ' ' ILE . 35.3 t -59.03 -49.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.9 mt-10 -45.51 -47.49 14.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.41 -59.01 6.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.7 -29.56 53.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.78 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -63.88 -65.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.78 HD12 HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -41.98 -44.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.52 78.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.658 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.5 mtp -66.81 -57.24 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' B' ' 119' ' ' GLU . 2.2 mm-40 -41.1 -48.55 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t80 -67.73 -31.17 70.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 1.03 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.02 -39.85 72.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.03 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.3 mt -61.79 -60.28 3.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 mt -54.95 -52.94 61.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.689 ' CD2' HD12 ' A' ' 28' ' ' LEU . 6.1 tt -55.71 -48.26 75.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.4 t -58.6 -66.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.8 mt -54.14 -20.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt -79.32 -43.86 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.689 HD12 ' CD2' ' A' ' 24' ' ' LEU . 9.1 mt -72.97 -49.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HD2' HG13 ' A' ' 25' ' ' VAL . 28.6 mtp85 -58.46 -47.7 83.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.47 -54.44 40.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 27' ' ' ILE . 13.5 t -44.46 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -68.9 -36.01 77.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.582 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.033 ' HB3' HD22 ' A' ' 5' ' ' LEU . 7.7 mt -52.84 -53.07 53.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.88 -37.37 2.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.898 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.9 mt -80.01 -40.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.026 HD12 ' HA ' ' B' ' 105' ' ' LEU . 42.8 mt -55.77 -36.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.775 HG13 HG21 ' A' ' 8' ' ' ILE . 5.4 mt -75.75 -55.08 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' B' ' 110' ' ' LEU . 18.1 mt -49.83 -48.15 51.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.898 HG23 ' O ' ' B' ' 107' ' ' ILE . 32.7 t -58.95 -49.72 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.9 mt-10 -45.35 -47.53 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.43 -58.84 6.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.75 -29.6 54.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.773 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -63.96 -66.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.773 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -41.92 -44.68 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.58 79.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.658 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.83 -57.22 7.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 2.2 mm-40 -41.23 -48.46 3.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 46.5 t80 -67.84 -31.02 70.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 1.017 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.08 -40.01 71.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 1.017 HD21 ' CH2' ' B' ' 121' ' ' TRP . 24.9 mt -61.73 -60.27 3.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.632 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.7 mt -54.92 -52.96 61.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.694 ' CD2' HD12 ' B' ' 128' ' ' LEU . 6.1 tt -55.68 -48.32 75.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.562 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.4 t -58.53 -66.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.8 mt -54.15 -20.66 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.643 ' O ' HG23 ' B' ' 131' ' ' VAL . 7.9 mt -79.38 -43.78 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' B' ' 124' ' ' LEU . 9.0 mt -73.11 -49.75 26.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.536 ' HD2' HG13 ' B' ' 125' ' ' VAL . 28.6 mtp85 -58.48 -47.73 83.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.34 -54.44 40.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.643 HG23 ' O ' ' B' ' 127' ' ' ILE . 13.7 t -44.51 -43.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -68.95 -35.84 77.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.582 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.035 ' HA ' HD12 ' A' ' 8' ' ' ILE . 8.5 mt -49.14 -53.47 20.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.13 -43.63 7.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.93 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.4 mt -72.75 -42.14 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.035 HD12 ' HA ' ' A' ' 5' ' ' LEU . 59.7 mt -52.53 -33.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.994 HG13 HD13 ' B' ' 108' ' ' ILE . 5.4 mt -75.62 -57.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 10' ' ' LEU . 34.3 mt -49.8 -45.36 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.7 t -60.73 -48.08 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.5 mt-10 -47.63 -47.96 28.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -57.44 -60.47 3.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.12 -28.28 51.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.811 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.62 -65.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.811 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -42.94 -42.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.39 80.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.725 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.4 -60.61 2.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 29.7 mt-10 -41.05 -48.09 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.9 t80 -66.02 -32.06 73.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.982 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.84 -42.35 70.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.982 HD21 ' CH2' ' A' ' 21' ' ' TRP . 23.0 mt -58.79 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.624 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.31 -56.16 18.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.749 HD23 HD12 ' A' ' 28' ' ' LEU . 2.5 tt -55.0 -40.65 70.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.1 t -63.86 -67.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.778 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.0 mt -55.27 -20.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 31' ' ' VAL . 15.9 mt -79.85 -40.87 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.749 HD12 HD23 ' A' ' 24' ' ' LEU . 10.2 mt -75.26 -49.5 19.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HD2' HG13 ' A' ' 25' ' ' VAL . 27.0 mtp180 -59.35 -47.19 86.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 9.5 m -62.17 -55.06 32.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.3 -43.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -68.61 -35.57 77.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.03 ' HA ' HD12 ' B' ' 108' ' ' ILE . 8.2 mt -49.11 -53.33 21.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.24 -43.8 7.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.931 ' O ' HG23 ' B' ' 111' ' ' VAL . 17.0 mt -72.61 -42.11 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.03 HD12 ' HA ' ' B' ' 105' ' ' LEU . 59.5 mt -52.51 -33.57 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.988 HG13 HD13 ' A' ' 8' ' ' ILE . 5.5 mt -75.65 -57.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' B' ' 110' ' ' LEU . 34.7 mt -49.7 -45.24 48.74 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.931 HG23 ' O ' ' B' ' 107' ' ' ILE . 18.1 t -60.91 -48.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.5 mt-10 -47.69 -48.06 29.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.3 -60.64 3.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.02 -28.32 51.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.785 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.61 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.785 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.94 -42.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.38 80.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.3 -60.65 2.58 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.0 mt-10 -41.05 -48.26 3.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 68.3 t80 -65.85 -32.02 73.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.76 -42.47 70.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' B' ' 121' ' ' TRP . 23.3 mt -58.8 -60.13 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.621 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.2 mt -53.26 -56.2 18.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.746 HD23 HD12 ' B' ' 128' ' ' LEU . 2.4 tt -55.01 -40.62 70.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.627 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.89 -66.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.778 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.41 -20.76 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.631 ' O ' HG23 ' B' ' 131' ' ' VAL . 16.3 mt -79.8 -40.79 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.746 HD12 HD23 ' B' ' 124' ' ' LEU . 10.3 mt -75.33 -49.63 18.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.491 ' HD2' HG13 ' B' ' 125' ' ' VAL . 25.6 mtp180 -59.23 -47.21 86.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.1 m -62.08 -54.89 35.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 127' ' ' ILE . 12.2 t -44.33 -43.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -68.58 -35.84 77.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 130' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.056 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.5 mt -51.48 -51.59 53.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -44.29 -42.99 7.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.939 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.8 mt -73.35 -42.18 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.056 HD12 ' HA ' ' A' ' 5' ' ' LEU . 61.4 mt -52.53 -33.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.998 HG13 HD13 ' B' ' 108' ' ' ILE . 4.5 mt -75.64 -57.3 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 10' ' ' LEU . 32.7 mt -49.72 -45.93 49.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.3 t -60.2 -48.42 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.4 mt-10 -47.2 -48.03 24.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -57.4 -60.48 3.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.05 -28.3 51.26 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.82 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.5 -65.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.82 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.07 -42.12 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.29 79.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.719 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.42 -60.76 2.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.7 mt-10 -40.97 -48.27 3.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 9.7 t80 -66.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 1.006 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.92 -41.2 71.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.006 HD21 ' CH2' ' A' ' 21' ' ' TRP . 39.4 mt -59.82 -60.15 4.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.689 HD11 HD22 ' B' ' 122' ' ' LEU . 5.4 mt -53.82 -54.73 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD23 HD12 ' A' ' 28' ' ' LEU . 3.4 tt -55.75 -42.36 75.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.611 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -62.55 -66.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.749 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.5 mt -55.01 -20.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.64 HD12 ' C ' ' A' ' 23' ' ' LEU . 12.0 mt -79.86 -42.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.752 HD12 HD23 ' A' ' 24' ' ' LEU . 9.9 mt -73.85 -49.32 25.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HD2' HG13 ' A' ' 25' ' ' VAL . 15.1 mtp180 -59.48 -47.58 84.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 11.5 m -62.46 -54.74 35.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 27' ' ' ILE . 11.4 t -44.24 -43.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -68.42 -34.95 76.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.553 ' NE ' ' NE ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.031 ' HA ' HD12 ' B' ' 108' ' ' ILE . 7.7 mt -50.61 -52.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.39 -43.47 7.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.931 ' O ' HG23 ' B' ' 111' ' ' VAL . 17.8 mt -72.61 -42.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.033 ' CG2' HG22 ' A' ' 8' ' ' ILE . 62.3 mt -52.48 -33.55 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.953 HG13 HD13 ' A' ' 8' ' ' ILE . 4.8 mt -75.57 -57.18 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' B' ' 110' ' ' LEU . 30.6 mt -49.84 -45.58 50.47 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.931 HG23 ' O ' ' B' ' 107' ' ' ILE . 17.7 t -60.53 -47.98 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.48 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.4 mt-10 -47.77 -47.99 30.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.38 -60.73 3.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.0 -28.29 50.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.798 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.44 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.798 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -43.1 -42.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.47 80.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.45 -60.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.446 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.7 mt-10 -40.93 -48.31 3.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.94 -32.16 73.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 1.005 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.83 -41.28 71.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 1.005 HD21 ' CH2' ' B' ' 121' ' ' TRP . 39.8 mt -59.76 -60.24 4.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.687 HD11 HD22 ' A' ' 22' ' ' LEU . 5.3 mt -53.74 -54.79 33.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.733 HD23 HD12 ' B' ' 128' ' ' LEU . 3.4 tt -55.63 -42.32 74.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.615 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -62.68 -66.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.749 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.4 mt -55.01 -20.7 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 131' ' ' VAL . 12.2 mt -79.76 -42.24 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.733 HD12 HD23 ' B' ' 124' ' ' LEU . 9.8 mt -73.93 -49.45 24.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.496 ' HD2' HG13 ' B' ' 125' ' ' VAL . 15.0 mtp180 -59.27 -47.53 85.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 11.2 m -62.38 -54.63 37.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 127' ' ' ILE . 11.7 t -44.25 -44.0 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -68.56 -34.92 76.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.553 ' NE ' ' NE ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.095 HD13 HD13 ' B' ' 105' ' ' LEU . 8.1 mt -53.41 -53.44 51.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.64 -37.16 2.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.888 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.7 mt -79.71 -40.81 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.002 ' CG2' HG22 ' B' ' 108' ' ' ILE . 41.6 mt -55.27 -36.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.753 HG13 HG21 ' B' ' 108' ' ' ILE . 3.9 mt -75.51 -54.82 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' A' ' 10' ' ' LEU . 19.4 mt -50.16 -46.95 54.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 7' ' ' ILE . 26.0 t -60.23 -47.86 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.6 mt-10 -47.17 -47.08 24.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.99 -60.57 3.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.69 -27.92 43.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.822 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.57 -66.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.822 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.06 -42.09 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.31 79.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.652 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.51 -60.33 2.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 30.5 mt-10 -41.13 -48.06 3.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 14.5 t80 -65.83 -32.1 73.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.74 -42.36 70.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.7 mt -58.87 -60.02 4.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.35 -56.08 19.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.734 HD23 HD12 ' A' ' 28' ' ' LEU . 2.3 tt -55.09 -40.75 70.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.1 t -63.69 -66.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.77 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.0 mt -55.5 -20.68 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 31' ' ' VAL . 15.5 mt -79.91 -40.5 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.734 HD12 HD23 ' A' ' 24' ' ' LEU . 10.2 mt -75.7 -49.45 18.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HD2' HG13 ' A' ' 25' ' ' VAL . 23.3 mtp180 -59.47 -46.81 87.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.43 -54.85 34.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.4 -43.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.22 -35.95 78.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.095 HD13 HD13 ' A' ' 5' ' ' LEU . 7.9 mt -53.38 -53.36 52.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.59 -37.18 2.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.909 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.7 mt -79.8 -40.66 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' B' ' 105' ' ' LEU . 42.3 mt -55.53 -36.31 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.745 HG13 HG21 ' A' ' 8' ' ' ILE . 3.9 mt -75.66 -54.79 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' B' ' 110' ' ' LEU . 18.8 mt -50.15 -46.79 54.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.909 HG23 ' O ' ' B' ' 107' ' ' ILE . 26.8 t -60.39 -47.74 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.6 mt-10 -47.24 -47.1 24.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.98 -60.56 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.72 -27.85 43.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.8 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.6 -66.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.8 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -43.14 -42.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.33 79.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.654 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.4 -60.38 2.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 29.8 mt-10 -41.2 -48.09 3.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 14.4 t80 -65.72 -32.04 73.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 0.976 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.91 -42.27 70.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.976 HD21 ' CH2' ' B' ' 121' ' ' TRP . 24.9 mt -58.9 -60.14 4.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.625 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.3 mt -53.24 -56.08 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.739 HD23 HD12 ' B' ' 128' ' ' LEU . 2.3 tt -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.622 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.59 -66.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.77 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.39 -20.84 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 131' ' ' VAL . 15.4 mt -79.83 -40.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.739 HD12 HD23 ' B' ' 124' ' ' LEU . 10.2 mt -75.71 -49.49 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.483 ' HD2' HG13 ' B' ' 125' ' ' VAL . 23.3 mtp180 -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.7 m -62.37 -54.79 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 127' ' ' ILE . 12.7 t -44.43 -43.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.19 -36.05 78.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 130' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.084 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.0 mt -48.57 -54.18 15.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.67 -40.87 6.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.908 ' O ' HG23 ' A' ' 11' ' ' VAL . 14.9 mt -75.05 -40.18 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.084 HD12 ' HA ' ' A' ' 5' ' ' LEU . 74.8 mt -52.54 -38.94 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.827 HG13 HG21 ' B' ' 108' ' ' ILE . 5.4 mt -72.88 -57.45 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 10' ' ' LEU . 21.1 mt -48.48 -39.58 23.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 7' ' ' ILE . 52.3 t -64.79 -46.47 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 1.6 mt-10 -49.97 -49.85 48.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -55.87 -61.34 2.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -50.58 -37.48 40.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.892 HG12 HD12 ' A' ' 16' ' ' ILE . 1.3 t -55.16 -66.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.892 HD12 HG12 ' A' ' 15' ' ' VAL . 1.2 mp -42.59 -39.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -58.62 -40.94 84.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.672 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 3.1 mtm -66.5 -55.58 14.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.522 ' CD ' ' CE ' ' B' ' 118' ' ' MET . 47.6 mt-10 -39.38 -47.71 1.81 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CZ ' HD12 ' A' ' 24' ' ' LEU . 23.7 t80 -67.37 -36.67 81.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 1.022 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.87 -39.6 90.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.022 HD21 ' CH2' ' A' ' 21' ' ' TRP . 17.9 mt -61.17 -61.15 2.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.598 HD11 HD22 ' B' ' 122' ' ' LEU . 6.7 mt -55.83 -52.68 63.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.643 ' CD2' HD12 ' A' ' 28' ' ' LEU . 5.2 tt -54.71 -48.67 72.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.588 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.6 t -59.14 -66.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.5 mt -53.29 -21.86 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt -78.42 -44.95 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.643 HD12 ' CD2' ' A' ' 24' ' ' LEU . 9.3 mt -72.08 -51.58 20.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.588 ' HD2' HG13 ' A' ' 25' ' ' VAL . 8.8 mtp180 -56.32 -47.55 78.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.0 m -62.68 -54.58 37.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 27' ' ' ILE . 16.1 t -44.33 -43.04 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -69.63 -35.0 74.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.601 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.078 HD22 ' HB3' ' A' ' 5' ' ' LEU . 8.7 mt -48.73 -54.25 15.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.51 -40.8 5.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.904 ' O ' HG23 ' B' ' 111' ' ' VAL . 14.9 mt -74.96 -40.46 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.077 HD12 ' HA ' ' B' ' 105' ' ' LEU . 74.9 mt -52.39 -38.97 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.813 HG13 HG21 ' A' ' 8' ' ' ILE . 5.3 mt -72.85 -57.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' B' ' 110' ' ' LEU . 20.8 mt -48.46 -39.57 23.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.904 HG23 ' O ' ' B' ' 107' ' ' ILE . 51.3 t -64.74 -46.41 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mt-10 -50.08 -49.92 49.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.75 -61.22 2.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.656 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.75 -37.5 42.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.872 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -55.13 -66.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.872 HD12 HG12 ' B' ' 115' ' ' VAL . 1.2 mp -42.55 -39.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' B' ' 114' ' ' ALA . . . -58.67 -40.84 84.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.659 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 3.1 mtm -66.53 -55.65 14.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 18' ' ' MET . 48.1 mt-10 -39.37 -47.61 1.79 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' B' ' 124' ' ' LEU . 23.9 t80 -67.47 -36.63 81.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 1.006 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -65.9 -39.62 90.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 1.006 HD21 ' CH2' ' B' ' 121' ' ' TRP . 17.9 mt -61.24 -61.05 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.601 HD11 HD22 ' A' ' 22' ' ' LEU . 6.5 mt -55.86 -52.73 63.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.643 ' CD2' HD12 ' B' ' 128' ' ' LEU . 5.2 tt -54.7 -48.55 72.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.575 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.6 t -59.15 -66.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.5 mt -53.36 -21.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.664 ' O ' HG23 ' B' ' 131' ' ' VAL . 9.0 mt -78.47 -44.81 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.643 HD12 ' CD2' ' B' ' 124' ' ' LEU . 9.4 mt -72.3 -51.37 21.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.575 ' HD2' HG13 ' B' ' 125' ' ' VAL . 8.8 mtp180 -56.54 -47.62 79.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.1 m -62.56 -54.46 39.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 127' ' ' ILE . 15.8 t -44.47 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -69.61 -34.84 74.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.601 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.7 mt -51.25 -54.28 27.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -44.75 -39.57 5.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.0 mt -78.27 -36.42 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.03 HG22 ' CG2' ' B' ' 108' ' ' ILE . 50.4 mt -57.53 -38.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.89 HG12 HD13 ' B' ' 108' ' ' ILE . 3.4 mt -73.78 -57.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 10' ' ' LEU . 28.1 mt -50.27 -39.83 46.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 7' ' ' ILE . 71.7 t -64.23 -45.73 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' CG ' ' HG2' ' B' ' 112' ' ' GLU . 1.1 mt-10 -50.81 -50.8 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -54.69 -60.25 3.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.683 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -51.05 -38.11 49.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.906 HG22 ' HE1' ' A' ' 18' ' ' MET . 1.4 t -55.51 -66.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.832 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -41.71 -40.23 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.43 -40.74 87.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.906 ' HE1' HG22 ' A' ' 15' ' ' VAL . 2.9 mtm -67.03 -55.19 15.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 119' ' ' GLU . 3.4 mm-40 -39.58 -47.98 2.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 29.4 t80 -68.47 -34.86 76.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 1.035 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -67.34 -38.75 85.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.035 HD21 ' CH2' ' A' ' 21' ' ' TRP . 20.1 mt -62.33 -61.02 2.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 27' ' ' ILE . 6.1 mt -55.67 -51.66 66.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CD2' HD12 ' A' ' 28' ' ' LEU . 5.8 tt -56.6 -47.69 79.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.7 t -59.6 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 6.2 mt -53.35 -21.3 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 23' ' ' LEU . 7.1 mt -78.84 -45.61 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.681 HD12 ' CD2' ' A' ' 24' ' ' LEU . 8.7 mt -71.6 -50.51 30.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HD2' HG13 ' A' ' 25' ' ' VAL . 18.3 mtp180 -57.4 -47.99 80.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.61 -54.34 41.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 27' ' ' ILE . 15.0 t -44.39 -43.45 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.35 -36.34 79.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.498 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.026 ' HA ' HD12 ' B' ' 108' ' ' ILE . 9.0 mt -51.26 -54.62 24.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -43.77 -41.18 4.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.908 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -75.69 -39.84 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.03 ' CG2' HG22 ' A' ' 8' ' ' ILE . 55.6 mt -53.93 -37.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.858 HG12 HD13 ' A' ' 8' ' ' ILE . 4.0 mt -73.31 -57.81 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' B' ' 110' ' ' LEU . 20.6 mt -48.72 -41.33 31.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.908 HG23 ' O ' ' B' ' 107' ' ' ILE . 48.4 t -64.35 -43.74 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.7 mm-40 -51.47 -50.57 59.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.88 -59.2 5.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.669 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.77 -38.37 47.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.843 HG11 HG11 ' A' ' 15' ' ' VAL . 1.3 t -55.37 -65.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.825 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -41.75 -40.27 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' B' ' 114' ' ' ALA . . . -59.53 -40.64 87.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.785 ' HE1' HG22 ' B' ' 115' ' ' VAL . 3.0 mtm -66.95 -55.27 15.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.476 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 3.7 mm-40 -39.65 -48.03 2.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 29.7 t80 -68.5 -34.59 76.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 1.041 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -67.47 -38.76 84.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 1.041 HD21 ' CH2' ' B' ' 121' ' ' TRP . 20.5 mt -62.47 -61.03 2.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.664 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.6 mt -55.47 -51.6 66.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.684 ' CD2' HD12 ' B' ' 128' ' ' LEU . 5.7 tt -56.83 -47.33 80.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.595 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.6 t -59.62 -66.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.6 mt -53.47 -21.04 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.664 HD12 ' C ' ' B' ' 123' ' ' LEU . 7.1 mt -79.04 -45.34 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.684 HD12 ' CD2' ' B' ' 124' ' ' LEU . 8.7 mt -71.76 -50.35 30.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.595 ' HD2' HG13 ' B' ' 125' ' ' VAL . 18.4 mtp180 -57.68 -48.05 80.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.56 -54.05 45.58 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 127' ' ' ILE . 14.0 t -44.59 -43.34 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.32 -36.57 79.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.498 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.036 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.4 mt -57.24 -51.06 70.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.95 -34.87 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.737 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.5 mt -81.87 -37.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.036 HD12 ' HA ' ' A' ' 5' ' ' LEU . 51.6 mt -58.88 -39.35 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.842 HG13 HG21 ' B' ' 108' ' ' ILE . 4.7 mt -74.47 -57.04 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 10' ' ' LEU . 26.7 mt -49.54 -44.6 46.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 7' ' ' ILE . 69.8 t -60.49 -47.92 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 mt-10 -48.78 -48.05 41.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -56.46 -61.06 2.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.93 -28.91 54.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.799 HG12 HD12 ' A' ' 16' ' ' ILE . 1.3 t -64.17 -65.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.799 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -42.89 -42.48 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.43 79.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.653 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.52 -60.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.9 mt-10 -40.88 -48.13 3.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 37.1 t80 -66.32 -32.24 73.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.979 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.23 -41.19 73.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.979 HD21 ' CH2' ' A' ' 21' ' ' TRP . 23.2 mt -60.43 -60.58 3.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.654 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.4 mt -53.53 -53.06 57.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.708 HD23 HD12 ' A' ' 28' ' ' LEU . 3.9 tt -57.33 -41.99 81.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.55 -66.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.752 ' CD1' HD12 ' B' ' 126' ' ' ILE . 5.5 mt -53.84 -20.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 23' ' ' LEU . 10.3 mt -80.04 -45.72 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.708 HD12 HD23 ' A' ' 24' ' ' LEU . 10.1 mt -69.64 -49.79 50.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.517 ' HD2' HG13 ' A' ' 25' ' ' VAL . 7.3 mtp180 -59.12 -50.2 74.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.615 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 25.2 m -62.96 -52.93 61.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' ILE . 3.6 t -44.28 -36.36 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 28' ' ' LEU . 23.2 mtmt -79.52 -35.57 39.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 30' ' ' THR . 6.2 mtp180 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.011 ' HB3' HD22 ' A' ' 5' ' ' LEU . 7.5 mt -56.22 -51.7 67.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.66 -35.75 1.91 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.868 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.7 mt -81.05 -41.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.001 ' CG2' HG22 ' A' ' 8' ' ' ILE . 36.5 mt -55.7 -38.53 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.783 HG13 HG21 ' A' ' 8' ' ' ILE . 5.0 mt -73.99 -57.52 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' B' ' 110' ' ' LEU . 27.7 mt -47.88 -45.48 30.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.868 HG23 ' O ' ' B' ' 107' ' ' ILE . 61.4 t -60.37 -47.93 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.8 mm-40 -48.21 -46.63 35.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -58.14 -60.09 4.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.17 -29.71 46.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.789 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -63.18 -65.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.789 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.93 -42.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.1 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.675 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -67.09 -60.43 2.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.448 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 30.3 mt-10 -40.67 -47.83 2.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 37.2 t80 -66.32 -32.64 74.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 0.969 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.07 -41.09 74.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.969 HD21 ' CH2' ' B' ' 121' ' ' TRP . 21.8 mt -60.14 -60.56 3.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.665 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.7 mt -53.75 -53.38 53.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.69 HD23 HD12 ' B' ' 128' ' ' LEU . 3.8 tt -56.77 -42.16 78.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.602 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.57 -66.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.752 HD12 ' CD1' ' A' ' 26' ' ' ILE . 5.8 mt -53.82 -20.67 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.665 HD12 ' C ' ' B' ' 123' ' ' LEU . 10.5 mt -80.13 -45.74 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.69 HD12 HD23 ' B' ' 124' ' ' LEU . 10.2 mt -69.65 -49.65 51.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.515 ' HD2' HG13 ' B' ' 125' ' ' VAL . 7.3 mtp180 -59.25 -50.24 74.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.628 ' HA ' ' HG3' ' B' ' 133' ' ' ARG . 25.3 m -62.92 -52.83 61.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 127' ' ' ILE . 3.7 t -44.39 -36.39 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' B' ' 128' ' ' LEU . 23.2 mtmt -79.47 -35.33 40.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.628 ' HG3' ' HA ' ' B' ' 130' ' ' THR . 6.1 mtp180 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.062 HD13 HD13 ' B' ' 105' ' ' LEU . 8.4 mt -54.08 -52.51 60.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -43.9 -36.17 2.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.727 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.2 mt -81.27 -36.59 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 5' ' ' LEU . 50.5 mt -59.63 -38.35 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.821 HG13 HG21 ' B' ' 108' ' ' ILE . 4.5 mt -74.94 -56.82 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 10' ' ' LEU . 34.9 mt -50.55 -44.04 56.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 7' ' ' ILE . 73.1 t -61.27 -46.81 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.5 mt-10 -49.74 -48.45 50.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -56.42 -61.44 2.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.94 -28.59 52.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.791 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.31 -65.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.791 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.03 -42.42 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.59 80.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.691 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.36 -59.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 mt-10 -41.38 -48.27 3.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 59.6 t80 -67.54 -30.08 69.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 1.01 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -72.03 -38.49 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD21 ' CH2' ' A' ' 21' ' ' TRP . 32.1 mt -64.24 -60.79 2.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 27' ' ' ILE . 6.0 mt -52.38 -48.25 65.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 28' ' ' LEU . 3.8 tt -64.6 -38.32 90.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.57 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.4 t -66.48 -65.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.795 ' CD1' HD12 ' B' ' 126' ' ' ILE . 7.6 mt -52.37 -21.61 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 31' ' ' VAL . 9.1 mt -79.62 -49.79 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.753 HD12 HD23 ' A' ' 24' ' ' LEU . 9.6 mt -66.42 -50.4 63.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HD2' HG13 ' A' ' 25' ' ' VAL . 27.7 mtp85 -57.99 -53.34 59.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.973 HG22 HH22 ' B' ' 133' ' ' ARG . 22.4 m -58.99 -49.1 79.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 27' ' ' ILE . 4.4 t -44.93 -42.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 27.3 mtmt -77.41 -33.4 55.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.961 HH22 HG22 ' B' ' 130' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 5' ' ' LEU . 8.6 mt -52.63 -53.19 50.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.06 -37.83 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.903 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.3 mt -79.53 -41.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.062 HD12 ' HA ' ' B' ' 105' ' ' LEU . 33.5 mt -54.56 -37.11 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.828 HG13 HD13 ' A' ' 8' ' ' ILE . 5.4 mt -74.49 -57.72 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 110' ' ' LEU . 35.3 mt -47.93 -44.76 30.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.903 HG23 ' O ' ' B' ' 107' ' ' ILE . 43.5 t -61.29 -47.7 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.7 mm-40 -48.36 -46.85 37.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.5 m -58.17 -60.28 4.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.29 -29.44 47.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.781 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -63.32 -65.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.781 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.96 -42.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.49 78.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.655 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.84 -59.12 3.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.401 ' OE1' ' HE3' ' A' ' 18' ' ' MET . 30.3 mt-10 -41.42 -47.79 3.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.413 ' CZ ' HD12 ' B' ' 124' ' ' LEU . 60.0 t80 -67.76 -30.33 69.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 0.997 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.7 -38.54 70.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.997 HD21 ' CH2' ' B' ' 121' ' ' TRP . 31.9 mt -64.24 -60.79 2.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.604 ' O ' HD12 ' B' ' 127' ' ' ILE . 6.3 mt -52.38 -48.26 65.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.775 HD23 HD12 ' B' ' 128' ' ' LEU . 3.9 tt -64.52 -38.49 91.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.4 t -66.42 -66.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.795 HD12 ' CD1' ' A' ' 26' ' ' ILE . 7.9 mt -52.28 -21.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.702 ' O ' HG23 ' B' ' 131' ' ' VAL . 8.7 mt -79.59 -50.03 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.775 HD12 HD23 ' B' ' 124' ' ' LEU . 9.3 mt -66.36 -50.26 64.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.565 ' HD2' HG13 ' B' ' 125' ' ' VAL . 27.6 mtp85 -58.07 -53.1 62.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.961 HG22 HH22 ' A' ' 33' ' ' ARG . 22.2 m -59.2 -48.64 80.86 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.702 HG23 ' O ' ' B' ' 127' ' ' ILE . 4.6 t -45.09 -42.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.445 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 27.4 mtmt -77.15 -33.4 56.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.973 HH22 HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.013 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.1 mt -49.41 -53.85 20.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -43.97 -44.12 7.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.942 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.8 mt -72.16 -41.79 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.046 HG22 ' CG2' ' B' ' 108' ' ' ILE . 49.8 mt -54.1 -33.23 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.969 HG13 HD13 ' B' ' 108' ' ' ILE . 3.9 mt -74.61 -56.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 10' ' ' LEU . 42.5 mt -51.26 -48.74 62.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.4 t -56.92 -48.31 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.9 mt-10 -47.75 -51.25 22.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -53.3 -60.13 3.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -56.84 -26.35 58.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.786 HG11 HG21 ' B' ' 115' ' ' VAL . 1.2 t -69.82 -63.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.697 HD12 HG12 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -43.46 -38.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.36 -29.29 59.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.825 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 3.2 mtp -63.54 -54.23 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.58 ' OE1' ' HE2' ' B' ' 118' ' ' MET . 23.7 mt-10 -59.91 -46.44 89.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.86 -64.32 0.87 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.825 ' CD1' ' HA ' ' A' ' 18' ' ' MET . 0.6 OUTLIER -57.43 -37.56 72.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.506 ' CD2' HD11 ' B' ' 123' ' ' LEU . 12.4 mt -55.5 -61.63 2.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 mt -59.42 -51.14 71.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -41.57 62.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -69.51 -66.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.647 HG22 HG22 ' B' ' 126' ' ' ILE . 4.8 mt -50.83 -20.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 31' ' ' VAL . 18.1 mt -81.22 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.18 -48.33 73.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 25' ' ' VAL . 15.9 mtp-105 -60.78 -52.52 64.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 7.6 m -57.31 -51.58 68.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 27' ' ' ILE . 19.5 t -44.64 -47.62 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -68.16 -34.01 75.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.028 ' HA ' HD12 ' B' ' 108' ' ' ILE . 8.8 mt -49.55 -53.91 21.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -43.87 -44.16 6.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.94 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -72.15 -41.89 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.046 ' CG2' HG22 ' A' ' 8' ' ' ILE . 49.0 mt -54.06 -33.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.989 HG13 HD13 ' A' ' 8' ' ' ILE . 3.9 mt -74.54 -56.4 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' B' ' 110' ' ' LEU . 42.4 mt -51.38 -48.85 62.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.94 HG23 ' O ' ' B' ' 107' ' ' ILE . 17.5 t -56.68 -48.41 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 1.9 mt-10 -47.77 -51.37 22.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -53.1 -60.12 3.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -56.85 -26.35 58.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 15' ' ' VAL . 1.2 t -69.92 -63.31 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.682 ' N ' HG12 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -43.55 -38.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.4 59.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.828 ' HA ' ' CD1' ' B' ' 121' ' ' TRP . 3.2 mtp -63.46 -54.02 43.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.585 ' OE1' ' HE2' ' A' ' 18' ' ' MET . 23.8 mt-10 -60.09 -46.56 89.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -53.77 -64.17 0.91 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 0.828 ' CD1' ' HA ' ' B' ' 118' ' ' MET . 0.6 OUTLIER -57.47 -37.63 73.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.498 HD23 ' CH2' ' B' ' 121' ' ' TRP . 12.4 mt -55.51 -61.49 2.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.594 ' C ' HD12 ' B' ' 127' ' ' ILE . 8.6 mt -59.57 -51.09 71.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -41.41 62.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.607 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -69.67 -66.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.647 HG22 HG22 ' A' ' 26' ' ' ILE . 4.9 mt -50.81 -21.04 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.714 ' O ' HG23 ' B' ' 131' ' ' VAL . 18.6 mt -81.21 -49.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.98 -48.24 74.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.586 ' HD2' HG13 ' B' ' 125' ' ' VAL . 16.0 mtp-105 -60.92 -52.71 63.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 7.5 m -57.12 -51.5 69.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 127' ' ' ILE . 20.3 t -44.56 -47.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -68.59 -33.57 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.043 ' HA ' HD12 ' A' ' 8' ' ' ILE . 8.7 mt -51.62 -54.12 31.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.74 -40.3 4.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.899 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.8 mt -76.68 -41.01 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.043 HD12 ' HA ' ' A' ' 5' ' ' LEU . 46.4 mt -54.05 -35.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.776 HG12 HG21 ' B' ' 108' ' ' ILE . 1.6 mt -75.54 -56.53 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 10' ' ' LEU . 20.0 mt -49.57 -45.53 47.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 7' ' ' ILE . 23.2 t -61.22 -47.51 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.6 mt-10 -47.61 -47.84 28.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -58.07 -59.92 4.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.23 -28.26 51.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.813 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.61 -65.91 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.813 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.0 -42.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.39 80.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.701 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.66 -60.14 2.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 30.3 mt-10 -41.2 -47.97 3.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 17.1 t80 -66.37 -31.59 72.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.976 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.0 -41.86 70.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.976 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.5 mt -59.75 -60.15 4.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.34 -54.78 31.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.751 HD23 HD12 ' A' ' 28' ' ' LEU . 2.6 tt -56.26 -41.33 75.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.39 -66.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.763 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.7 mt -54.69 -22.15 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.716 HD12 ' C ' ' A' ' 23' ' ' LEU . 11.6 mt -78.28 -43.54 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.751 HD12 HD23 ' A' ' 24' ' ' LEU . 10.1 mt -72.19 -52.71 15.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.484 ' HD2' HG13 ' A' ' 25' ' ' VAL . 12.7 mtp180 -55.98 -46.98 78.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.582 HG22 ' CZ ' ' B' ' 133' ' ' ARG . 16.6 m -64.48 -54.98 23.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 27' ' ' ILE . 7.5 t -44.2 -34.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -79.89 -33.59 39.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.519 ' HE ' ' HE ' ' B' ' 133' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 1.043 HD22 ' HB3' ' A' ' 5' ' ' LEU . 9.0 mt -51.7 -54.09 32.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.72 -40.28 4.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.917 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -76.74 -41.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 1.028 HG22 ' CG2' ' A' ' 8' ' ' ILE . 44.8 mt -54.13 -34.99 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.763 HG12 HG21 ' A' ' 8' ' ' ILE . 1.6 mt -75.61 -56.32 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' B' ' 110' ' ' LEU . 19.8 mt -49.64 -45.66 48.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.917 HG23 ' O ' ' B' ' 107' ' ' ILE . 22.0 t -61.11 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.6 mt-10 -47.39 -47.85 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -58.09 -60.06 4.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.17 -28.1 50.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.789 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -64.81 -65.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.789 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.99 -42.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.39 80.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.43 -60.46 2.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.445 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.5 mt-10 -41.12 -48.2 3.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 17.3 t80 -66.11 -31.66 72.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' TRP . . . . . 0.972 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.9 -41.95 70.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.972 HD21 ' CH2' ' B' ' 121' ' ' TRP . 25.4 mt -59.8 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.679 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.2 mt -53.22 -54.96 28.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.757 HD23 HD12 ' B' ' 128' ' ' LEU . 2.5 tt -56.42 -40.72 75.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.604 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.3 t -63.95 -66.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.763 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.7 mt -54.39 -23.57 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.737 ' O ' HG23 ' B' ' 131' ' ' VAL . 12.9 mt -76.68 -45.52 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.757 HD12 HD23 ' B' ' 124' ' ' LEU . 10.0 mt -70.53 -54.49 11.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.501 ' HD2' HG13 ' B' ' 125' ' ' VAL . 12.6 mtp180 -53.55 -45.37 69.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' B' ' 133' ' ' ARG . 21.2 m -68.02 -50.64 54.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 127' ' ' ILE . 3.8 t -42.98 -35.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -87.96 -27.94 21.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ARG . . . . . 0.582 ' CZ ' HG22 ' A' ' 30' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.666 ' HG3' HD12 ' A' ' 5' ' ' LEU . 9.8 ttpp -72.18 -22.12 61.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -48.61 -52.81 21.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -43.99 -58.04 3.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.033 HD22 ' HB3' ' B' ' 105' ' ' LEU . 7.8 mt -52.39 -53.37 45.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.92 -37.82 3.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.881 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.9 mt -79.34 -39.6 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.012 ' CG2' HG22 ' B' ' 108' ' ' ILE . 49.1 mt -55.97 -36.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.802 HG13 HG21 ' B' ' 108' ' ' ILE . 5.4 mt -75.72 -55.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 10' ' ' LEU . 18.4 mt -49.91 -48.14 51.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 7' ' ' ILE . 35.3 t -59.03 -49.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.9 mt-10 -45.51 -47.49 14.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.41 -59.01 6.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.7 -29.56 53.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.78 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -63.88 -65.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.78 HD12 HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -41.98 -44.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.52 78.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.658 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.5 mtp -66.81 -57.24 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' B' ' 119' ' ' GLU . 2.2 mm-40 -41.1 -48.55 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t80 -67.73 -31.17 70.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 1.03 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.02 -39.85 72.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.03 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.3 mt -61.79 -60.28 3.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 mt -54.95 -52.94 61.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.689 ' CD2' HD12 ' A' ' 28' ' ' LEU . 6.1 tt -55.71 -48.26 75.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.4 t -58.6 -66.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.8 mt -54.14 -20.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt -79.32 -43.86 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.689 HD12 ' CD2' ' A' ' 24' ' ' LEU . 9.1 mt -72.97 -49.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HD2' HG13 ' A' ' 25' ' ' VAL . 28.6 mtp85 -58.46 -47.7 83.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.47 -54.44 40.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 27' ' ' ILE . 13.5 t -44.46 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.2 mttt -68.9 -36.01 77.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.582 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -49.48 -29.82 7.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -70.32 -66.16 0.63 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 32' ' ' LYS . 3.5 p30 -69.17 -5.9 25.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . -59.98 -24.43 60.55 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.64 ' HG3' HD12 ' B' ' 105' ' ' LEU . 10.6 ttpp -73.85 -21.82 59.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -48.08 -53.33 16.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -43.95 -58.3 2.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.033 ' HB3' HD22 ' A' ' 5' ' ' LEU . 7.7 mt -52.84 -53.07 53.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.88 -37.37 2.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.898 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.9 mt -80.01 -40.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.026 HD12 ' HA ' ' B' ' 105' ' ' LEU . 42.8 mt -55.77 -36.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.775 HG13 HG21 ' A' ' 8' ' ' ILE . 5.4 mt -75.75 -55.08 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' B' ' 110' ' ' LEU . 18.1 mt -49.83 -48.15 51.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.898 HG23 ' O ' ' B' ' 107' ' ' ILE . 32.7 t -58.95 -49.72 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.9 mt-10 -45.35 -47.53 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.43 -58.84 6.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.75 -29.6 54.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.773 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -63.96 -66.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.773 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -41.92 -44.68 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.58 79.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.658 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.83 -57.22 7.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 2.2 mm-40 -41.23 -48.46 3.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 46.5 t80 -67.84 -31.02 70.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 1.017 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.08 -40.01 71.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 1.017 HD21 ' CH2' ' B' ' 121' ' ' TRP . 24.9 mt -61.73 -60.27 3.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.632 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.7 mt -54.92 -52.96 61.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.694 ' CD2' HD12 ' B' ' 128' ' ' LEU . 6.1 tt -55.68 -48.32 75.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.562 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.4 t -58.53 -66.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.8 mt -54.15 -20.66 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.643 ' O ' HG23 ' B' ' 131' ' ' VAL . 7.9 mt -79.38 -43.78 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' B' ' 124' ' ' LEU . 9.0 mt -73.11 -49.75 26.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.536 ' HD2' HG13 ' B' ' 125' ' ' VAL . 28.6 mtp85 -58.48 -47.73 83.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.34 -54.44 40.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.643 HG23 ' O ' ' B' ' 127' ' ' ILE . 13.7 t -44.51 -43.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 136' ' ' GLY . 68.5 mttt -68.95 -35.84 77.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.582 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -49.56 -29.81 7.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -70.36 -66.33 0.61 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' B' ' 132' ' ' LYS . 3.4 p30 -68.83 -5.76 22.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 132' ' ' LYS . . . -59.97 -24.55 60.66 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -71.98 -22.14 61.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.0 m -51.54 -46.59 63.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.58 -58.21 5.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.035 ' HA ' HD12 ' A' ' 8' ' ' ILE . 8.5 mt -49.14 -53.47 20.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.13 -43.63 7.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.93 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.4 mt -72.75 -42.14 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.035 HD12 ' HA ' ' A' ' 5' ' ' LEU . 59.7 mt -52.53 -33.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.994 HG13 HD13 ' B' ' 108' ' ' ILE . 5.4 mt -75.62 -57.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 10' ' ' LEU . 34.3 mt -49.8 -45.36 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.7 t -60.73 -48.08 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.5 mt-10 -47.63 -47.96 28.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -57.44 -60.47 3.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.12 -28.28 51.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.811 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.62 -65.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.811 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -42.94 -42.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.39 80.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.725 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.4 -60.61 2.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 29.7 mt-10 -41.05 -48.09 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.9 t80 -66.02 -32.06 73.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.982 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.84 -42.35 70.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.982 HD21 ' CH2' ' A' ' 21' ' ' TRP . 23.0 mt -58.79 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.624 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.31 -56.16 18.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.749 HD23 HD12 ' A' ' 28' ' ' LEU . 2.5 tt -55.0 -40.65 70.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.1 t -63.86 -67.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.778 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.0 mt -55.27 -20.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 31' ' ' VAL . 15.9 mt -79.85 -40.87 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.749 HD12 HD23 ' A' ' 24' ' ' LEU . 10.2 mt -75.26 -49.5 19.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HD2' HG13 ' A' ' 25' ' ' VAL . 27.0 mtp180 -59.35 -47.19 86.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 9.5 m -62.17 -55.06 32.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.3 -43.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -68.61 -35.57 77.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.89 -29.7 8.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.49 -39.58 62.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 37' ' ' GLY . 14.8 m-20 -68.79 -63.99 0.95 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.9 -21.13 0.19 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 C--N 1.336 0.536 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -73.21 -22.28 60.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 60.8 m -51.12 -46.7 61.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.6 -58.27 4.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.03 ' HA ' HD12 ' B' ' 108' ' ' ILE . 8.2 mt -49.11 -53.33 21.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.24 -43.8 7.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.931 ' O ' HG23 ' B' ' 111' ' ' VAL . 17.0 mt -72.61 -42.11 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.03 HD12 ' HA ' ' B' ' 105' ' ' LEU . 59.5 mt -52.51 -33.57 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.988 HG13 HD13 ' A' ' 8' ' ' ILE . 5.5 mt -75.65 -57.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' B' ' 110' ' ' LEU . 34.7 mt -49.7 -45.24 48.74 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.931 HG23 ' O ' ' B' ' 107' ' ' ILE . 18.1 t -60.91 -48.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.5 mt-10 -47.69 -48.06 29.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.3 -60.64 3.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.02 -28.32 51.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.785 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.61 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.785 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.94 -42.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.38 80.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.3 -60.65 2.58 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.0 mt-10 -41.05 -48.26 3.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 68.3 t80 -65.85 -32.02 73.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.76 -42.47 70.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' B' ' 121' ' ' TRP . 23.3 mt -58.8 -60.13 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.621 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.2 mt -53.26 -56.2 18.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.746 HD23 HD12 ' B' ' 128' ' ' LEU . 2.4 tt -55.01 -40.62 70.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.627 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.89 -66.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.778 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.41 -20.76 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.631 ' O ' HG23 ' B' ' 131' ' ' VAL . 16.3 mt -79.8 -40.79 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.746 HD12 HD23 ' B' ' 124' ' ' LEU . 10.3 mt -75.33 -49.63 18.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.491 ' HD2' HG13 ' B' ' 125' ' ' VAL . 25.6 mtp180 -59.23 -47.21 86.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.1 m -62.08 -54.89 35.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 127' ' ' ILE . 12.2 t -44.33 -43.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -68.58 -35.84 77.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.549 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -49.6 -29.66 7.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.63 -39.74 61.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ASN . . . . . 0.457 ' C ' ' N ' ' B' ' 137' ' ' GLY . 15.2 m-20 -68.37 -64.16 0.92 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -43.84 -20.91 0.17 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' HZ3' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -66.61 -21.2 66.13 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.9 m -53.89 -45.09 70.96 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -58.29 6.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.056 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.5 mt -51.48 -51.59 53.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -44.29 -42.99 7.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.939 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.8 mt -73.35 -42.18 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.056 HD12 ' HA ' ' A' ' 5' ' ' LEU . 61.4 mt -52.53 -33.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.998 HG13 HD13 ' B' ' 108' ' ' ILE . 4.5 mt -75.64 -57.3 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 10' ' ' LEU . 32.7 mt -49.72 -45.93 49.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.3 t -60.2 -48.42 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.4 mt-10 -47.2 -48.03 24.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -57.4 -60.48 3.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.05 -28.3 51.26 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.82 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.5 -65.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.82 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.07 -42.12 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.29 79.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.719 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.42 -60.76 2.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.7 mt-10 -40.97 -48.27 3.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 9.7 t80 -66.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 1.006 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.92 -41.2 71.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.006 HD21 ' CH2' ' A' ' 21' ' ' TRP . 39.4 mt -59.82 -60.15 4.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.689 HD11 HD22 ' B' ' 122' ' ' LEU . 5.4 mt -53.82 -54.73 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD23 HD12 ' A' ' 28' ' ' LEU . 3.4 tt -55.75 -42.36 75.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.611 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -62.55 -66.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.749 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.5 mt -55.01 -20.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.64 HD12 ' C ' ' A' ' 23' ' ' LEU . 12.0 mt -79.86 -42.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.752 HD12 HD23 ' A' ' 24' ' ' LEU . 9.9 mt -73.85 -49.32 25.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HD2' HG13 ' A' ' 25' ' ' VAL . 15.1 mtp180 -59.48 -47.58 84.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 11.5 m -62.46 -54.74 35.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 27' ' ' ILE . 11.4 t -44.24 -43.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -68.42 -34.95 76.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -50.73 -29.04 10.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 36' ' ' GLY . . . -75.79 -46.25 31.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -57.82 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -89.07 37.44 3.32 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.508 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.632 ' HB2' ' HZ3' ' B' ' 102' ' ' LYS . 0.0 OUTLIER -64.83 -21.63 66.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -53.58 -45.71 70.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -58.19 6.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.031 ' HA ' HD12 ' B' ' 108' ' ' ILE . 7.7 mt -50.61 -52.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.39 -43.47 7.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.931 ' O ' HG23 ' B' ' 111' ' ' VAL . 17.8 mt -72.61 -42.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.033 ' CG2' HG22 ' A' ' 8' ' ' ILE . 62.3 mt -52.48 -33.55 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.953 HG13 HD13 ' A' ' 8' ' ' ILE . 4.8 mt -75.57 -57.18 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' B' ' 110' ' ' LEU . 30.6 mt -49.84 -45.58 50.47 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.931 HG23 ' O ' ' B' ' 107' ' ' ILE . 17.7 t -60.53 -47.98 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.48 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.4 mt-10 -47.77 -47.99 30.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.38 -60.73 3.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.0 -28.29 50.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.798 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.44 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.798 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -43.1 -42.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.47 80.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.45 -60.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.446 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.7 mt-10 -40.93 -48.31 3.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.94 -32.16 73.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 1.005 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.83 -41.28 71.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 1.005 HD21 ' CH2' ' B' ' 121' ' ' TRP . 39.8 mt -59.76 -60.24 4.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.687 HD11 HD22 ' A' ' 22' ' ' LEU . 5.3 mt -53.74 -54.79 33.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.733 HD23 HD12 ' B' ' 128' ' ' LEU . 3.4 tt -55.63 -42.32 74.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.615 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -62.68 -66.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.749 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.4 mt -55.01 -20.7 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 131' ' ' VAL . 12.2 mt -79.76 -42.24 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.733 HD12 HD23 ' B' ' 124' ' ' LEU . 9.8 mt -73.93 -49.45 24.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.496 ' HD2' HG13 ' B' ' 125' ' ' VAL . 15.0 mtp180 -59.27 -47.53 85.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 11.2 m -62.38 -54.63 37.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 127' ' ' ILE . 11.7 t -44.25 -44.0 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -68.56 -34.92 76.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.58 ' CZ ' ' HA ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.639 ' C ' ' H ' ' B' ' 136' ' ' GLY . . . -75.55 -46.18 33.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -57.5 4.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' B' ' 134' ' ' ALA . . . -88.83 37.4 3.31 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.744 ' HG3' HD12 ' A' ' 5' ' ' LEU . 14.7 ttmm -54.34 -21.52 9.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.1 m -47.59 -51.79 19.96 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -44.09 -57.54 3.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.095 HD13 HD13 ' B' ' 105' ' ' LEU . 8.1 mt -53.41 -53.44 51.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.64 -37.16 2.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.888 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.7 mt -79.71 -40.81 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.002 ' CG2' HG22 ' B' ' 108' ' ' ILE . 41.6 mt -55.27 -36.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.753 HG13 HG21 ' B' ' 108' ' ' ILE . 3.9 mt -75.51 -54.82 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' A' ' 10' ' ' LEU . 19.4 mt -50.16 -46.95 54.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 7' ' ' ILE . 26.0 t -60.23 -47.86 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.6 mt-10 -47.17 -47.08 24.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.99 -60.57 3.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.69 -27.92 43.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.822 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.57 -66.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.822 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.06 -42.09 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.31 79.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.652 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.51 -60.33 2.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 30.5 mt-10 -41.13 -48.06 3.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 14.5 t80 -65.83 -32.1 73.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.74 -42.36 70.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.7 mt -58.87 -60.02 4.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.35 -56.08 19.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.734 HD23 HD12 ' A' ' 28' ' ' LEU . 2.3 tt -55.09 -40.75 70.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.1 t -63.69 -66.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.77 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.0 mt -55.5 -20.68 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 31' ' ' VAL . 15.5 mt -79.91 -40.5 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.734 HD12 HD23 ' A' ' 24' ' ' LEU . 10.2 mt -75.7 -49.45 18.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HD2' HG13 ' A' ' 25' ' ' VAL . 23.3 mtp180 -59.47 -46.81 87.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.43 -54.85 34.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.4 -43.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.22 -35.95 78.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.46 -29.88 7.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.26 -41.61 61.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -66.86 -30.47 70.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.39 24.22 1.29 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.541 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.749 ' HG3' HD12 ' B' ' 105' ' ' LEU . 14.7 ttmm -54.96 -21.38 11.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.4 m -47.41 -51.96 18.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -43.97 -57.88 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.095 HD13 HD13 ' A' ' 5' ' ' LEU . 7.9 mt -53.38 -53.36 52.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.59 -37.18 2.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.909 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.7 mt -79.8 -40.66 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' B' ' 105' ' ' LEU . 42.3 mt -55.53 -36.31 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.745 HG13 HG21 ' A' ' 8' ' ' ILE . 3.9 mt -75.66 -54.79 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' B' ' 110' ' ' LEU . 18.8 mt -50.15 -46.79 54.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.909 HG23 ' O ' ' B' ' 107' ' ' ILE . 26.8 t -60.39 -47.74 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.6 mt-10 -47.24 -47.1 24.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.98 -60.56 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.72 -27.85 43.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.8 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.6 -66.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.8 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -43.14 -42.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.33 79.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.654 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.4 -60.38 2.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 29.8 mt-10 -41.2 -48.09 3.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 14.4 t80 -65.72 -32.04 73.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.976 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.91 -42.27 70.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.976 HD21 ' CH2' ' B' ' 121' ' ' TRP . 24.9 mt -58.9 -60.14 4.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.625 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.3 mt -53.24 -56.08 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.739 HD23 HD12 ' B' ' 128' ' ' LEU . 2.3 tt -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.622 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.59 -66.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.77 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.39 -20.84 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 131' ' ' VAL . 15.4 mt -79.83 -40.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.739 HD12 HD23 ' B' ' 124' ' ' LEU . 10.2 mt -75.71 -49.49 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.483 ' HD2' HG13 ' B' ' 125' ' ' VAL . 23.3 mtp180 -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.7 m -62.37 -54.79 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 127' ' ' ILE . 12.7 t -44.43 -43.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.19 -36.05 78.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.548 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -49.36 -29.88 6.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.548 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.2 -41.54 61.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -66.87 -30.32 70.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.48 24.49 1.25 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.554 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.715 ' HG3' HD12 ' A' ' 5' ' ' LEU . 15.7 ttmt -68.69 -23.47 64.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.5 m -49.91 -49.35 50.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -45.71 -58.3 3.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.084 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.0 mt -48.57 -54.18 15.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.67 -40.87 6.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.908 ' O ' HG23 ' A' ' 11' ' ' VAL . 14.9 mt -75.05 -40.18 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.084 HD12 ' HA ' ' A' ' 5' ' ' LEU . 74.8 mt -52.54 -38.94 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.827 HG13 HG21 ' B' ' 108' ' ' ILE . 5.4 mt -72.88 -57.45 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 10' ' ' LEU . 21.1 mt -48.48 -39.58 23.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 7' ' ' ILE . 52.3 t -64.79 -46.47 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 1.6 mt-10 -49.97 -49.85 48.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -55.87 -61.34 2.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -50.58 -37.48 40.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.892 HG12 HD12 ' A' ' 16' ' ' ILE . 1.3 t -55.16 -66.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.892 HD12 HG12 ' A' ' 15' ' ' VAL . 1.2 mp -42.59 -39.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -58.62 -40.94 84.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.672 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 3.1 mtm -66.5 -55.58 14.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.522 ' CD ' ' CE ' ' B' ' 118' ' ' MET . 47.6 mt-10 -39.38 -47.71 1.81 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CZ ' HD12 ' A' ' 24' ' ' LEU . 23.7 t80 -67.37 -36.67 81.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 1.022 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.87 -39.6 90.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.022 HD21 ' CH2' ' A' ' 21' ' ' TRP . 17.9 mt -61.17 -61.15 2.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.598 HD11 HD22 ' B' ' 122' ' ' LEU . 6.7 mt -55.83 -52.68 63.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.643 ' CD2' HD12 ' A' ' 28' ' ' LEU . 5.2 tt -54.71 -48.67 72.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.588 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.6 t -59.14 -66.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.5 mt -53.29 -21.86 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt -78.42 -44.95 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.643 HD12 ' CD2' ' A' ' 24' ' ' LEU . 9.3 mt -72.08 -51.58 20.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.588 ' HD2' HG13 ' A' ' 25' ' ' VAL . 8.8 mtp180 -56.32 -47.55 78.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.0 m -62.68 -54.58 37.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 27' ' ' ILE . 16.1 t -44.33 -43.04 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -69.63 -35.0 74.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.601 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -50.47 -30.19 12.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -73.41 -31.45 63.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -78.92 -25.69 43.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.12 -14.36 11.12 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.695 ' HG3' HD12 ' B' ' 105' ' ' LEU . 16.0 ttmt -69.0 -23.88 64.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 56.1 m -49.68 -49.39 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -45.75 -58.31 3.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.078 HD22 ' HB3' ' A' ' 5' ' ' LEU . 8.7 mt -48.73 -54.25 15.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.51 -40.8 5.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.904 ' O ' HG23 ' B' ' 111' ' ' VAL . 14.9 mt -74.96 -40.46 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.077 HD12 ' HA ' ' B' ' 105' ' ' LEU . 74.9 mt -52.39 -38.97 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.813 HG13 HG21 ' A' ' 8' ' ' ILE . 5.3 mt -72.85 -57.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' B' ' 110' ' ' LEU . 20.8 mt -48.46 -39.57 23.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.904 HG23 ' O ' ' B' ' 107' ' ' ILE . 51.3 t -64.74 -46.41 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mt-10 -50.08 -49.92 49.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.75 -61.22 2.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.656 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.75 -37.5 42.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.872 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -55.13 -66.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.872 HD12 HG12 ' B' ' 115' ' ' VAL . 1.2 mp -42.55 -39.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' B' ' 114' ' ' ALA . . . -58.67 -40.84 84.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.659 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 3.1 mtm -66.53 -55.65 14.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 18' ' ' MET . 48.1 mt-10 -39.37 -47.61 1.79 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' B' ' 124' ' ' LEU . 23.9 t80 -67.47 -36.63 81.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 1.006 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -65.9 -39.62 90.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 1.006 HD21 ' CH2' ' B' ' 121' ' ' TRP . 17.9 mt -61.24 -61.05 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.601 HD11 HD22 ' A' ' 22' ' ' LEU . 6.5 mt -55.86 -52.73 63.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.643 ' CD2' HD12 ' B' ' 128' ' ' LEU . 5.2 tt -54.7 -48.55 72.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.575 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.6 t -59.15 -66.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.5 mt -53.36 -21.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.664 ' O ' HG23 ' B' ' 131' ' ' VAL . 9.0 mt -78.47 -44.81 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.643 HD12 ' CD2' ' B' ' 124' ' ' LEU . 9.4 mt -72.3 -51.37 21.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.575 ' HD2' HG13 ' B' ' 125' ' ' VAL . 8.8 mtp180 -56.54 -47.62 79.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.1 m -62.56 -54.46 39.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 127' ' ' ILE . 15.8 t -44.47 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -69.61 -34.84 74.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.601 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -50.63 -30.11 12.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.563 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -73.36 -31.44 63.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -78.91 -25.77 43.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.76 -14.24 9.52 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.535 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HG2' HD12 ' A' ' 5' ' ' LEU . 11.9 ttpt -70.25 -23.31 62.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.2 m -49.44 -52.12 31.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -44.09 -56.04 4.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.7 mt -51.25 -54.28 27.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -44.75 -39.57 5.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.0 mt -78.27 -36.42 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.03 HG22 ' CG2' ' B' ' 108' ' ' ILE . 50.4 mt -57.53 -38.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.89 HG12 HD13 ' B' ' 108' ' ' ILE . 3.4 mt -73.78 -57.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 10' ' ' LEU . 28.1 mt -50.27 -39.83 46.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 7' ' ' ILE . 71.7 t -64.23 -45.73 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' CG ' ' HG2' ' B' ' 112' ' ' GLU . 1.1 mt-10 -50.81 -50.8 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -54.69 -60.25 3.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.683 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -51.05 -38.11 49.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.906 HG22 ' HE1' ' A' ' 18' ' ' MET . 1.4 t -55.51 -66.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.832 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -41.71 -40.23 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.43 -40.74 87.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.906 ' HE1' HG22 ' A' ' 15' ' ' VAL . 2.9 mtm -67.03 -55.19 15.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 119' ' ' GLU . 3.4 mm-40 -39.58 -47.98 2.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 29.4 t80 -68.47 -34.86 76.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 1.035 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -67.34 -38.75 85.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.035 HD21 ' CH2' ' A' ' 21' ' ' TRP . 20.1 mt -62.33 -61.02 2.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 27' ' ' ILE . 6.1 mt -55.67 -51.66 66.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CD2' HD12 ' A' ' 28' ' ' LEU . 5.8 tt -56.6 -47.69 79.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.7 t -59.6 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 6.2 mt -53.35 -21.3 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 23' ' ' LEU . 7.1 mt -78.84 -45.61 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.681 HD12 ' CD2' ' A' ' 24' ' ' LEU . 8.7 mt -71.6 -50.51 30.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HD2' HG13 ' A' ' 25' ' ' VAL . 18.3 mtp180 -57.4 -47.99 80.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.61 -54.34 41.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 27' ' ' ILE . 15.0 t -44.39 -43.45 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.35 -36.34 79.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.0 -29.76 5.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.49 -41.55 60.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 37' ' ' GLY . 14.3 m-20 -65.82 -22.01 66.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.16 2.72 0.15 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 CA--C 1.523 0.539 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.456 ' HG2' HD12 ' B' ' 105' ' ' LEU . 11.9 ttpt -68.91 -24.85 64.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 48.8 m -49.65 -51.06 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.51 -56.04 4.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.026 ' HA ' HD12 ' B' ' 108' ' ' ILE . 9.0 mt -51.26 -54.62 24.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -43.77 -41.18 4.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.908 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -75.69 -39.84 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.03 ' CG2' HG22 ' A' ' 8' ' ' ILE . 55.6 mt -53.93 -37.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.858 HG12 HD13 ' A' ' 8' ' ' ILE . 4.0 mt -73.31 -57.81 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' B' ' 110' ' ' LEU . 20.6 mt -48.72 -41.33 31.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.908 HG23 ' O ' ' B' ' 107' ' ' ILE . 48.4 t -64.35 -43.74 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.7 mm-40 -51.47 -50.57 59.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.88 -59.2 5.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.669 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.77 -38.37 47.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.843 HG11 HG11 ' A' ' 15' ' ' VAL . 1.3 t -55.37 -65.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.825 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -41.75 -40.27 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' B' ' 114' ' ' ALA . . . -59.53 -40.64 87.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.785 ' HE1' HG22 ' B' ' 115' ' ' VAL . 3.0 mtm -66.95 -55.27 15.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.476 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 3.7 mm-40 -39.65 -48.03 2.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 29.7 t80 -68.5 -34.59 76.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 1.041 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -67.47 -38.76 84.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 1.041 HD21 ' CH2' ' B' ' 121' ' ' TRP . 20.5 mt -62.47 -61.03 2.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.664 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.6 mt -55.47 -51.6 66.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.684 ' CD2' HD12 ' B' ' 128' ' ' LEU . 5.7 tt -56.83 -47.33 80.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.595 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.6 t -59.62 -66.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.6 mt -53.47 -21.04 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.664 HD12 ' C ' ' B' ' 123' ' ' LEU . 7.1 mt -79.04 -45.34 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.684 HD12 ' CD2' ' B' ' 124' ' ' LEU . 8.7 mt -71.76 -50.35 30.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.595 ' HD2' HG13 ' B' ' 125' ' ' VAL . 18.4 mtp180 -57.68 -48.05 80.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.56 -54.05 45.58 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 127' ' ' ILE . 14.0 t -44.59 -43.34 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.32 -36.57 79.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -48.78 -29.78 4.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.32 -41.66 60.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ASN . . . . . 0.59 ' C ' ' H ' ' B' ' 137' ' ' GLY . 14.3 m-20 -65.69 -21.83 66.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.05 2.8 0.14 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 CA--C 1.522 0.494 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.657 ' HG3' HD12 ' A' ' 5' ' ' LEU . 20.2 ttpt -70.36 -21.96 62.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -47.51 -51.68 19.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -44.89 -56.26 4.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.036 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.4 mt -57.24 -51.06 70.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.95 -34.87 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.737 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.5 mt -81.87 -37.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.036 HD12 ' HA ' ' A' ' 5' ' ' LEU . 51.6 mt -58.88 -39.35 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.842 HG13 HG21 ' B' ' 108' ' ' ILE . 4.7 mt -74.47 -57.04 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 10' ' ' LEU . 26.7 mt -49.54 -44.6 46.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 7' ' ' ILE . 69.8 t -60.49 -47.92 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 mt-10 -48.78 -48.05 41.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -56.46 -61.06 2.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.93 -28.91 54.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.799 HG12 HD12 ' A' ' 16' ' ' ILE . 1.3 t -64.17 -65.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.799 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -42.89 -42.48 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.43 79.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.653 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.52 -60.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.9 mt-10 -40.88 -48.13 3.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 37.1 t80 -66.32 -32.24 73.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.979 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.23 -41.19 73.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.979 HD21 ' CH2' ' A' ' 21' ' ' TRP . 23.2 mt -60.43 -60.58 3.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.654 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.4 mt -53.53 -53.06 57.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.708 HD23 HD12 ' A' ' 28' ' ' LEU . 3.9 tt -57.33 -41.99 81.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.55 -66.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.752 ' CD1' HD12 ' B' ' 126' ' ' ILE . 5.5 mt -53.84 -20.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 23' ' ' LEU . 10.3 mt -80.04 -45.72 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.708 HD12 HD23 ' A' ' 24' ' ' LEU . 10.1 mt -69.64 -49.79 50.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' HD2' HG13 ' A' ' 25' ' ' VAL . 7.3 mtp180 -59.12 -50.2 74.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.615 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 25.2 m -62.96 -52.93 61.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' ILE . 3.6 t -44.28 -36.36 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 28' ' ' LEU . 23.2 mtmt -79.52 -35.57 39.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 30' ' ' THR . 6.2 mtp180 -52.32 -35.89 51.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 36' ' ' GLY . . . -67.85 -31.33 71.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 37' ' ' GLY . 26.5 m-20 -74.35 15.47 0.33 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -50.48 -10.06 0.32 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.652 ' HG3' HD12 ' B' ' 105' ' ' LEU . 20.7 ttpt -70.25 -21.98 62.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 14.4 m -48.2 -51.03 27.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -45.1 -56.65 4.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.011 ' HB3' HD22 ' A' ' 5' ' ' LEU . 7.5 mt -56.22 -51.7 67.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.66 -35.75 1.91 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.868 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.7 mt -81.05 -41.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.001 ' CG2' HG22 ' A' ' 8' ' ' ILE . 36.5 mt -55.7 -38.53 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.783 HG13 HG21 ' A' ' 8' ' ' ILE . 5.0 mt -73.99 -57.52 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' B' ' 110' ' ' LEU . 27.7 mt -47.88 -45.48 30.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.868 HG23 ' O ' ' B' ' 107' ' ' ILE . 61.4 t -60.37 -47.93 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.8 mm-40 -48.21 -46.63 35.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -58.14 -60.09 4.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.17 -29.71 46.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.789 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -63.18 -65.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.789 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.93 -42.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.1 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.675 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -67.09 -60.43 2.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.448 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 30.3 mt-10 -40.67 -47.83 2.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 37.2 t80 -66.32 -32.64 74.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.969 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.07 -41.09 74.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.969 HD21 ' CH2' ' B' ' 121' ' ' TRP . 21.8 mt -60.14 -60.56 3.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.665 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.7 mt -53.75 -53.38 53.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.69 HD23 HD12 ' B' ' 128' ' ' LEU . 3.8 tt -56.77 -42.16 78.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.602 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.57 -66.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.752 HD12 ' CD1' ' A' ' 26' ' ' ILE . 5.8 mt -53.82 -20.67 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.665 HD12 ' C ' ' B' ' 123' ' ' LEU . 10.5 mt -80.13 -45.74 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.69 HD12 HD23 ' B' ' 124' ' ' LEU . 10.2 mt -69.65 -49.65 51.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.515 ' HD2' HG13 ' B' ' 125' ' ' VAL . 7.3 mtp180 -59.25 -50.24 74.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.628 ' HA ' ' HG3' ' B' ' 133' ' ' ARG . 25.3 m -62.92 -52.83 61.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 127' ' ' ILE . 3.7 t -44.39 -36.39 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' B' ' 128' ' ' LEU . 23.2 mtmt -79.47 -35.33 40.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.628 ' HG3' ' HA ' ' B' ' 130' ' ' THR . 6.1 mtp180 -52.59 -36.12 55.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' B' ' 136' ' ' GLY . . . -67.58 -31.53 71.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' B' ' 137' ' ' GLY . 26.2 m-20 -74.25 15.86 0.29 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' B' ' 134' ' ' ALA . . . -50.48 -10.0 0.31 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 C--N 1.336 0.532 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.669 ' HG3' HD12 ' A' ' 5' ' ' LEU . 28.1 ttpt -71.44 -21.51 61.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -47.37 -53.53 13.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -43.8 -57.42 3.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.062 HD13 HD13 ' B' ' 105' ' ' LEU . 8.4 mt -54.08 -52.51 60.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -43.9 -36.17 2.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.727 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.2 mt -81.27 -36.59 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 5' ' ' LEU . 50.5 mt -59.63 -38.35 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.821 HG13 HG21 ' B' ' 108' ' ' ILE . 4.5 mt -74.94 -56.82 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 10' ' ' LEU . 34.9 mt -50.55 -44.04 56.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 7' ' ' ILE . 73.1 t -61.27 -46.81 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.5 mt-10 -49.74 -48.45 50.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -56.42 -61.44 2.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.94 -28.59 52.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.791 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.31 -65.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.791 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.03 -42.42 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.59 80.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.691 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.36 -59.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 mt-10 -41.38 -48.27 3.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 59.6 t80 -67.54 -30.08 69.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 1.01 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -72.03 -38.49 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD21 ' CH2' ' A' ' 21' ' ' TRP . 32.1 mt -64.24 -60.79 2.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 27' ' ' ILE . 6.0 mt -52.38 -48.25 65.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 28' ' ' LEU . 3.8 tt -64.6 -38.32 90.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.57 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.4 t -66.48 -65.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.795 ' CD1' HD12 ' B' ' 126' ' ' ILE . 7.6 mt -52.37 -21.61 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 31' ' ' VAL . 9.1 mt -79.62 -49.79 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.753 HD12 HD23 ' A' ' 24' ' ' LEU . 9.6 mt -66.42 -50.4 63.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HD2' HG13 ' A' ' 25' ' ' VAL . 27.7 mtp85 -57.99 -53.34 59.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.973 HG22 HH22 ' B' ' 133' ' ' ARG . 22.4 m -58.99 -49.1 79.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 27' ' ' ILE . 4.4 t -44.93 -42.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 27.3 mtmt -77.41 -33.4 55.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.961 HH22 HG22 ' B' ' 130' ' ' THR . 0.0 OUTLIER -55.09 -30.03 58.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.674 ' N ' ' HD3' ' A' ' 33' ' ' ARG . . . -75.18 -51.55 13.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -49.48 -66.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.68 74.74 0.04 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.713 ' HG3' HD12 ' B' ' 105' ' ' LEU . 28.3 ttpt -72.22 -21.67 61.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -47.04 -53.35 12.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.89 -58.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 5' ' ' LEU . 8.6 mt -52.63 -53.19 50.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.06 -37.83 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.903 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.3 mt -79.53 -41.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.062 HD12 ' HA ' ' B' ' 105' ' ' LEU . 33.5 mt -54.56 -37.11 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.828 HG13 HD13 ' A' ' 8' ' ' ILE . 5.4 mt -74.49 -57.72 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 110' ' ' LEU . 35.3 mt -47.93 -44.76 30.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.903 HG23 ' O ' ' B' ' 107' ' ' ILE . 43.5 t -61.29 -47.7 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.7 mm-40 -48.36 -46.85 37.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.5 m -58.17 -60.28 4.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.29 -29.44 47.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.781 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -63.32 -65.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.781 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.96 -42.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.49 78.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.655 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.84 -59.12 3.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.401 ' OE1' ' HE3' ' A' ' 18' ' ' MET . 30.3 mt-10 -41.42 -47.79 3.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.413 ' CZ ' HD12 ' B' ' 124' ' ' LEU . 60.0 t80 -67.76 -30.33 69.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.997 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.7 -38.54 70.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.997 HD21 ' CH2' ' B' ' 121' ' ' TRP . 31.9 mt -64.24 -60.79 2.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.604 ' O ' HD12 ' B' ' 127' ' ' ILE . 6.3 mt -52.38 -48.26 65.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.775 HD23 HD12 ' B' ' 128' ' ' LEU . 3.9 tt -64.52 -38.49 91.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.4 t -66.42 -66.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.795 HD12 ' CD1' ' A' ' 26' ' ' ILE . 7.9 mt -52.28 -21.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.702 ' O ' HG23 ' B' ' 131' ' ' VAL . 8.7 mt -79.59 -50.03 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.775 HD12 HD23 ' B' ' 124' ' ' LEU . 9.3 mt -66.36 -50.26 64.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.565 ' HD2' HG13 ' B' ' 125' ' ' VAL . 27.6 mtp85 -58.07 -53.1 62.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.961 HG22 HH22 ' A' ' 33' ' ' ARG . 22.2 m -59.2 -48.64 80.86 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.702 HG23 ' O ' ' B' ' 127' ' ' ILE . 4.6 t -45.09 -42.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.445 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 27.4 mtmt -77.15 -33.4 56.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.973 HH22 HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -55.16 -29.78 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.663 ' N ' ' HD3' ' B' ' 133' ' ' ARG . . . -75.32 -50.74 15.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -50.13 -66.1 0.45 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 170.55 74.7 0.04 OUTLIER Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HG2' HD12 ' A' ' 5' ' ' LEU . 15.6 ttmt -50.99 -21.71 1.91 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.5 m -50.54 -47.24 57.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -47.84 -58.13 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.013 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.1 mt -49.41 -53.85 20.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -43.97 -44.12 7.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.942 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.8 mt -72.16 -41.79 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.046 HG22 ' CG2' ' B' ' 108' ' ' ILE . 49.8 mt -54.1 -33.23 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.969 HG13 HD13 ' B' ' 108' ' ' ILE . 3.9 mt -74.61 -56.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 10' ' ' LEU . 42.5 mt -51.26 -48.74 62.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.4 t -56.92 -48.31 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.9 mt-10 -47.75 -51.25 22.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -53.3 -60.13 3.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -56.84 -26.35 58.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.786 HG11 HG21 ' B' ' 115' ' ' VAL . 1.2 t -69.82 -63.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.697 HD12 HG12 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -43.46 -38.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.36 -29.29 59.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.825 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 3.2 mtp -63.54 -54.23 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.58 ' OE1' ' HE2' ' B' ' 118' ' ' MET . 23.7 mt-10 -59.91 -46.44 89.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.86 -64.32 0.87 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.825 ' CD1' ' HA ' ' A' ' 18' ' ' MET . 0.6 OUTLIER -57.43 -37.56 72.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.506 ' CD2' HD11 ' B' ' 123' ' ' LEU . 12.4 mt -55.5 -61.63 2.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 mt -59.42 -51.14 71.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -41.57 62.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -69.51 -66.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.647 HG22 HG22 ' B' ' 126' ' ' ILE . 4.8 mt -50.83 -20.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 31' ' ' VAL . 18.1 mt -81.22 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.18 -48.33 73.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 25' ' ' VAL . 15.9 mtp-105 -60.78 -52.52 64.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 7.6 m -57.31 -51.58 68.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 27' ' ' ILE . 19.5 t -44.64 -47.62 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -68.16 -34.01 75.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -52.44 -32.41 39.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -62.12 -35.94 80.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' ND2' ' C ' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -100.72 -2.08 33.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.41 -66.16 2.39 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.428 ' HG2' HD12 ' B' ' 105' ' ' LEU . 15.6 ttmt -52.03 -21.8 3.47 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 36.0 m -50.27 -47.38 55.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -47.67 -58.16 4.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.028 ' HA ' HD12 ' B' ' 108' ' ' ILE . 8.8 mt -49.55 -53.91 21.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -43.87 -44.16 6.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.94 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -72.15 -41.89 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.046 ' CG2' HG22 ' A' ' 8' ' ' ILE . 49.0 mt -54.06 -33.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.989 HG13 HD13 ' A' ' 8' ' ' ILE . 3.9 mt -74.54 -56.4 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' B' ' 110' ' ' LEU . 42.4 mt -51.38 -48.85 62.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.94 HG23 ' O ' ' B' ' 107' ' ' ILE . 17.5 t -56.68 -48.41 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 1.9 mt-10 -47.77 -51.37 22.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -53.1 -60.12 3.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -56.85 -26.35 58.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 15' ' ' VAL . 1.2 t -69.92 -63.31 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.682 ' N ' HG12 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -43.55 -38.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.4 59.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.828 ' HA ' ' CD1' ' B' ' 121' ' ' TRP . 3.2 mtp -63.46 -54.02 43.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.585 ' OE1' ' HE2' ' A' ' 18' ' ' MET . 23.8 mt-10 -60.09 -46.56 89.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -53.77 -64.17 0.91 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.828 ' CD1' ' HA ' ' B' ' 118' ' ' MET . 0.6 OUTLIER -57.47 -37.63 73.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.498 HD23 ' CH2' ' B' ' 121' ' ' TRP . 12.4 mt -55.51 -61.49 2.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.594 ' C ' HD12 ' B' ' 127' ' ' ILE . 8.6 mt -59.57 -51.09 71.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -41.41 62.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.607 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -69.67 -66.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.647 HG22 HG22 ' A' ' 26' ' ' ILE . 4.9 mt -50.81 -21.04 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.714 ' O ' HG23 ' B' ' 131' ' ' VAL . 18.6 mt -81.21 -49.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.98 -48.24 74.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.586 ' HD2' HG13 ' B' ' 125' ' ' VAL . 16.0 mtp-105 -60.92 -52.71 63.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 7.5 m -57.12 -51.5 69.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 127' ' ' ILE . 20.3 t -44.56 -47.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -68.59 -33.57 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -52.79 -32.71 45.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -61.8 -35.71 78.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ASN . . . . . 0.441 ' ND2' ' C ' ' B' ' 135' ' ' ASN . 0.2 OUTLIER -101.27 -2.42 31.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -49.81 -66.14 2.47 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.622 ' HG3' HD12 ' A' ' 5' ' ' LEU . 4.9 ttpm? -62.31 -21.4 65.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 m -49.61 -52.22 31.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.15 -58.11 3.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.043 ' HA ' HD12 ' A' ' 8' ' ' ILE . 8.7 mt -51.62 -54.12 31.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.74 -40.3 4.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.899 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.8 mt -76.68 -41.01 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.043 HD12 ' HA ' ' A' ' 5' ' ' LEU . 46.4 mt -54.05 -35.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.776 HG12 HG21 ' B' ' 108' ' ' ILE . 1.6 mt -75.54 -56.53 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 10' ' ' LEU . 20.0 mt -49.57 -45.53 47.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 7' ' ' ILE . 23.2 t -61.22 -47.51 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.6 mt-10 -47.61 -47.84 28.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -58.07 -59.92 4.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.23 -28.26 51.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.813 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.61 -65.91 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.813 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.0 -42.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.39 80.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.701 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.66 -60.14 2.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 30.3 mt-10 -41.2 -47.97 3.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 17.1 t80 -66.37 -31.59 72.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.976 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.0 -41.86 70.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.976 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.5 mt -59.75 -60.15 4.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.34 -54.78 31.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.751 HD23 HD12 ' A' ' 28' ' ' LEU . 2.6 tt -56.26 -41.33 75.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.39 -66.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.763 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.7 mt -54.69 -22.15 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.716 HD12 ' C ' ' A' ' 23' ' ' LEU . 11.6 mt -78.28 -43.54 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.751 HD12 HD23 ' A' ' 24' ' ' LEU . 10.1 mt -72.19 -52.71 15.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' HD2' HG13 ' A' ' 25' ' ' VAL . 12.7 mtp180 -55.98 -46.98 78.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.582 HG22 ' CZ ' ' B' ' 133' ' ' ARG . 16.6 m -64.48 -54.98 23.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 27' ' ' ILE . 7.5 t -44.2 -34.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -79.89 -33.59 39.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -53.53 -23.41 10.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' HB2' ' NH2' ' B' ' 133' ' ' ARG . . . -81.25 -29.26 34.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -81.17 -50.44 9.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.34 38.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.613 ' HG3' HD12 ' B' ' 105' ' ' LEU . 4.9 ttpm? -61.6 -21.71 64.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 18.1 m -49.28 -52.62 26.39 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -43.98 -58.16 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.043 HD22 ' HB3' ' A' ' 5' ' ' LEU . 9.0 mt -51.7 -54.09 32.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.72 -40.28 4.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.917 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -76.74 -41.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 1.028 HG22 ' CG2' ' A' ' 8' ' ' ILE . 44.8 mt -54.13 -34.99 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.763 HG12 HG21 ' A' ' 8' ' ' ILE . 1.6 mt -75.61 -56.32 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' B' ' 110' ' ' LEU . 19.8 mt -49.64 -45.66 48.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.917 HG23 ' O ' ' B' ' 107' ' ' ILE . 22.0 t -61.11 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.6 mt-10 -47.39 -47.85 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -58.09 -60.06 4.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.17 -28.1 50.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.789 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -64.81 -65.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.789 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.99 -42.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.39 80.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.43 -60.46 2.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.445 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.5 mt-10 -41.12 -48.2 3.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 17.3 t80 -66.11 -31.66 72.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.972 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.9 -41.95 70.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.972 HD21 ' CH2' ' B' ' 121' ' ' TRP . 25.4 mt -59.8 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.679 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.2 mt -53.22 -54.96 28.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.757 HD23 HD12 ' B' ' 128' ' ' LEU . 2.5 tt -56.42 -40.72 75.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.604 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.3 t -63.95 -66.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.763 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.7 mt -54.39 -23.57 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.737 ' O ' HG23 ' B' ' 131' ' ' VAL . 12.9 mt -76.68 -45.52 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.757 HD12 HD23 ' B' ' 124' ' ' LEU . 10.0 mt -70.53 -54.49 11.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.501 ' HD2' HG13 ' B' ' 125' ' ' VAL . 12.6 mtp180 -53.55 -45.37 69.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' B' ' 133' ' ' ARG . 21.2 m -68.02 -50.64 54.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 127' ' ' ILE . 3.8 t -42.98 -35.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -87.96 -27.94 21.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.582 ' CZ ' HG22 ' A' ' 30' ' ' THR . 0.2 OUTLIER -63.68 -23.12 67.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.96 32.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -78.54 -50.3 11.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 158.71 38.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.033 HD22 ' HB3' ' B' ' 105' ' ' LEU . 7.8 mt -52.39 -53.37 45.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.92 -37.82 3.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.881 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.9 mt -79.34 -39.6 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.012 ' CG2' HG22 ' B' ' 108' ' ' ILE . 49.1 mt -55.97 -36.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.802 HG13 HG21 ' B' ' 108' ' ' ILE . 5.4 mt -75.72 -55.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 10' ' ' LEU . 18.4 mt -49.91 -48.14 51.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 7' ' ' ILE . 35.3 t -59.03 -49.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.9 mt-10 -45.51 -47.49 14.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.41 -59.01 6.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.7 -29.56 53.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.78 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -63.88 -65.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.78 HD12 HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -41.98 -44.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.52 78.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.658 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.5 mtp -66.81 -57.24 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' B' ' 119' ' ' GLU . 2.2 mm-40 -41.1 -48.55 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t80 -67.73 -31.17 70.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 1.03 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.02 -39.85 72.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.03 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.3 mt -61.79 -60.28 3.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 mt -54.95 -52.94 61.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.689 ' CD2' HD12 ' A' ' 28' ' ' LEU . 6.1 tt -55.71 -48.26 75.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.4 t -58.6 -66.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.8 mt -54.14 -20.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt -79.32 -43.86 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.689 HD12 ' CD2' ' A' ' 24' ' ' LEU . 9.1 mt -72.97 -49.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HD2' HG13 ' A' ' 25' ' ' VAL . 28.6 mtp85 -58.46 -47.7 83.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.47 -54.44 40.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 27' ' ' ILE . 13.5 t -44.46 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -68.9 -36.01 77.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.582 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.033 ' HB3' HD22 ' A' ' 5' ' ' LEU . 7.7 mt -52.84 -53.07 53.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.88 -37.37 2.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.898 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.9 mt -80.01 -40.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.026 HD12 ' HA ' ' B' ' 105' ' ' LEU . 42.8 mt -55.77 -36.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.775 HG13 HG21 ' A' ' 8' ' ' ILE . 5.4 mt -75.75 -55.08 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' B' ' 110' ' ' LEU . 18.1 mt -49.83 -48.15 51.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.898 HG23 ' O ' ' B' ' 107' ' ' ILE . 32.7 t -58.95 -49.72 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.9 mt-10 -45.35 -47.53 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.43 -58.84 6.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.75 -29.6 54.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.773 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -63.96 -66.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.773 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -41.92 -44.68 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.58 79.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.658 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.83 -57.22 7.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 2.2 mm-40 -41.23 -48.46 3.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 46.5 t80 -67.84 -31.02 70.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 1.017 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.08 -40.01 71.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 1.017 HD21 ' CH2' ' B' ' 121' ' ' TRP . 24.9 mt -61.73 -60.27 3.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.632 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.7 mt -54.92 -52.96 61.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.694 ' CD2' HD12 ' B' ' 128' ' ' LEU . 6.1 tt -55.68 -48.32 75.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.562 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.4 t -58.53 -66.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.8 mt -54.15 -20.66 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.643 ' O ' HG23 ' B' ' 131' ' ' VAL . 7.9 mt -79.38 -43.78 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' B' ' 124' ' ' LEU . 9.0 mt -73.11 -49.75 26.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.536 ' HD2' HG13 ' B' ' 125' ' ' VAL . 28.6 mtp85 -58.48 -47.73 83.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.34 -54.44 40.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.643 HG23 ' O ' ' B' ' 127' ' ' ILE . 13.7 t -44.51 -43.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -68.95 -35.84 77.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.582 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.035 ' HA ' HD12 ' A' ' 8' ' ' ILE . 8.5 mt -49.14 -53.47 20.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.13 -43.63 7.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.93 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.4 mt -72.75 -42.14 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.035 HD12 ' HA ' ' A' ' 5' ' ' LEU . 59.7 mt -52.53 -33.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.994 HG13 HD13 ' B' ' 108' ' ' ILE . 5.4 mt -75.62 -57.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 10' ' ' LEU . 34.3 mt -49.8 -45.36 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.7 t -60.73 -48.08 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.5 mt-10 -47.63 -47.96 28.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -57.44 -60.47 3.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.12 -28.28 51.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.811 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.62 -65.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.811 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -42.94 -42.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.39 80.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.725 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.4 -60.61 2.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 29.7 mt-10 -41.05 -48.09 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.9 t80 -66.02 -32.06 73.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.982 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.84 -42.35 70.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.982 HD21 ' CH2' ' A' ' 21' ' ' TRP . 23.0 mt -58.79 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.624 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.31 -56.16 18.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.749 HD23 HD12 ' A' ' 28' ' ' LEU . 2.5 tt -55.0 -40.65 70.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.1 t -63.86 -67.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.778 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.0 mt -55.27 -20.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 31' ' ' VAL . 15.9 mt -79.85 -40.87 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.749 HD12 HD23 ' A' ' 24' ' ' LEU . 10.2 mt -75.26 -49.5 19.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HD2' HG13 ' A' ' 25' ' ' VAL . 27.0 mtp180 -59.35 -47.19 86.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 9.5 m -62.17 -55.06 32.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.3 -43.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -68.61 -35.57 77.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.03 ' HA ' HD12 ' B' ' 108' ' ' ILE . 8.2 mt -49.11 -53.33 21.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.24 -43.8 7.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.931 ' O ' HG23 ' B' ' 111' ' ' VAL . 17.0 mt -72.61 -42.11 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.03 HD12 ' HA ' ' B' ' 105' ' ' LEU . 59.5 mt -52.51 -33.57 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.988 HG13 HD13 ' A' ' 8' ' ' ILE . 5.5 mt -75.65 -57.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' B' ' 110' ' ' LEU . 34.7 mt -49.7 -45.24 48.74 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.931 HG23 ' O ' ' B' ' 107' ' ' ILE . 18.1 t -60.91 -48.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.5 mt-10 -47.69 -48.06 29.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.3 -60.64 3.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.02 -28.32 51.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.785 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.61 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.785 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.94 -42.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.38 80.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.3 -60.65 2.58 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.0 mt-10 -41.05 -48.26 3.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 68.3 t80 -65.85 -32.02 73.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.76 -42.47 70.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' B' ' 121' ' ' TRP . 23.3 mt -58.8 -60.13 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.621 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.2 mt -53.26 -56.2 18.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.746 HD23 HD12 ' B' ' 128' ' ' LEU . 2.4 tt -55.01 -40.62 70.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.627 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.89 -66.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.778 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.41 -20.76 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.631 ' O ' HG23 ' B' ' 131' ' ' VAL . 16.3 mt -79.8 -40.79 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.746 HD12 HD23 ' B' ' 124' ' ' LEU . 10.3 mt -75.33 -49.63 18.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.491 ' HD2' HG13 ' B' ' 125' ' ' VAL . 25.6 mtp180 -59.23 -47.21 86.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.1 m -62.08 -54.89 35.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 127' ' ' ILE . 12.2 t -44.33 -43.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -68.58 -35.84 77.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 130' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.056 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.5 mt -51.48 -51.59 53.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -44.29 -42.99 7.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.939 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.8 mt -73.35 -42.18 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.056 HD12 ' HA ' ' A' ' 5' ' ' LEU . 61.4 mt -52.53 -33.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.998 HG13 HD13 ' B' ' 108' ' ' ILE . 4.5 mt -75.64 -57.3 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 10' ' ' LEU . 32.7 mt -49.72 -45.93 49.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.3 t -60.2 -48.42 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.4 mt-10 -47.2 -48.03 24.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -57.4 -60.48 3.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.05 -28.3 51.26 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.82 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.5 -65.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.82 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.07 -42.12 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.29 79.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.719 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.42 -60.76 2.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.7 mt-10 -40.97 -48.27 3.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 9.7 t80 -66.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 1.006 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.92 -41.2 71.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.006 HD21 ' CH2' ' A' ' 21' ' ' TRP . 39.4 mt -59.82 -60.15 4.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.689 HD11 HD22 ' B' ' 122' ' ' LEU . 5.4 mt -53.82 -54.73 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD23 HD12 ' A' ' 28' ' ' LEU . 3.4 tt -55.75 -42.36 75.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.611 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -62.55 -66.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.749 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.5 mt -55.01 -20.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.64 HD12 ' C ' ' A' ' 23' ' ' LEU . 12.0 mt -79.86 -42.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.752 HD12 HD23 ' A' ' 24' ' ' LEU . 9.9 mt -73.85 -49.32 25.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HD2' HG13 ' A' ' 25' ' ' VAL . 15.1 mtp180 -59.48 -47.58 84.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 11.5 m -62.46 -54.74 35.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 27' ' ' ILE . 11.4 t -44.24 -43.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -68.42 -34.95 76.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.553 ' NE ' ' NE ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.031 ' HA ' HD12 ' B' ' 108' ' ' ILE . 7.7 mt -50.61 -52.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.39 -43.47 7.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.931 ' O ' HG23 ' B' ' 111' ' ' VAL . 17.8 mt -72.61 -42.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.033 ' CG2' HG22 ' A' ' 8' ' ' ILE . 62.3 mt -52.48 -33.55 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.953 HG13 HD13 ' A' ' 8' ' ' ILE . 4.8 mt -75.57 -57.18 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' B' ' 110' ' ' LEU . 30.6 mt -49.84 -45.58 50.47 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.931 HG23 ' O ' ' B' ' 107' ' ' ILE . 17.7 t -60.53 -47.98 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.48 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.4 mt-10 -47.77 -47.99 30.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.38 -60.73 3.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.0 -28.29 50.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.798 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.44 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.798 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -43.1 -42.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.47 80.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.45 -60.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.446 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.7 mt-10 -40.93 -48.31 3.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.94 -32.16 73.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 1.005 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.83 -41.28 71.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 1.005 HD21 ' CH2' ' B' ' 121' ' ' TRP . 39.8 mt -59.76 -60.24 4.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.687 HD11 HD22 ' A' ' 22' ' ' LEU . 5.3 mt -53.74 -54.79 33.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.733 HD23 HD12 ' B' ' 128' ' ' LEU . 3.4 tt -55.63 -42.32 74.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.615 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -62.68 -66.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.749 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.4 mt -55.01 -20.7 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 131' ' ' VAL . 12.2 mt -79.76 -42.24 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.733 HD12 HD23 ' B' ' 124' ' ' LEU . 9.8 mt -73.93 -49.45 24.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.496 ' HD2' HG13 ' B' ' 125' ' ' VAL . 15.0 mtp180 -59.27 -47.53 85.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 11.2 m -62.38 -54.63 37.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 127' ' ' ILE . 11.7 t -44.25 -44.0 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -68.56 -34.92 76.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.553 ' NE ' ' NE ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.095 HD13 HD13 ' B' ' 105' ' ' LEU . 8.1 mt -53.41 -53.44 51.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.64 -37.16 2.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.888 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.7 mt -79.71 -40.81 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.002 ' CG2' HG22 ' B' ' 108' ' ' ILE . 41.6 mt -55.27 -36.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.753 HG13 HG21 ' B' ' 108' ' ' ILE . 3.9 mt -75.51 -54.82 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' A' ' 10' ' ' LEU . 19.4 mt -50.16 -46.95 54.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 7' ' ' ILE . 26.0 t -60.23 -47.86 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.6 mt-10 -47.17 -47.08 24.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.99 -60.57 3.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.69 -27.92 43.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.822 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.57 -66.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.822 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.06 -42.09 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.31 79.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.652 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.51 -60.33 2.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 30.5 mt-10 -41.13 -48.06 3.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 14.5 t80 -65.83 -32.1 73.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.74 -42.36 70.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.7 mt -58.87 -60.02 4.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.35 -56.08 19.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.734 HD23 HD12 ' A' ' 28' ' ' LEU . 2.3 tt -55.09 -40.75 70.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.1 t -63.69 -66.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.77 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.0 mt -55.5 -20.68 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 31' ' ' VAL . 15.5 mt -79.91 -40.5 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.734 HD12 HD23 ' A' ' 24' ' ' LEU . 10.2 mt -75.7 -49.45 18.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HD2' HG13 ' A' ' 25' ' ' VAL . 23.3 mtp180 -59.47 -46.81 87.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.43 -54.85 34.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.4 -43.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.22 -35.95 78.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.095 HD13 HD13 ' A' ' 5' ' ' LEU . 7.9 mt -53.38 -53.36 52.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.59 -37.18 2.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.909 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.7 mt -79.8 -40.66 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' B' ' 105' ' ' LEU . 42.3 mt -55.53 -36.31 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.745 HG13 HG21 ' A' ' 8' ' ' ILE . 3.9 mt -75.66 -54.79 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' B' ' 110' ' ' LEU . 18.8 mt -50.15 -46.79 54.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.909 HG23 ' O ' ' B' ' 107' ' ' ILE . 26.8 t -60.39 -47.74 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.6 mt-10 -47.24 -47.1 24.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.98 -60.56 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.72 -27.85 43.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.8 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.6 -66.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.8 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -43.14 -42.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.33 79.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.654 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.4 -60.38 2.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 29.8 mt-10 -41.2 -48.09 3.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 14.4 t80 -65.72 -32.04 73.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 0.976 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.91 -42.27 70.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.976 HD21 ' CH2' ' B' ' 121' ' ' TRP . 24.9 mt -58.9 -60.14 4.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.625 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.3 mt -53.24 -56.08 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.739 HD23 HD12 ' B' ' 128' ' ' LEU . 2.3 tt -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.622 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.59 -66.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.77 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.39 -20.84 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 131' ' ' VAL . 15.4 mt -79.83 -40.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.739 HD12 HD23 ' B' ' 124' ' ' LEU . 10.2 mt -75.71 -49.49 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.483 ' HD2' HG13 ' B' ' 125' ' ' VAL . 23.3 mtp180 -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.7 m -62.37 -54.79 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 127' ' ' ILE . 12.7 t -44.43 -43.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.19 -36.05 78.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 130' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.084 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.0 mt -48.57 -54.18 15.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.67 -40.87 6.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.908 ' O ' HG23 ' A' ' 11' ' ' VAL . 14.9 mt -75.05 -40.18 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.084 HD12 ' HA ' ' A' ' 5' ' ' LEU . 74.8 mt -52.54 -38.94 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.827 HG13 HG21 ' B' ' 108' ' ' ILE . 5.4 mt -72.88 -57.45 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 10' ' ' LEU . 21.1 mt -48.48 -39.58 23.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 7' ' ' ILE . 52.3 t -64.79 -46.47 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 1.6 mt-10 -49.97 -49.85 48.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -55.87 -61.34 2.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -50.58 -37.48 40.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.892 HG12 HD12 ' A' ' 16' ' ' ILE . 1.3 t -55.16 -66.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.892 HD12 HG12 ' A' ' 15' ' ' VAL . 1.2 mp -42.59 -39.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -58.62 -40.94 84.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.672 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 3.1 mtm -66.5 -55.58 14.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.522 ' CD ' ' CE ' ' B' ' 118' ' ' MET . 47.6 mt-10 -39.38 -47.71 1.81 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CZ ' HD12 ' A' ' 24' ' ' LEU . 23.7 t80 -67.37 -36.67 81.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 1.022 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.87 -39.6 90.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.022 HD21 ' CH2' ' A' ' 21' ' ' TRP . 17.9 mt -61.17 -61.15 2.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.598 HD11 HD22 ' B' ' 122' ' ' LEU . 6.7 mt -55.83 -52.68 63.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.643 ' CD2' HD12 ' A' ' 28' ' ' LEU . 5.2 tt -54.71 -48.67 72.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.588 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.6 t -59.14 -66.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.5 mt -53.29 -21.86 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt -78.42 -44.95 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.643 HD12 ' CD2' ' A' ' 24' ' ' LEU . 9.3 mt -72.08 -51.58 20.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.588 ' HD2' HG13 ' A' ' 25' ' ' VAL . 8.8 mtp180 -56.32 -47.55 78.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.0 m -62.68 -54.58 37.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 27' ' ' ILE . 16.1 t -44.33 -43.04 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -69.63 -35.0 74.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.601 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.078 HD22 ' HB3' ' A' ' 5' ' ' LEU . 8.7 mt -48.73 -54.25 15.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.51 -40.8 5.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.904 ' O ' HG23 ' B' ' 111' ' ' VAL . 14.9 mt -74.96 -40.46 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.077 HD12 ' HA ' ' B' ' 105' ' ' LEU . 74.9 mt -52.39 -38.97 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.813 HG13 HG21 ' A' ' 8' ' ' ILE . 5.3 mt -72.85 -57.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' B' ' 110' ' ' LEU . 20.8 mt -48.46 -39.57 23.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.904 HG23 ' O ' ' B' ' 107' ' ' ILE . 51.3 t -64.74 -46.41 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mt-10 -50.08 -49.92 49.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.75 -61.22 2.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.656 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.75 -37.5 42.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.872 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -55.13 -66.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.872 HD12 HG12 ' B' ' 115' ' ' VAL . 1.2 mp -42.55 -39.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' B' ' 114' ' ' ALA . . . -58.67 -40.84 84.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.659 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 3.1 mtm -66.53 -55.65 14.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 18' ' ' MET . 48.1 mt-10 -39.37 -47.61 1.79 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' B' ' 124' ' ' LEU . 23.9 t80 -67.47 -36.63 81.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 1.006 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -65.9 -39.62 90.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 1.006 HD21 ' CH2' ' B' ' 121' ' ' TRP . 17.9 mt -61.24 -61.05 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.601 HD11 HD22 ' A' ' 22' ' ' LEU . 6.5 mt -55.86 -52.73 63.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.643 ' CD2' HD12 ' B' ' 128' ' ' LEU . 5.2 tt -54.7 -48.55 72.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.575 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.6 t -59.15 -66.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.5 mt -53.36 -21.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.664 ' O ' HG23 ' B' ' 131' ' ' VAL . 9.0 mt -78.47 -44.81 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.643 HD12 ' CD2' ' B' ' 124' ' ' LEU . 9.4 mt -72.3 -51.37 21.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.575 ' HD2' HG13 ' B' ' 125' ' ' VAL . 8.8 mtp180 -56.54 -47.62 79.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.1 m -62.56 -54.46 39.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 127' ' ' ILE . 15.8 t -44.47 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -69.61 -34.84 74.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.601 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.7 mt -51.25 -54.28 27.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -44.75 -39.57 5.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.0 mt -78.27 -36.42 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.03 HG22 ' CG2' ' B' ' 108' ' ' ILE . 50.4 mt -57.53 -38.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.89 HG12 HD13 ' B' ' 108' ' ' ILE . 3.4 mt -73.78 -57.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 10' ' ' LEU . 28.1 mt -50.27 -39.83 46.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 7' ' ' ILE . 71.7 t -64.23 -45.73 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' CG ' ' HG2' ' B' ' 112' ' ' GLU . 1.1 mt-10 -50.81 -50.8 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -54.69 -60.25 3.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.683 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -51.05 -38.11 49.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.906 HG22 ' HE1' ' A' ' 18' ' ' MET . 1.4 t -55.51 -66.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.832 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -41.71 -40.23 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.43 -40.74 87.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.906 ' HE1' HG22 ' A' ' 15' ' ' VAL . 2.9 mtm -67.03 -55.19 15.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 119' ' ' GLU . 3.4 mm-40 -39.58 -47.98 2.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 29.4 t80 -68.47 -34.86 76.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 1.035 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -67.34 -38.75 85.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.035 HD21 ' CH2' ' A' ' 21' ' ' TRP . 20.1 mt -62.33 -61.02 2.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 27' ' ' ILE . 6.1 mt -55.67 -51.66 66.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CD2' HD12 ' A' ' 28' ' ' LEU . 5.8 tt -56.6 -47.69 79.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.7 t -59.6 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 6.2 mt -53.35 -21.3 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 23' ' ' LEU . 7.1 mt -78.84 -45.61 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.681 HD12 ' CD2' ' A' ' 24' ' ' LEU . 8.7 mt -71.6 -50.51 30.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HD2' HG13 ' A' ' 25' ' ' VAL . 18.3 mtp180 -57.4 -47.99 80.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.61 -54.34 41.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 27' ' ' ILE . 15.0 t -44.39 -43.45 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.35 -36.34 79.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.498 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.026 ' HA ' HD12 ' B' ' 108' ' ' ILE . 9.0 mt -51.26 -54.62 24.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -43.77 -41.18 4.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.908 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -75.69 -39.84 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.03 ' CG2' HG22 ' A' ' 8' ' ' ILE . 55.6 mt -53.93 -37.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.858 HG12 HD13 ' A' ' 8' ' ' ILE . 4.0 mt -73.31 -57.81 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' B' ' 110' ' ' LEU . 20.6 mt -48.72 -41.33 31.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.908 HG23 ' O ' ' B' ' 107' ' ' ILE . 48.4 t -64.35 -43.74 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.7 mm-40 -51.47 -50.57 59.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.88 -59.2 5.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.669 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.77 -38.37 47.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.843 HG11 HG11 ' A' ' 15' ' ' VAL . 1.3 t -55.37 -65.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.825 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -41.75 -40.27 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' B' ' 114' ' ' ALA . . . -59.53 -40.64 87.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.785 ' HE1' HG22 ' B' ' 115' ' ' VAL . 3.0 mtm -66.95 -55.27 15.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.476 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 3.7 mm-40 -39.65 -48.03 2.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 29.7 t80 -68.5 -34.59 76.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 1.041 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -67.47 -38.76 84.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 1.041 HD21 ' CH2' ' B' ' 121' ' ' TRP . 20.5 mt -62.47 -61.03 2.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.664 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.6 mt -55.47 -51.6 66.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.684 ' CD2' HD12 ' B' ' 128' ' ' LEU . 5.7 tt -56.83 -47.33 80.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.595 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.6 t -59.62 -66.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.6 mt -53.47 -21.04 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.664 HD12 ' C ' ' B' ' 123' ' ' LEU . 7.1 mt -79.04 -45.34 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.684 HD12 ' CD2' ' B' ' 124' ' ' LEU . 8.7 mt -71.76 -50.35 30.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.595 ' HD2' HG13 ' B' ' 125' ' ' VAL . 18.4 mtp180 -57.68 -48.05 80.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.56 -54.05 45.58 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 127' ' ' ILE . 14.0 t -44.59 -43.34 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.32 -36.57 79.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.498 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.516 ' HA ' HD22 ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.036 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.4 mt -57.24 -51.06 70.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.95 -34.87 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.737 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.5 mt -81.87 -37.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.036 HD12 ' HA ' ' A' ' 5' ' ' LEU . 51.6 mt -58.88 -39.35 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.842 HG13 HG21 ' B' ' 108' ' ' ILE . 4.7 mt -74.47 -57.04 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 10' ' ' LEU . 26.7 mt -49.54 -44.6 46.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 7' ' ' ILE . 69.8 t -60.49 -47.92 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 mt-10 -48.78 -48.05 41.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -56.46 -61.06 2.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.93 -28.91 54.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.799 HG12 HD12 ' A' ' 16' ' ' ILE . 1.3 t -64.17 -65.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.799 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -42.89 -42.48 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.43 79.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.653 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.52 -60.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.9 mt-10 -40.88 -48.13 3.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 37.1 t80 -66.32 -32.24 73.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.979 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.23 -41.19 73.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.979 HD21 ' CH2' ' A' ' 21' ' ' TRP . 23.2 mt -60.43 -60.58 3.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.654 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.4 mt -53.53 -53.06 57.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.708 HD23 HD12 ' A' ' 28' ' ' LEU . 3.9 tt -57.33 -41.99 81.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.55 -66.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.752 ' CD1' HD12 ' B' ' 126' ' ' ILE . 5.5 mt -53.84 -20.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 23' ' ' LEU . 10.3 mt -80.04 -45.72 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.708 HD12 HD23 ' A' ' 24' ' ' LEU . 10.1 mt -69.64 -49.79 50.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.517 ' HD2' HG13 ' A' ' 25' ' ' VAL . 7.3 mtp180 -59.12 -50.2 74.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.615 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 25.2 m -62.96 -52.93 61.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' ILE . 3.6 t -44.28 -36.36 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 28' ' ' LEU . 23.2 mtmt -79.52 -35.57 39.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 30' ' ' THR . 6.2 mtp180 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' B' ' 104' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.011 ' HB3' HD22 ' A' ' 5' ' ' LEU . 7.5 mt -56.22 -51.7 67.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.66 -35.75 1.91 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.868 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.7 mt -81.05 -41.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.001 ' CG2' HG22 ' A' ' 8' ' ' ILE . 36.5 mt -55.7 -38.53 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.783 HG13 HG21 ' A' ' 8' ' ' ILE . 5.0 mt -73.99 -57.52 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' B' ' 110' ' ' LEU . 27.7 mt -47.88 -45.48 30.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.868 HG23 ' O ' ' B' ' 107' ' ' ILE . 61.4 t -60.37 -47.93 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.8 mm-40 -48.21 -46.63 35.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -58.14 -60.09 4.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.17 -29.71 46.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.789 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -63.18 -65.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.789 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.93 -42.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.1 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.675 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -67.09 -60.43 2.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.448 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 30.3 mt-10 -40.67 -47.83 2.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 37.2 t80 -66.32 -32.64 74.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 0.969 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.07 -41.09 74.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.969 HD21 ' CH2' ' B' ' 121' ' ' TRP . 21.8 mt -60.14 -60.56 3.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.665 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.7 mt -53.75 -53.38 53.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.69 HD23 HD12 ' B' ' 128' ' ' LEU . 3.8 tt -56.77 -42.16 78.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.602 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.57 -66.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.752 HD12 ' CD1' ' A' ' 26' ' ' ILE . 5.8 mt -53.82 -20.67 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.665 HD12 ' C ' ' B' ' 123' ' ' LEU . 10.5 mt -80.13 -45.74 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.69 HD12 HD23 ' B' ' 124' ' ' LEU . 10.2 mt -69.65 -49.65 51.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.515 ' HD2' HG13 ' B' ' 125' ' ' VAL . 7.3 mtp180 -59.25 -50.24 74.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.628 ' HA ' ' HG3' ' B' ' 133' ' ' ARG . 25.3 m -62.92 -52.83 61.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 127' ' ' ILE . 3.7 t -44.39 -36.39 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' B' ' 128' ' ' LEU . 23.2 mtmt -79.47 -35.33 40.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.628 ' HG3' ' HA ' ' B' ' 130' ' ' THR . 6.1 mtp180 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.062 HD13 HD13 ' B' ' 105' ' ' LEU . 8.4 mt -54.08 -52.51 60.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -43.9 -36.17 2.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.727 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.2 mt -81.27 -36.59 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 5' ' ' LEU . 50.5 mt -59.63 -38.35 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.821 HG13 HG21 ' B' ' 108' ' ' ILE . 4.5 mt -74.94 -56.82 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 10' ' ' LEU . 34.9 mt -50.55 -44.04 56.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 7' ' ' ILE . 73.1 t -61.27 -46.81 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.5 mt-10 -49.74 -48.45 50.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -56.42 -61.44 2.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.94 -28.59 52.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.791 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.31 -65.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.791 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.03 -42.42 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.59 80.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.691 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.36 -59.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 mt-10 -41.38 -48.27 3.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 59.6 t80 -67.54 -30.08 69.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 1.01 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -72.03 -38.49 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD21 ' CH2' ' A' ' 21' ' ' TRP . 32.1 mt -64.24 -60.79 2.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 27' ' ' ILE . 6.0 mt -52.38 -48.25 65.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 28' ' ' LEU . 3.8 tt -64.6 -38.32 90.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.57 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.4 t -66.48 -65.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.795 ' CD1' HD12 ' B' ' 126' ' ' ILE . 7.6 mt -52.37 -21.61 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 31' ' ' VAL . 9.1 mt -79.62 -49.79 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.753 HD12 HD23 ' A' ' 24' ' ' LEU . 9.6 mt -66.42 -50.4 63.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HD2' HG13 ' A' ' 25' ' ' VAL . 27.7 mtp85 -57.99 -53.34 59.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.973 HG22 HH22 ' B' ' 133' ' ' ARG . 22.4 m -58.99 -49.1 79.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 27' ' ' ILE . 4.4 t -44.93 -42.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 27.3 mtmt -77.41 -33.4 55.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.961 HH22 HG22 ' B' ' 130' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 5' ' ' LEU . 8.6 mt -52.63 -53.19 50.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.06 -37.83 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.903 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.3 mt -79.53 -41.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.062 HD12 ' HA ' ' B' ' 105' ' ' LEU . 33.5 mt -54.56 -37.11 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.828 HG13 HD13 ' A' ' 8' ' ' ILE . 5.4 mt -74.49 -57.72 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 110' ' ' LEU . 35.3 mt -47.93 -44.76 30.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.903 HG23 ' O ' ' B' ' 107' ' ' ILE . 43.5 t -61.29 -47.7 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.7 mm-40 -48.36 -46.85 37.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.5 m -58.17 -60.28 4.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.29 -29.44 47.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.781 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -63.32 -65.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.781 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.96 -42.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.49 78.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.655 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.84 -59.12 3.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.401 ' OE1' ' HE3' ' A' ' 18' ' ' MET . 30.3 mt-10 -41.42 -47.79 3.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.413 ' CZ ' HD12 ' B' ' 124' ' ' LEU . 60.0 t80 -67.76 -30.33 69.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 0.997 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.7 -38.54 70.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.997 HD21 ' CH2' ' B' ' 121' ' ' TRP . 31.9 mt -64.24 -60.79 2.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.604 ' O ' HD12 ' B' ' 127' ' ' ILE . 6.3 mt -52.38 -48.26 65.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.775 HD23 HD12 ' B' ' 128' ' ' LEU . 3.9 tt -64.52 -38.49 91.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.4 t -66.42 -66.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.795 HD12 ' CD1' ' A' ' 26' ' ' ILE . 7.9 mt -52.28 -21.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.702 ' O ' HG23 ' B' ' 131' ' ' VAL . 8.7 mt -79.59 -50.03 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.775 HD12 HD23 ' B' ' 124' ' ' LEU . 9.3 mt -66.36 -50.26 64.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.565 ' HD2' HG13 ' B' ' 125' ' ' VAL . 27.6 mtp85 -58.07 -53.1 62.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.961 HG22 HH22 ' A' ' 33' ' ' ARG . 22.2 m -59.2 -48.64 80.86 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.702 HG23 ' O ' ' B' ' 127' ' ' ILE . 4.6 t -45.09 -42.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.445 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 27.4 mtmt -77.15 -33.4 56.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.973 HH22 HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.013 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.1 mt -49.41 -53.85 20.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -43.97 -44.12 7.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.942 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.8 mt -72.16 -41.79 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.046 HG22 ' CG2' ' B' ' 108' ' ' ILE . 49.8 mt -54.1 -33.23 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.969 HG13 HD13 ' B' ' 108' ' ' ILE . 3.9 mt -74.61 -56.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 10' ' ' LEU . 42.5 mt -51.26 -48.74 62.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.4 t -56.92 -48.31 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.9 mt-10 -47.75 -51.25 22.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -53.3 -60.13 3.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -56.84 -26.35 58.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.786 HG11 HG21 ' B' ' 115' ' ' VAL . 1.2 t -69.82 -63.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.697 HD12 HG12 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -43.46 -38.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.36 -29.29 59.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.825 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 3.2 mtp -63.54 -54.23 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.58 ' OE1' ' HE2' ' B' ' 118' ' ' MET . 23.7 mt-10 -59.91 -46.44 89.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.86 -64.32 0.87 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.825 ' CD1' ' HA ' ' A' ' 18' ' ' MET . 0.6 OUTLIER -57.43 -37.56 72.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.506 ' CD2' HD11 ' B' ' 123' ' ' LEU . 12.4 mt -55.5 -61.63 2.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 mt -59.42 -51.14 71.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -41.57 62.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -69.51 -66.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.647 HG22 HG22 ' B' ' 126' ' ' ILE . 4.8 mt -50.83 -20.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 31' ' ' VAL . 18.1 mt -81.22 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.18 -48.33 73.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 25' ' ' VAL . 15.9 mtp-105 -60.78 -52.52 64.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 7.6 m -57.31 -51.58 68.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 27' ' ' ILE . 19.5 t -44.64 -47.62 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -68.16 -34.01 75.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.028 ' HA ' HD12 ' B' ' 108' ' ' ILE . 8.8 mt -49.55 -53.91 21.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -43.87 -44.16 6.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.94 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -72.15 -41.89 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.046 ' CG2' HG22 ' A' ' 8' ' ' ILE . 49.0 mt -54.06 -33.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.989 HG13 HD13 ' A' ' 8' ' ' ILE . 3.9 mt -74.54 -56.4 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' B' ' 110' ' ' LEU . 42.4 mt -51.38 -48.85 62.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.94 HG23 ' O ' ' B' ' 107' ' ' ILE . 17.5 t -56.68 -48.41 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 1.9 mt-10 -47.77 -51.37 22.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -53.1 -60.12 3.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -56.85 -26.35 58.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 15' ' ' VAL . 1.2 t -69.92 -63.31 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.682 ' N ' HG12 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -43.55 -38.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.4 59.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.828 ' HA ' ' CD1' ' B' ' 121' ' ' TRP . 3.2 mtp -63.46 -54.02 43.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.585 ' OE1' ' HE2' ' A' ' 18' ' ' MET . 23.8 mt-10 -60.09 -46.56 89.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -53.77 -64.17 0.91 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 0.828 ' CD1' ' HA ' ' B' ' 118' ' ' MET . 0.6 OUTLIER -57.47 -37.63 73.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.498 HD23 ' CH2' ' B' ' 121' ' ' TRP . 12.4 mt -55.51 -61.49 2.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.594 ' C ' HD12 ' B' ' 127' ' ' ILE . 8.6 mt -59.57 -51.09 71.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -41.41 62.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.607 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -69.67 -66.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.647 HG22 HG22 ' A' ' 26' ' ' ILE . 4.9 mt -50.81 -21.04 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.714 ' O ' HG23 ' B' ' 131' ' ' VAL . 18.6 mt -81.21 -49.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.98 -48.24 74.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.586 ' HD2' HG13 ' B' ' 125' ' ' VAL . 16.0 mtp-105 -60.92 -52.71 63.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 7.5 m -57.12 -51.5 69.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 127' ' ' ILE . 20.3 t -44.56 -47.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -68.59 -33.57 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.043 ' HA ' HD12 ' A' ' 8' ' ' ILE . 8.7 mt -51.62 -54.12 31.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.74 -40.3 4.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.899 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.8 mt -76.68 -41.01 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.043 HD12 ' HA ' ' A' ' 5' ' ' LEU . 46.4 mt -54.05 -35.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.776 HG12 HG21 ' B' ' 108' ' ' ILE . 1.6 mt -75.54 -56.53 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 10' ' ' LEU . 20.0 mt -49.57 -45.53 47.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 7' ' ' ILE . 23.2 t -61.22 -47.51 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.6 mt-10 -47.61 -47.84 28.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -58.07 -59.92 4.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.23 -28.26 51.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.813 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.61 -65.91 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.813 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.0 -42.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.39 80.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.701 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.66 -60.14 2.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 30.3 mt-10 -41.2 -47.97 3.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 17.1 t80 -66.37 -31.59 72.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.976 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.0 -41.86 70.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.976 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.5 mt -59.75 -60.15 4.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.34 -54.78 31.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.751 HD23 HD12 ' A' ' 28' ' ' LEU . 2.6 tt -56.26 -41.33 75.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.39 -66.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.763 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.7 mt -54.69 -22.15 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.716 HD12 ' C ' ' A' ' 23' ' ' LEU . 11.6 mt -78.28 -43.54 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.751 HD12 HD23 ' A' ' 24' ' ' LEU . 10.1 mt -72.19 -52.71 15.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.484 ' HD2' HG13 ' A' ' 25' ' ' VAL . 12.7 mtp180 -55.98 -46.98 78.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.582 HG22 ' CZ ' ' B' ' 133' ' ' ARG . 16.6 m -64.48 -54.98 23.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 27' ' ' ILE . 7.5 t -44.2 -34.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -79.89 -33.59 39.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.519 ' HE ' ' HE ' ' B' ' 133' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 1.043 HD22 ' HB3' ' A' ' 5' ' ' LEU . 9.0 mt -51.7 -54.09 32.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.72 -40.28 4.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.917 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -76.74 -41.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 1.028 HG22 ' CG2' ' A' ' 8' ' ' ILE . 44.8 mt -54.13 -34.99 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.763 HG12 HG21 ' A' ' 8' ' ' ILE . 1.6 mt -75.61 -56.32 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' B' ' 110' ' ' LEU . 19.8 mt -49.64 -45.66 48.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.917 HG23 ' O ' ' B' ' 107' ' ' ILE . 22.0 t -61.11 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.6 mt-10 -47.39 -47.85 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -58.09 -60.06 4.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.17 -28.1 50.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.789 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -64.81 -65.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.789 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.99 -42.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.39 80.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.43 -60.46 2.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.445 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.5 mt-10 -41.12 -48.2 3.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 17.3 t80 -66.11 -31.66 72.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' TRP . . . . . 0.972 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.9 -41.95 70.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.972 HD21 ' CH2' ' B' ' 121' ' ' TRP . 25.4 mt -59.8 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.679 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.2 mt -53.22 -54.96 28.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.757 HD23 HD12 ' B' ' 128' ' ' LEU . 2.5 tt -56.42 -40.72 75.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.604 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.3 t -63.95 -66.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.763 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.7 mt -54.39 -23.57 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.737 ' O ' HG23 ' B' ' 131' ' ' VAL . 12.9 mt -76.68 -45.52 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.757 HD12 HD23 ' B' ' 124' ' ' LEU . 10.0 mt -70.53 -54.49 11.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.501 ' HD2' HG13 ' B' ' 125' ' ' VAL . 12.6 mtp180 -53.55 -45.37 69.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' B' ' 133' ' ' ARG . 21.2 m -68.02 -50.64 54.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 127' ' ' ILE . 3.8 t -42.98 -35.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -87.96 -27.94 21.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . 0.582 ' CZ ' HG22 ' A' ' 30' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.666 ' HG3' HD12 ' A' ' 5' ' ' LEU . 9.8 ttpp -72.18 -22.12 61.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -48.61 -52.81 21.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -43.99 -58.04 3.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.033 HD22 ' HB3' ' B' ' 105' ' ' LEU . 7.8 mt -52.39 -53.37 45.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.92 -37.82 3.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.881 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.9 mt -79.34 -39.6 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.012 ' CG2' HG22 ' B' ' 108' ' ' ILE . 49.1 mt -55.97 -36.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.802 HG13 HG21 ' B' ' 108' ' ' ILE . 5.4 mt -75.72 -55.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 10' ' ' LEU . 18.4 mt -49.91 -48.14 51.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 7' ' ' ILE . 35.3 t -59.03 -49.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.9 mt-10 -45.51 -47.49 14.2 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.41 -59.01 6.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.7 -29.56 53.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.78 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -63.88 -65.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.78 HD12 HG12 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -41.98 -44.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.52 78.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.658 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.5 mtp -66.81 -57.24 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' B' ' 119' ' ' GLU . 2.2 mm-40 -41.1 -48.55 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t80 -67.73 -31.17 70.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 1.03 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.02 -39.85 72.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.03 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.3 mt -61.79 -60.28 3.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 mt -54.95 -52.94 61.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.689 ' CD2' HD12 ' A' ' 28' ' ' LEU . 6.1 tt -55.71 -48.26 75.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.4 t -58.6 -66.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.8 mt -54.14 -20.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt -79.32 -43.86 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.689 HD12 ' CD2' ' A' ' 24' ' ' LEU . 9.1 mt -72.97 -49.82 26.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HD2' HG13 ' A' ' 25' ' ' VAL . 28.6 mtp85 -58.46 -47.7 83.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.47 -54.44 40.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 27' ' ' ILE . 13.5 t -44.46 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.2 mttt -68.9 -36.01 77.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.582 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -49.48 -29.82 7.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -70.32 -66.16 0.63 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 32' ' ' LYS . 3.5 p30 -69.17 -5.9 25.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . -59.98 -24.43 60.55 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.64 ' HG3' HD12 ' B' ' 105' ' ' LEU . 10.6 ttpp -73.85 -21.82 59.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -48.08 -53.33 16.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -43.95 -58.3 2.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.033 ' HB3' HD22 ' A' ' 5' ' ' LEU . 7.7 mt -52.84 -53.07 53.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -43.88 -37.37 2.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.898 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.9 mt -80.01 -40.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.026 HD12 ' HA ' ' B' ' 105' ' ' LEU . 42.8 mt -55.77 -36.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.775 HG13 HG21 ' A' ' 8' ' ' ILE . 5.4 mt -75.75 -55.08 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' B' ' 110' ' ' LEU . 18.1 mt -49.83 -48.15 51.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.898 HG23 ' O ' ' B' ' 107' ' ' ILE . 32.7 t -58.95 -49.72 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.9 mt-10 -45.35 -47.53 13.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.43 -58.84 6.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.75 -29.6 54.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.773 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -63.96 -66.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.773 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -41.92 -44.68 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.58 79.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.658 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.83 -57.22 7.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 2.2 mm-40 -41.23 -48.46 3.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 46.5 t80 -67.84 -31.02 70.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 1.017 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.08 -40.01 71.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 1.017 HD21 ' CH2' ' B' ' 121' ' ' TRP . 24.9 mt -61.73 -60.27 3.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.632 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.7 mt -54.92 -52.96 61.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.694 ' CD2' HD12 ' B' ' 128' ' ' LEU . 6.1 tt -55.68 -48.32 75.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.562 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.4 t -58.53 -66.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.641 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.8 mt -54.15 -20.66 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.643 ' O ' HG23 ' B' ' 131' ' ' VAL . 7.9 mt -79.38 -43.78 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.694 HD12 ' CD2' ' B' ' 124' ' ' LEU . 9.0 mt -73.11 -49.75 26.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.536 ' HD2' HG13 ' B' ' 125' ' ' VAL . 28.6 mtp85 -58.48 -47.73 83.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.34 -54.44 40.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.643 HG23 ' O ' ' B' ' 127' ' ' ILE . 13.7 t -44.51 -43.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 136' ' ' GLY . 68.5 mttt -68.95 -35.84 77.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.582 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -49.56 -29.81 7.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -70.36 -66.33 0.61 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' B' ' 132' ' ' LYS . 3.4 p30 -68.83 -5.76 22.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 132' ' ' LYS . . . -59.97 -24.55 60.66 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -71.98 -22.14 61.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.0 m -51.54 -46.59 63.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.58 -58.21 5.04 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.035 ' HA ' HD12 ' A' ' 8' ' ' ILE . 8.5 mt -49.14 -53.47 20.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.13 -43.63 7.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.93 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.4 mt -72.75 -42.14 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.035 HD12 ' HA ' ' A' ' 5' ' ' LEU . 59.7 mt -52.53 -33.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.994 HG13 HD13 ' B' ' 108' ' ' ILE . 5.4 mt -75.62 -57.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 10' ' ' LEU . 34.3 mt -49.8 -45.36 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.7 t -60.73 -48.08 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.5 mt-10 -47.63 -47.96 28.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -57.44 -60.47 3.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.12 -28.28 51.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.811 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.62 -65.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.811 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -42.94 -42.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.39 80.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.725 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.4 -60.61 2.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 29.7 mt-10 -41.05 -48.09 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.9 t80 -66.02 -32.06 73.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.982 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.84 -42.35 70.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.982 HD21 ' CH2' ' A' ' 21' ' ' TRP . 23.0 mt -58.79 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.624 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.31 -56.16 18.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.749 HD23 HD12 ' A' ' 28' ' ' LEU . 2.5 tt -55.0 -40.65 70.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.1 t -63.86 -67.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.778 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.0 mt -55.27 -20.77 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 31' ' ' VAL . 15.9 mt -79.85 -40.87 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.749 HD12 HD23 ' A' ' 24' ' ' LEU . 10.2 mt -75.26 -49.5 19.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HD2' HG13 ' A' ' 25' ' ' VAL . 27.0 mtp180 -59.35 -47.19 86.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 9.5 m -62.17 -55.06 32.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.3 -43.13 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -68.61 -35.57 77.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.89 -29.7 8.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.49 -39.58 62.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 37' ' ' GLY . 14.8 m-20 -68.79 -63.99 0.95 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.9 -21.13 0.19 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 C--N 1.336 0.536 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -73.21 -22.28 60.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 60.8 m -51.12 -46.7 61.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.6 -58.27 4.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.03 ' HA ' HD12 ' B' ' 108' ' ' ILE . 8.2 mt -49.11 -53.33 21.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -44.24 -43.8 7.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.931 ' O ' HG23 ' B' ' 111' ' ' VAL . 17.0 mt -72.61 -42.11 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.03 HD12 ' HA ' ' B' ' 105' ' ' LEU . 59.5 mt -52.51 -33.57 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.988 HG13 HD13 ' A' ' 8' ' ' ILE . 5.5 mt -75.65 -57.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' B' ' 110' ' ' LEU . 34.7 mt -49.7 -45.24 48.74 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.931 HG23 ' O ' ' B' ' 107' ' ' ILE . 18.1 t -60.91 -48.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.5 mt-10 -47.69 -48.06 29.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.3 -60.64 3.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.02 -28.32 51.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.785 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.61 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.785 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.94 -42.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.38 80.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.3 -60.65 2.58 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.0 mt-10 -41.05 -48.26 3.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 68.3 t80 -65.85 -32.02 73.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.76 -42.47 70.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' B' ' 121' ' ' TRP . 23.3 mt -58.8 -60.13 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.621 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.2 mt -53.26 -56.2 18.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.746 HD23 HD12 ' B' ' 128' ' ' LEU . 2.4 tt -55.01 -40.62 70.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.627 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.89 -66.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.778 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.41 -20.76 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.631 ' O ' HG23 ' B' ' 131' ' ' VAL . 16.3 mt -79.8 -40.79 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.746 HD12 HD23 ' B' ' 124' ' ' LEU . 10.3 mt -75.33 -49.63 18.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.491 ' HD2' HG13 ' B' ' 125' ' ' VAL . 25.6 mtp180 -59.23 -47.21 86.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.1 m -62.08 -54.89 35.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 127' ' ' ILE . 12.2 t -44.33 -43.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -68.58 -35.84 77.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.549 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -49.6 -29.66 7.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.63 -39.74 61.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . 0.457 ' C ' ' N ' ' B' ' 137' ' ' GLY . 15.2 m-20 -68.37 -64.16 0.92 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -43.84 -20.91 0.17 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' HZ3' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -66.61 -21.2 66.13 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.9 m -53.89 -45.09 70.96 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -58.29 6.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.056 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.5 mt -51.48 -51.59 53.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -44.29 -42.99 7.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.939 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.8 mt -73.35 -42.18 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.056 HD12 ' HA ' ' A' ' 5' ' ' LEU . 61.4 mt -52.53 -33.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.998 HG13 HD13 ' B' ' 108' ' ' ILE . 4.5 mt -75.64 -57.3 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 10' ' ' LEU . 32.7 mt -49.72 -45.93 49.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.3 t -60.2 -48.42 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 2.4 mt-10 -47.2 -48.03 24.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -57.4 -60.48 3.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.05 -28.3 51.26 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.82 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.5 -65.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.82 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.07 -42.12 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.29 79.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.719 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.42 -60.76 2.45 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.7 mt-10 -40.97 -48.27 3.15 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 9.7 t80 -66.02 -32.13 73.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 1.006 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.92 -41.2 71.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.006 HD21 ' CH2' ' A' ' 21' ' ' TRP . 39.4 mt -59.82 -60.15 4.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.689 HD11 HD22 ' B' ' 122' ' ' LEU . 5.4 mt -53.82 -54.73 34.33 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD23 HD12 ' A' ' 28' ' ' LEU . 3.4 tt -55.75 -42.36 75.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.611 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -62.55 -66.66 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.749 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.5 mt -55.01 -20.59 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.64 HD12 ' C ' ' A' ' 23' ' ' LEU . 12.0 mt -79.86 -42.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.752 HD12 HD23 ' A' ' 24' ' ' LEU . 9.9 mt -73.85 -49.32 25.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HD2' HG13 ' A' ' 25' ' ' VAL . 15.1 mtp180 -59.48 -47.58 84.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 11.5 m -62.46 -54.74 35.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 27' ' ' ILE . 11.4 t -44.24 -43.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -68.42 -34.95 76.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -50.73 -29.04 10.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 36' ' ' GLY . . . -75.79 -46.25 31.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -57.82 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -89.07 37.44 3.32 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.508 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.632 ' HB2' ' HZ3' ' B' ' 102' ' ' LYS . 0.0 OUTLIER -64.83 -21.63 66.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -53.58 -45.71 70.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -58.19 6.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.031 ' HA ' HD12 ' B' ' 108' ' ' ILE . 7.7 mt -50.61 -52.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.39 -43.47 7.65 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.931 ' O ' HG23 ' B' ' 111' ' ' VAL . 17.8 mt -72.61 -42.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.033 ' CG2' HG22 ' A' ' 8' ' ' ILE . 62.3 mt -52.48 -33.55 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.953 HG13 HD13 ' A' ' 8' ' ' ILE . 4.8 mt -75.57 -57.18 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' B' ' 110' ' ' LEU . 30.6 mt -49.84 -45.58 50.47 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.931 HG23 ' O ' ' B' ' 107' ' ' ILE . 17.7 t -60.53 -47.98 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.48 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.4 mt-10 -47.77 -47.99 30.4 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.38 -60.73 3.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.0 -28.29 50.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.798 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.44 -65.9 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.798 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -43.1 -42.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.47 80.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.45 -60.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.446 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.7 mt-10 -40.93 -48.31 3.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.94 -32.16 73.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 1.005 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.83 -41.28 71.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 1.005 HD21 ' CH2' ' B' ' 121' ' ' TRP . 39.8 mt -59.76 -60.24 4.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.687 HD11 HD22 ' A' ' 22' ' ' LEU . 5.3 mt -53.74 -54.79 33.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.733 HD23 HD12 ' B' ' 128' ' ' LEU . 3.4 tt -55.63 -42.32 74.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.615 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -62.68 -66.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.749 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.4 mt -55.01 -20.7 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 131' ' ' VAL . 12.2 mt -79.76 -42.24 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.733 HD12 HD23 ' B' ' 124' ' ' LEU . 9.8 mt -73.93 -49.45 24.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.496 ' HD2' HG13 ' B' ' 125' ' ' VAL . 15.0 mtp180 -59.27 -47.53 85.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 11.2 m -62.38 -54.63 37.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 127' ' ' ILE . 11.7 t -44.25 -44.0 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -68.56 -34.92 76.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.58 ' CZ ' ' HA ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.639 ' C ' ' H ' ' B' ' 136' ' ' GLY . . . -75.55 -46.18 33.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -57.5 4.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' B' ' 134' ' ' ALA . . . -88.83 37.4 3.31 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.744 ' HG3' HD12 ' A' ' 5' ' ' LEU . 14.7 ttmm -54.34 -21.52 9.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.1 m -47.59 -51.79 19.96 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.09 -57.54 3.33 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.095 HD13 HD13 ' B' ' 105' ' ' LEU . 8.1 mt -53.41 -53.44 51.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.64 -37.16 2.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.888 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.7 mt -79.71 -40.81 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.002 ' CG2' HG22 ' B' ' 108' ' ' ILE . 41.6 mt -55.27 -36.44 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.753 HG13 HG21 ' B' ' 108' ' ' ILE . 3.9 mt -75.51 -54.82 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' A' ' 10' ' ' LEU . 19.4 mt -50.16 -46.95 54.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 7' ' ' ILE . 26.0 t -60.23 -47.86 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.6 mt-10 -47.17 -47.08 24.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -58.99 -60.57 3.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.69 -27.92 43.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.822 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.57 -66.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.822 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.06 -42.09 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.31 79.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.652 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.51 -60.33 2.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 30.5 mt-10 -41.13 -48.06 3.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 14.5 t80 -65.83 -32.1 73.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.74 -42.36 70.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.7 mt -58.87 -60.02 4.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.35 -56.08 19.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.734 HD23 HD12 ' A' ' 28' ' ' LEU . 2.3 tt -55.09 -40.75 70.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.1 t -63.69 -66.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.77 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.0 mt -55.5 -20.68 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 31' ' ' VAL . 15.5 mt -79.91 -40.5 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.734 HD12 HD23 ' A' ' 24' ' ' LEU . 10.2 mt -75.7 -49.45 18.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HD2' HG13 ' A' ' 25' ' ' VAL . 23.3 mtp180 -59.47 -46.81 87.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.43 -54.85 34.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.7 t -44.4 -43.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.22 -35.95 78.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.46 -29.88 7.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.26 -41.61 61.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -66.86 -30.47 70.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.39 24.22 1.29 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.541 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.749 ' HG3' HD12 ' B' ' 105' ' ' LEU . 14.7 ttmm -54.96 -21.38 11.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.4 m -47.41 -51.96 18.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.97 -57.88 3.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.095 HD13 HD13 ' A' ' 5' ' ' LEU . 7.9 mt -53.38 -53.36 52.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -43.59 -37.18 2.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.909 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.7 mt -79.8 -40.66 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' B' ' 105' ' ' LEU . 42.3 mt -55.53 -36.31 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.745 HG13 HG21 ' A' ' 8' ' ' ILE . 3.9 mt -75.66 -54.79 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' B' ' 110' ' ' LEU . 18.8 mt -50.15 -46.79 54.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.909 HG23 ' O ' ' B' ' 107' ' ' ILE . 26.8 t -60.39 -47.74 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.6 mt-10 -47.24 -47.1 24.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -58.98 -60.56 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.72 -27.85 43.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.8 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -64.6 -66.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.8 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -43.14 -42.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.33 79.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.654 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.4 -60.38 2.81 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 29.8 mt-10 -41.2 -48.09 3.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 14.4 t80 -65.72 -32.04 73.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.976 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.91 -42.27 70.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.976 HD21 ' CH2' ' B' ' 121' ' ' TRP . 24.9 mt -58.9 -60.14 4.33 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.625 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.3 mt -53.24 -56.08 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.739 HD23 HD12 ' B' ' 128' ' ' LEU . 2.3 tt -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.622 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.59 -66.94 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.77 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 mt -55.39 -20.84 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.629 ' O ' HG23 ' B' ' 131' ' ' VAL . 15.4 mt -79.83 -40.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.739 HD12 HD23 ' B' ' 124' ' ' LEU . 10.2 mt -75.71 -49.49 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.483 ' HD2' HG13 ' B' ' 125' ' ' VAL . 23.3 mtp180 -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.7 m -62.37 -54.79 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 127' ' ' ILE . 12.7 t -44.43 -43.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -68.19 -36.05 78.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.548 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -49.36 -29.88 6.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.548 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.2 -41.54 61.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -66.87 -30.32 70.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.48 24.49 1.25 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.554 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.715 ' HG3' HD12 ' A' ' 5' ' ' LEU . 15.7 ttmt -68.69 -23.47 64.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.5 m -49.91 -49.35 50.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -45.71 -58.3 3.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.084 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.0 mt -48.57 -54.18 15.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.67 -40.87 6.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.908 ' O ' HG23 ' A' ' 11' ' ' VAL . 14.9 mt -75.05 -40.18 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.084 HD12 ' HA ' ' A' ' 5' ' ' LEU . 74.8 mt -52.54 -38.94 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.827 HG13 HG21 ' B' ' 108' ' ' ILE . 5.4 mt -72.88 -57.45 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 10' ' ' LEU . 21.1 mt -48.48 -39.58 23.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 7' ' ' ILE . 52.3 t -64.79 -46.47 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 1.6 mt-10 -49.97 -49.85 48.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -55.87 -61.34 2.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -50.58 -37.48 40.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.892 HG12 HD12 ' A' ' 16' ' ' ILE . 1.3 t -55.16 -66.3 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.892 HD12 HG12 ' A' ' 15' ' ' VAL . 1.2 mp -42.59 -39.7 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -58.62 -40.94 84.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.672 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 3.1 mtm -66.5 -55.58 14.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.522 ' CD ' ' CE ' ' B' ' 118' ' ' MET . 47.6 mt-10 -39.38 -47.71 1.81 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CZ ' HD12 ' A' ' 24' ' ' LEU . 23.7 t80 -67.37 -36.67 81.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 1.022 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.87 -39.6 90.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.022 HD21 ' CH2' ' A' ' 21' ' ' TRP . 17.9 mt -61.17 -61.15 2.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.598 HD11 HD22 ' B' ' 122' ' ' LEU . 6.7 mt -55.83 -52.68 63.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.643 ' CD2' HD12 ' A' ' 28' ' ' LEU . 5.2 tt -54.71 -48.67 72.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.588 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.6 t -59.14 -66.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 5.5 mt -53.29 -21.86 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt -78.42 -44.95 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.643 HD12 ' CD2' ' A' ' 24' ' ' LEU . 9.3 mt -72.08 -51.58 20.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.588 ' HD2' HG13 ' A' ' 25' ' ' VAL . 8.8 mtp180 -56.32 -47.55 78.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.0 m -62.68 -54.58 37.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 27' ' ' ILE . 16.1 t -44.33 -43.04 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -69.63 -35.0 74.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.601 ' HD2' ' HD2' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -50.47 -30.19 12.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -73.41 -31.45 63.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -78.92 -25.69 43.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.12 -14.36 11.12 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.695 ' HG3' HD12 ' B' ' 105' ' ' LEU . 16.0 ttmt -69.0 -23.88 64.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 56.1 m -49.68 -49.39 47.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -45.75 -58.31 3.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.078 HD22 ' HB3' ' A' ' 5' ' ' LEU . 8.7 mt -48.73 -54.25 15.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -44.51 -40.8 5.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.904 ' O ' HG23 ' B' ' 111' ' ' VAL . 14.9 mt -74.96 -40.46 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.077 HD12 ' HA ' ' B' ' 105' ' ' LEU . 74.9 mt -52.39 -38.97 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.813 HG13 HG21 ' A' ' 8' ' ' ILE . 5.3 mt -72.85 -57.44 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' B' ' 110' ' ' LEU . 20.8 mt -48.46 -39.57 23.37 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.904 HG23 ' O ' ' B' ' 107' ' ' ILE . 51.3 t -64.74 -46.41 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mt-10 -50.08 -49.92 49.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.75 -61.22 2.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.656 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.75 -37.5 42.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.872 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -55.13 -66.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.872 HD12 HG12 ' B' ' 115' ' ' VAL . 1.2 mp -42.55 -39.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' B' ' 114' ' ' ALA . . . -58.67 -40.84 84.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.659 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 3.1 mtm -66.53 -55.65 14.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 18' ' ' MET . 48.1 mt-10 -39.37 -47.61 1.79 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' B' ' 124' ' ' LEU . 23.9 t80 -67.47 -36.63 81.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 1.006 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -65.9 -39.62 90.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 1.006 HD21 ' CH2' ' B' ' 121' ' ' TRP . 17.9 mt -61.24 -61.05 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.601 HD11 HD22 ' A' ' 22' ' ' LEU . 6.5 mt -55.86 -52.73 63.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.643 ' CD2' HD12 ' B' ' 128' ' ' LEU . 5.2 tt -54.7 -48.55 72.32 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.575 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.6 t -59.15 -66.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.5 mt -53.36 -21.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.664 ' O ' HG23 ' B' ' 131' ' ' VAL . 9.0 mt -78.47 -44.81 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.643 HD12 ' CD2' ' B' ' 124' ' ' LEU . 9.4 mt -72.3 -51.37 21.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.575 ' HD2' HG13 ' B' ' 125' ' ' VAL . 8.8 mtp180 -56.54 -47.62 79.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 8.1 m -62.56 -54.46 39.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 127' ' ' ILE . 15.8 t -44.47 -43.01 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -69.61 -34.84 74.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.601 ' HD2' ' HD2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -50.63 -30.11 12.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.563 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -73.36 -31.44 63.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -78.91 -25.77 43.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -56.76 -14.24 9.52 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.535 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HG2' HD12 ' A' ' 5' ' ' LEU . 11.9 ttpt -70.25 -23.31 62.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.2 m -49.44 -52.12 31.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -44.09 -56.04 4.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.7 mt -51.25 -54.28 27.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -44.75 -39.57 5.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.0 mt -78.27 -36.42 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.03 HG22 ' CG2' ' B' ' 108' ' ' ILE . 50.4 mt -57.53 -38.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.89 HG12 HD13 ' B' ' 108' ' ' ILE . 3.4 mt -73.78 -57.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 10' ' ' LEU . 28.1 mt -50.27 -39.83 46.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 7' ' ' ILE . 71.7 t -64.23 -45.73 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' CG ' ' HG2' ' B' ' 112' ' ' GLU . 1.1 mt-10 -50.81 -50.8 55.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -54.69 -60.25 3.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.683 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -51.05 -38.11 49.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.906 HG22 ' HE1' ' A' ' 18' ' ' MET . 1.4 t -55.51 -66.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.832 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -41.71 -40.23 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.43 -40.74 87.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.906 ' HE1' HG22 ' A' ' 15' ' ' VAL . 2.9 mtm -67.03 -55.19 15.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 119' ' ' GLU . 3.4 mm-40 -39.58 -47.98 2.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 29.4 t80 -68.47 -34.86 76.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 1.035 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -67.34 -38.75 85.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.035 HD21 ' CH2' ' A' ' 21' ' ' TRP . 20.1 mt -62.33 -61.02 2.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 27' ' ' ILE . 6.1 mt -55.67 -51.66 66.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CD2' HD12 ' A' ' 28' ' ' LEU . 5.8 tt -56.6 -47.69 79.05 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.7 t -59.6 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' B' ' 126' ' ' ILE . 6.2 mt -53.35 -21.3 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 23' ' ' LEU . 7.1 mt -78.84 -45.61 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.681 HD12 ' CD2' ' A' ' 24' ' ' LEU . 8.7 mt -71.6 -50.51 30.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HD2' HG13 ' A' ' 25' ' ' VAL . 18.3 mtp180 -57.4 -47.99 80.26 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 8.8 m -62.61 -54.34 41.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 27' ' ' ILE . 15.0 t -44.39 -43.45 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.35 -36.34 79.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -49.0 -29.76 5.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -74.49 -41.55 60.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 37' ' ' GLY . 14.3 m-20 -65.82 -22.01 66.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.16 2.72 0.15 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 CA--C 1.523 0.539 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.456 ' HG2' HD12 ' B' ' 105' ' ' LEU . 11.9 ttpt -68.91 -24.85 64.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 48.8 m -49.65 -51.06 40.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.51 -56.04 4.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.026 ' HA ' HD12 ' B' ' 108' ' ' ILE . 9.0 mt -51.26 -54.62 24.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -43.77 -41.18 4.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.908 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -75.69 -39.84 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.03 ' CG2' HG22 ' A' ' 8' ' ' ILE . 55.6 mt -53.93 -37.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.858 HG12 HD13 ' A' ' 8' ' ' ILE . 4.0 mt -73.31 -57.81 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' B' ' 110' ' ' LEU . 20.6 mt -48.72 -41.33 31.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.908 HG23 ' O ' ' B' ' 107' ' ' ILE . 48.4 t -64.35 -43.74 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.7 mm-40 -51.47 -50.57 59.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.8 m -55.88 -59.2 5.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.669 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -50.77 -38.37 47.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.843 HG11 HG11 ' A' ' 15' ' ' VAL . 1.3 t -55.37 -65.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.825 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -41.75 -40.27 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' B' ' 114' ' ' ALA . . . -59.53 -40.64 87.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.785 ' HE1' HG22 ' B' ' 115' ' ' VAL . 3.0 mtm -66.95 -55.27 15.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.476 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 3.7 mm-40 -39.65 -48.03 2.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 29.7 t80 -68.5 -34.59 76.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 1.041 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -67.47 -38.76 84.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 1.041 HD21 ' CH2' ' B' ' 121' ' ' TRP . 20.5 mt -62.47 -61.03 2.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.664 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.6 mt -55.47 -51.6 66.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.684 ' CD2' HD12 ' B' ' 128' ' ' LEU . 5.7 tt -56.83 -47.33 80.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.595 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.6 t -59.62 -66.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.632 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 5.6 mt -53.47 -21.04 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.664 HD12 ' C ' ' B' ' 123' ' ' LEU . 7.1 mt -79.04 -45.34 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.684 HD12 ' CD2' ' B' ' 124' ' ' LEU . 8.7 mt -71.76 -50.35 30.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.595 ' HD2' HG13 ' B' ' 125' ' ' VAL . 18.4 mtp180 -57.68 -48.05 80.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 9.0 m -62.56 -54.05 45.58 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 127' ' ' ILE . 14.0 t -44.59 -43.34 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -68.32 -36.57 79.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' B' ' 134' ' ' ALA . 0.0 OUTLIER -48.78 -29.78 4.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -74.32 -41.66 60.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . 0.59 ' C ' ' H ' ' B' ' 137' ' ' GLY . 14.3 m-20 -65.69 -21.83 66.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.05 2.8 0.14 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 CA--C 1.522 0.494 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.657 ' HG3' HD12 ' A' ' 5' ' ' LEU . 20.2 ttpt -70.36 -21.96 62.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 m -47.51 -51.68 19.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.516 ' HA ' HD22 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -44.89 -56.26 4.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.036 ' HA ' HD12 ' A' ' 8' ' ' ILE . 7.4 mt -57.24 -51.06 70.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.95 -34.87 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.737 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.5 mt -81.87 -37.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.036 HD12 ' HA ' ' A' ' 5' ' ' LEU . 51.6 mt -58.88 -39.35 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.842 HG13 HG21 ' B' ' 108' ' ' ILE . 4.7 mt -74.47 -57.04 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 10' ' ' LEU . 26.7 mt -49.54 -44.6 46.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 7' ' ' ILE . 69.8 t -60.49 -47.92 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 mt-10 -48.78 -48.05 41.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -56.46 -61.06 2.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.93 -28.91 54.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.799 HG12 HD12 ' A' ' 16' ' ' ILE . 1.3 t -64.17 -65.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.799 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -42.89 -42.48 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.43 79.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.653 ' CE ' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.52 -60.62 2.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE1' ' CG1' ' A' ' 15' ' ' VAL . 28.9 mt-10 -40.88 -48.13 3.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 37.1 t80 -66.32 -32.24 73.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.979 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.23 -41.19 73.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.979 HD21 ' CH2' ' A' ' 21' ' ' TRP . 23.2 mt -60.43 -60.58 3.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.654 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.4 mt -53.53 -53.06 57.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.708 HD23 HD12 ' A' ' 28' ' ' LEU . 3.9 tt -57.33 -41.99 81.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.55 -66.45 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.752 ' CD1' HD12 ' B' ' 126' ' ' ILE . 5.5 mt -53.84 -20.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 23' ' ' LEU . 10.3 mt -80.04 -45.72 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.708 HD12 HD23 ' A' ' 24' ' ' LEU . 10.1 mt -69.64 -49.79 50.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' HD2' HG13 ' A' ' 25' ' ' VAL . 7.3 mtp180 -59.12 -50.2 74.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.615 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 25.2 m -62.96 -52.93 61.1 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' ILE . 3.6 t -44.28 -36.36 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 28' ' ' LEU . 23.2 mtmt -79.52 -35.57 39.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 30' ' ' THR . 6.2 mtp180 -52.32 -35.89 51.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 36' ' ' GLY . . . -67.85 -31.33 71.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 37' ' ' GLY . 26.5 m-20 -74.35 15.47 0.33 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -50.48 -10.06 0.32 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 35' ' ' ASN . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.652 ' HG3' HD12 ' B' ' 105' ' ' LEU . 20.7 ttpt -70.25 -21.98 62.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 14.4 m -48.2 -51.03 27.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' B' ' 104' ' ' ASN . 0.0 OUTLIER -45.1 -56.65 4.51 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.011 ' HB3' HD22 ' A' ' 5' ' ' LEU . 7.5 mt -56.22 -51.7 67.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -43.66 -35.75 1.91 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.868 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.7 mt -81.05 -41.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.001 ' CG2' HG22 ' A' ' 8' ' ' ILE . 36.5 mt -55.7 -38.53 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.783 HG13 HG21 ' A' ' 8' ' ' ILE . 5.0 mt -73.99 -57.52 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' B' ' 110' ' ' LEU . 27.7 mt -47.88 -45.48 30.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.868 HG23 ' O ' ' B' ' 107' ' ' ILE . 61.4 t -60.37 -47.93 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.8 mm-40 -48.21 -46.63 35.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -58.14 -60.09 4.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.17 -29.71 46.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.789 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -63.18 -65.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.789 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.93 -42.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.1 78.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.675 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -67.09 -60.43 2.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.448 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 30.3 mt-10 -40.67 -47.83 2.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 37.2 t80 -66.32 -32.64 74.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.969 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.07 -41.09 74.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.969 HD21 ' CH2' ' B' ' 121' ' ' TRP . 21.8 mt -60.14 -60.56 3.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.665 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.7 mt -53.75 -53.38 53.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.69 HD23 HD12 ' B' ' 128' ' ' LEU . 3.8 tt -56.77 -42.16 78.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.602 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -63.57 -66.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.752 HD12 ' CD1' ' A' ' 26' ' ' ILE . 5.8 mt -53.82 -20.67 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.665 HD12 ' C ' ' B' ' 123' ' ' LEU . 10.5 mt -80.13 -45.74 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.69 HD12 HD23 ' B' ' 124' ' ' LEU . 10.2 mt -69.65 -49.65 51.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.515 ' HD2' HG13 ' B' ' 125' ' ' VAL . 7.3 mtp180 -59.25 -50.24 74.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.628 ' HA ' ' HG3' ' B' ' 133' ' ' ARG . 25.3 m -62.92 -52.83 61.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 127' ' ' ILE . 3.7 t -44.39 -36.39 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' B' ' 128' ' ' LEU . 23.2 mtmt -79.47 -35.33 40.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.628 ' HG3' ' HA ' ' B' ' 130' ' ' THR . 6.1 mtp180 -52.59 -36.12 55.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' B' ' 136' ' ' GLY . . . -67.58 -31.53 71.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' B' ' 137' ' ' GLY . 26.2 m-20 -74.25 15.86 0.29 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' B' ' 134' ' ' ALA . . . -50.48 -10.0 0.31 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' B' ' 135' ' ' ASN . . . . . . . . 0 C--N 1.336 0.532 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.669 ' HG3' HD12 ' A' ' 5' ' ' LEU . 28.1 ttpt -71.44 -21.51 61.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -47.37 -53.53 13.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -43.8 -57.42 3.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.062 HD13 HD13 ' B' ' 105' ' ' LEU . 8.4 mt -54.08 -52.51 60.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -43.9 -36.17 2.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.727 ' O ' HG23 ' A' ' 11' ' ' VAL . 17.2 mt -81.27 -36.59 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 5' ' ' LEU . 50.5 mt -59.63 -38.35 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.821 HG13 HG21 ' B' ' 108' ' ' ILE . 4.5 mt -74.94 -56.82 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 10' ' ' LEU . 34.9 mt -50.55 -44.04 56.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 7' ' ' ILE . 73.1 t -61.27 -46.81 95.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.5 mt-10 -49.74 -48.45 50.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -56.42 -61.44 2.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -54.94 -28.59 52.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.791 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.31 -65.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.791 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.03 -42.42 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.59 80.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.691 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.36 -59.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 mt-10 -41.38 -48.27 3.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 59.6 t80 -67.54 -30.08 69.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 1.01 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -72.03 -38.49 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD21 ' CH2' ' A' ' 21' ' ' TRP . 32.1 mt -64.24 -60.79 2.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 27' ' ' ILE . 6.0 mt -52.38 -48.25 65.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 28' ' ' LEU . 3.8 tt -64.6 -38.32 90.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.57 HG13 ' HD2' ' A' ' 29' ' ' ARG . 2.4 t -66.48 -65.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.795 ' CD1' HD12 ' B' ' 126' ' ' ILE . 7.6 mt -52.37 -21.61 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 31' ' ' VAL . 9.1 mt -79.62 -49.79 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.753 HD12 HD23 ' A' ' 24' ' ' LEU . 9.6 mt -66.42 -50.4 63.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HD2' HG13 ' A' ' 25' ' ' VAL . 27.7 mtp85 -57.99 -53.34 59.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.973 HG22 HH22 ' B' ' 133' ' ' ARG . 22.4 m -58.99 -49.1 79.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 27' ' ' ILE . 4.4 t -44.93 -42.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 27.3 mtmt -77.41 -33.4 55.01 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.961 HH22 HG22 ' B' ' 130' ' ' THR . 0.0 OUTLIER -55.09 -30.03 58.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.674 ' N ' ' HD3' ' A' ' 33' ' ' ARG . . . -75.18 -51.55 13.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -49.48 -66.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.68 74.74 0.04 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.713 ' HG3' HD12 ' B' ' 105' ' ' LEU . 28.3 ttpt -72.22 -21.67 61.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -47.04 -53.35 12.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.89 -58.03 2.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 5' ' ' LEU . 8.6 mt -52.63 -53.19 50.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.06 -37.83 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.903 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.3 mt -79.53 -41.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.062 HD12 ' HA ' ' B' ' 105' ' ' LEU . 33.5 mt -54.56 -37.11 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.828 HG13 HD13 ' A' ' 8' ' ' ILE . 5.4 mt -74.49 -57.72 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 110' ' ' LEU . 35.3 mt -47.93 -44.76 30.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.903 HG23 ' O ' ' B' ' 107' ' ' ILE . 43.5 t -61.29 -47.7 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.655 ' HG3' HG23 ' A' ' 8' ' ' ILE . 1.7 mm-40 -48.36 -46.85 37.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.5 m -58.17 -60.28 4.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -54.29 -29.44 47.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.781 HG12 HD12 ' B' ' 116' ' ' ILE . 1.4 t -63.32 -65.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.781 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.96 -42.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.49 78.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.655 ' HE2' ' HA ' ' B' ' 115' ' ' VAL . 1.5 mtp -66.84 -59.12 3.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.401 ' OE1' ' HE3' ' A' ' 18' ' ' MET . 30.3 mt-10 -41.42 -47.79 3.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.413 ' CZ ' HD12 ' B' ' 124' ' ' LEU . 60.0 t80 -67.76 -30.33 69.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.997 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -71.7 -38.54 70.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.997 HD21 ' CH2' ' B' ' 121' ' ' TRP . 31.9 mt -64.24 -60.79 2.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.604 ' O ' HD12 ' B' ' 127' ' ' ILE . 6.3 mt -52.38 -48.26 65.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.775 HD23 HD12 ' B' ' 128' ' ' LEU . 3.9 tt -64.52 -38.49 91.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' B' ' 129' ' ' ARG . 2.4 t -66.42 -66.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.795 HD12 ' CD1' ' A' ' 26' ' ' ILE . 7.9 mt -52.28 -21.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.702 ' O ' HG23 ' B' ' 131' ' ' VAL . 8.7 mt -79.59 -50.03 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.775 HD12 HD23 ' B' ' 124' ' ' LEU . 9.3 mt -66.36 -50.26 64.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.565 ' HD2' HG13 ' B' ' 125' ' ' VAL . 27.6 mtp85 -58.07 -53.1 62.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.961 HG22 HH22 ' A' ' 33' ' ' ARG . 22.2 m -59.2 -48.64 80.86 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.702 HG23 ' O ' ' B' ' 127' ' ' ILE . 4.6 t -45.09 -42.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.445 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 27.4 mtmt -77.15 -33.4 56.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.973 HH22 HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -55.16 -29.78 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.663 ' N ' ' HD3' ' B' ' 133' ' ' ARG . . . -75.32 -50.74 15.07 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -50.13 -66.1 0.45 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 170.55 74.7 0.04 OUTLIER Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HG2' HD12 ' A' ' 5' ' ' LEU . 15.6 ttmt -50.99 -21.71 1.91 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.5 m -50.54 -47.24 57.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -47.84 -58.13 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.013 ' HA ' HD12 ' A' ' 8' ' ' ILE . 9.1 mt -49.41 -53.85 20.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -43.97 -44.12 7.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.942 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.8 mt -72.16 -41.79 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.046 HG22 ' CG2' ' B' ' 108' ' ' ILE . 49.8 mt -54.1 -33.23 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.969 HG13 HD13 ' B' ' 108' ' ' ILE . 3.9 mt -74.61 -56.42 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 10' ' ' LEU . 42.5 mt -51.26 -48.74 62.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 7' ' ' ILE . 17.4 t -56.92 -48.31 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.9 mt-10 -47.75 -51.25 22.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -53.3 -60.13 3.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -56.84 -26.35 58.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.786 HG11 HG21 ' B' ' 115' ' ' VAL . 1.2 t -69.82 -63.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.697 HD12 HG12 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -43.46 -38.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.36 -29.29 59.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.825 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 3.2 mtp -63.54 -54.23 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.58 ' OE1' ' HE2' ' B' ' 118' ' ' MET . 23.7 mt-10 -59.91 -46.44 89.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.86 -64.32 0.87 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.825 ' CD1' ' HA ' ' A' ' 18' ' ' MET . 0.6 OUTLIER -57.43 -37.56 72.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.506 ' CD2' HD11 ' B' ' 123' ' ' LEU . 12.4 mt -55.5 -61.63 2.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 mt -59.42 -51.14 71.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -41.57 62.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -69.51 -66.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.647 HG22 HG22 ' B' ' 126' ' ' ILE . 4.8 mt -50.83 -20.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.713 ' O ' HG23 ' A' ' 31' ' ' VAL . 18.1 mt -81.22 -49.39 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.18 -48.33 73.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 25' ' ' VAL . 15.9 mtp-105 -60.78 -52.52 64.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 7.6 m -57.31 -51.58 68.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 27' ' ' ILE . 19.5 t -44.64 -47.62 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.526 ' HA ' ' ND2' ' A' ' 35' ' ' ASN . 69.0 mttt -68.16 -34.01 75.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' B' ' 133' ' ' ARG . 0.0 OUTLIER -52.44 -32.41 39.27 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -62.12 -35.94 80.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 32' ' ' LYS . 4.7 p30 -100.72 -2.08 33.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.41 -66.16 2.39 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.428 ' HG2' HD12 ' B' ' 105' ' ' LEU . 15.6 ttmt -52.03 -21.8 3.47 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 36.0 m -50.27 -47.38 55.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -47.67 -58.16 4.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.028 ' HA ' HD12 ' B' ' 108' ' ' ILE . 8.8 mt -49.55 -53.91 21.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -43.87 -44.16 6.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.94 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -72.15 -41.89 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.046 ' CG2' HG22 ' A' ' 8' ' ' ILE . 49.0 mt -54.06 -33.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.989 HG13 HD13 ' A' ' 8' ' ' ILE . 3.9 mt -74.54 -56.4 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' B' ' 110' ' ' LEU . 42.4 mt -51.38 -48.85 62.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.94 HG23 ' O ' ' B' ' 107' ' ' ILE . 17.5 t -56.68 -48.41 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 1.9 mt-10 -47.77 -51.37 22.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -53.1 -60.12 3.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -56.85 -26.35 58.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 15' ' ' VAL . 1.2 t -69.92 -63.31 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.682 ' N ' HG12 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -43.55 -38.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.4 59.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.828 ' HA ' ' CD1' ' B' ' 121' ' ' TRP . 3.2 mtp -63.46 -54.02 43.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.585 ' OE1' ' HE2' ' A' ' 18' ' ' MET . 23.8 mt-10 -60.09 -46.56 89.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -53.77 -64.17 0.91 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.828 ' CD1' ' HA ' ' B' ' 118' ' ' MET . 0.6 OUTLIER -57.47 -37.63 73.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.498 HD23 ' CH2' ' B' ' 121' ' ' TRP . 12.4 mt -55.51 -61.49 2.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.594 ' C ' HD12 ' B' ' 127' ' ' ILE . 8.6 mt -59.57 -51.09 71.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -41.41 62.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.607 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.2 t -69.67 -66.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.647 HG22 HG22 ' A' ' 26' ' ' ILE . 4.9 mt -50.81 -21.04 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.714 ' O ' HG23 ' B' ' 131' ' ' VAL . 18.6 mt -81.21 -49.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.1 mt -64.98 -48.24 74.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.586 ' HD2' HG13 ' B' ' 125' ' ' VAL . 16.0 mtp-105 -60.92 -52.71 63.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 126' ' ' ILE . 7.5 m -57.12 -51.5 69.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 127' ' ' ILE . 20.3 t -44.56 -47.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.516 ' HA ' ' ND2' ' B' ' 135' ' ' ASN . 69.2 mttt -68.59 -33.57 74.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.593 ' CD ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -52.79 -32.71 45.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' B' ' 133' ' ' ARG . . . -61.8 -35.71 78.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' B' ' 132' ' ' LYS . 4.6 p30 -101.27 -2.42 31.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -49.81 -66.14 2.47 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.622 ' HG3' HD12 ' A' ' 5' ' ' LEU . 4.9 ttpm? -62.31 -21.4 65.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 m -49.61 -52.22 31.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.15 -58.11 3.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.043 ' HA ' HD12 ' A' ' 8' ' ' ILE . 8.7 mt -51.62 -54.12 31.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.74 -40.3 4.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.899 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.8 mt -76.68 -41.01 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.043 HD12 ' HA ' ' A' ' 5' ' ' LEU . 46.4 mt -54.05 -35.06 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.776 HG12 HG21 ' B' ' 108' ' ' ILE . 1.6 mt -75.54 -56.53 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 10' ' ' LEU . 20.0 mt -49.57 -45.53 47.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 7' ' ' ILE . 23.2 t -61.22 -47.51 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' B' ' 112' ' ' GLU . 2.6 mt-10 -47.61 -47.84 28.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -58.07 -59.92 4.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 18' ' ' MET . . . -55.23 -28.26 51.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.813 HG12 HD12 ' A' ' 16' ' ' ILE . 1.4 t -64.61 -65.91 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.813 HD12 HG12 ' A' ' 15' ' ' VAL . 1.1 mp -43.0 -42.35 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.39 80.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.701 ' HE2' ' HA ' ' A' ' 15' ' ' VAL . 1.6 mtp -66.66 -60.14 2.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 30.3 mt-10 -41.2 -47.97 3.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 17.1 t80 -66.37 -31.59 72.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.976 ' CH2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -71.0 -41.86 70.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.976 HD21 ' CH2' ' A' ' 21' ' ' TRP . 24.5 mt -59.75 -60.15 4.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.2 mt -53.34 -54.78 31.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.751 HD23 HD12 ' A' ' 28' ' ' LEU . 2.6 tt -56.26 -41.33 75.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 26' ' ' ILE . 2.2 t -63.39 -66.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.763 ' CD1' HD12 ' B' ' 126' ' ' ILE . 4.7 mt -54.69 -22.15 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.716 HD12 ' C ' ' A' ' 23' ' ' LEU . 11.6 mt -78.28 -43.54 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.751 HD12 HD23 ' A' ' 24' ' ' LEU . 10.1 mt -72.19 -52.71 15.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' HD2' HG13 ' A' ' 25' ' ' VAL . 12.7 mtp180 -55.98 -46.98 78.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.582 HG22 ' CZ ' ' B' ' 133' ' ' ARG . 16.6 m -64.48 -54.98 23.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 27' ' ' ILE . 7.5 t -44.2 -34.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -79.89 -33.59 39.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -53.53 -23.41 10.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' HB2' ' NH2' ' B' ' 133' ' ' ARG . . . -81.25 -29.26 34.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -81.17 -50.44 9.59 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.34 38.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.613 ' HG3' HD12 ' B' ' 105' ' ' LEU . 4.9 ttpm? -61.6 -21.71 64.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 18.1 m -49.28 -52.62 26.39 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.98 -58.16 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.043 HD22 ' HB3' ' A' ' 5' ' ' LEU . 9.0 mt -51.7 -54.09 32.02 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -43.72 -40.28 4.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.917 ' O ' HG23 ' B' ' 111' ' ' VAL . 16.6 mt -76.74 -41.03 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 1.028 HG22 ' CG2' ' A' ' 8' ' ' ILE . 44.8 mt -54.13 -34.99 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.763 HG12 HG21 ' A' ' 8' ' ' ILE . 1.6 mt -75.61 -56.32 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' B' ' 110' ' ' LEU . 19.8 mt -49.64 -45.66 48.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.917 HG23 ' O ' ' B' ' 107' ' ' ILE . 22.0 t -61.11 -47.69 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.492 ' HG2' ' HG2' ' A' ' 12' ' ' GLU . 2.6 mt-10 -47.39 -47.85 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -58.09 -60.06 4.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' B' ' 118' ' ' MET . . . -55.17 -28.1 50.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.789 HG12 HD12 ' B' ' 116' ' ' ILE . 1.3 t -64.81 -65.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.789 HD12 HG12 ' B' ' 115' ' ' VAL . 1.1 mp -42.99 -42.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.39 80.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.655 ' CE ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 mtp -66.43 -60.46 2.73 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.445 ' OE1' ' CG1' ' B' ' 115' ' ' VAL . 29.5 mt-10 -41.12 -48.2 3.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 17.3 t80 -66.11 -31.66 72.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.972 ' CH2' HD21 ' B' ' 122' ' ' LEU . 0.0 OUTLIER -70.9 -41.95 70.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.972 HD21 ' CH2' ' B' ' 121' ' ' TRP . 25.4 mt -59.8 -60.13 4.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.679 ' C ' HD12 ' B' ' 127' ' ' ILE . 5.2 mt -53.22 -54.96 28.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.757 HD23 HD12 ' B' ' 128' ' ' LEU . 2.5 tt -56.42 -40.72 75.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.604 HG12 ' N ' ' B' ' 126' ' ' ILE . 2.3 t -63.95 -66.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.763 HD12 ' CD1' ' A' ' 26' ' ' ILE . 4.7 mt -54.39 -23.57 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.737 ' O ' HG23 ' B' ' 131' ' ' VAL . 12.9 mt -76.68 -45.52 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.757 HD12 HD23 ' B' ' 124' ' ' LEU . 10.0 mt -70.53 -54.49 11.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.501 ' HD2' HG13 ' B' ' 125' ' ' VAL . 12.6 mtp180 -53.55 -45.37 69.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' B' ' 133' ' ' ARG . 21.2 m -68.02 -50.64 54.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 127' ' ' ILE . 3.8 t -42.98 -35.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -87.96 -27.94 21.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.582 ' CZ ' HG22 ' A' ' 30' ' ' THR . 0.2 OUTLIER -63.68 -23.12 67.24 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.79 -28.96 32.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -78.54 -50.3 11.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 158.71 38.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.962 . . . . . . . . 0 0 . 1 stop_ save_